
    
<!DOCTYPE html>




<html lang="en" >
<head >
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">

    <!-- Mobile properties -->
    <meta name="HandheldFriendly" content="True">
    <meta name="MobileOptimized" content="320">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">

  
    <!-- Stylesheets -->
    <link rel="stylesheet" href="/pmc/static/CACHE/css/output.04fe9e55f2b2.css" type="text/css">
  
  <link rel="stylesheet" href="/pmc/static/CACHE/css/output.aafaa535cb7f.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.ca6dfa7b90b5.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.3766d7ad0d2d.css" type="text/css"><link rel="stylesheet" href="/pmc/static/CACHE/css/output.e3c3c2c84eb3.css" type="text/css">

  
    <link rel="stylesheet" href="https://maxcdn.bootstrapcdn.com/font-awesome/4.7.0/css/font-awesome.min.css"/>
  
<link type="text/css" href="/pmc/static/bundles/base/base.a2ef7ca69e4b20dff539.css" rel="stylesheet" />


    <link rel="stylesheet" href="/corehtml/pmc/css/fonts/stix/stixfonts.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.18/pmcrefs1.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/pmc2020_1.1/ncbi_web.min.css?_=a" type="text/css" /><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-journal.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style>

    <link type="text/css" href="/pmc/static/bundles/article/article.3c5d12ff2e4beea20136.css" rel="stylesheet" />
    <link type="text/css" href="/pmc/static/django_pmc_cite_box/lib/cite-box.css" rel="stylesheet" />


    <title>Cholesterol metabolism: from lipidomics to immunology - PMC</title>

  
  <!-- Favicons -->
  <link rel="shortcut icon" type="image/ico" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.ico" />
  <link rel="icon" type="image/png" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon.png" />

  <!-- 192x192, as recommended for Android
  http://updates.html5rocks.com/2014/11/Support-for-theme-color-in-Chrome-39-for-Android
  -->
  <link rel="icon" type="image/png" sizes="192x192" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png" />

  <!-- 57x57 (precomposed) for iPhone 3GS, pre-2011 iPod Touch and older Android devices -->
  <link rel="apple-touch-icon-precomposed" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-57.png">
  <!-- 72x72 (precomposed) for 1st generation iPad, iPad 2 and iPad mini -->
  <link rel="apple-touch-icon-precomposed" sizes="72x72" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-72.png">
  <!-- 114x114 (precomposed) for iPhone 4, 4S, 5 and post-2011 iPod Touch -->
  <link rel="apple-touch-icon-precomposed" sizes="114x114" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-114.png">
  <!-- 144x144 (precomposed) for iPad 3rd and 4th generation -->
  <link rel="apple-touch-icon-precomposed" sizes="144x144" href="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-144.png">



    
        <!-- Logging params: Pinger defaults -->

<meta name="ncbi_app" content="pmc-frontend" />

<meta name="ncbi_db" content="pmc" />

<meta name="ncbi_phid" content="939B05DA97DE58650000372464BD8DAC.1.m_2" />


        <!-- Logging params: Pinger custom -->

<meta name="ncbi_pdid" content="article" />

<meta name="ncbi_op" content="retrieved" />

<meta name="ncbi_app_version" content="1.6.0.post2+24fead6" />

<meta name="ncbi_domain" content="jlr" />

<meta name="ncbi_type" content="fulltext" />

<meta name="ncbi_pcid" content="/articles/PMC8953665/" />


    


    <script>
        
            var ncbiBaseUrl = "https://www.ncbi.nlm.nih.gov";
        
        var useOfficialGovtHeader = true;
    </script>


    <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953665/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Lipid Research" /><meta name="citation_title" content="Cholesterol metabolism: from lipidomics to immunology" /><meta name="citation_author" content="William J. Griffiths" /><meta name="citation_author" content="Yuqin Wang" /><meta name="citation_publication_date" content="2022/02" /><meta name="citation_issue" content="2" /><meta name="citation_volume" content="63" /><meta name="citation_doi" content="10.1016/j.jlr.2021.100165" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC8953665/?report=abstract" /><meta name="citation_fulltext_html_url" content="/pmc/articles/PMC8953665/" /><meta name="citation_pmid" content="34953867" /><meta name="DC.Title" content="Cholesterol metabolism: from lipidomics to immunology" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="American Society for Biochemistry and Molecular Biology" /><meta name="DC.Contributor" content="William J. Griffiths" /><meta name="DC.Contributor" content="Yuqin Wang" /><meta name="DC.Date" content="2022 Feb" /><meta name="DC.Identifier" content="10.1016/j.jlr.2021.100165" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Cholesterol metabolism: from lipidomics to immunology" /><meta property="og:type" content="article" /><meta property="og:description" content="Oxysterols, the oxidized forms of cholesterol or of its precursors, are formed in the first steps of cholesterol metabolism. Oxysterols have interested chemists, biologists, and physicians for many decades, but their exact biological relevance in&#x000a0;vivo, ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953665/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-card-share.jpg?_=0" /><meta name="twitter:card" content="summary_large_image" /><meta name="twitter:site" content="@ncbi" /><meta name="ncbi_feature" content="associated_data" />


</head>
<body >

   
    
        <button
          class="back-to-top back-to-top--bottom"
          data-ga-category="pagination"
          data-ga-action="back_to_top">
          Back to Top
        </button>
    

    <a class="usa-skipnav" href="#main-content">Skip to main content</a>
    <!-- ========== BEGIN HEADER ========== -->
<section class="usa-banner" style="display: none;">
  <div class="usa-accordion">
    <header class="usa-banner-header">
      <div class="usa-grid usa-banner-inner">
        <img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
        <p>An official website of the United States government</p>
        <button
          class="usa-accordion-button usa-banner-button"
          aria-expanded="false"
          aria-controls="gov-banner-top"
        >
          <span class="usa-banner-button-text">Here's how you know</span>
        </button>
      </div>
    </header>
    <div
      class="usa-banner-content usa-grid usa-accordion-content"
      id="gov-banner-top"
    >
      <div class="usa-banner-guidance-gov usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg"
          alt="Dot gov"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The .gov means it’s official.</strong>
            <br />
            Federal government websites often end in .gov or .mil. Before
            sharing sensitive information, make sure you’re on a federal
            government site.
          </p>
        </div>
      </div>
      <div class="usa-banner-guidance-ssl usa-width-one-half">
        <img
          class="usa-banner-icon usa-media_block-img"
          src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg"
          alt="Https"
        />
        <div class="usa-media_block-body">
          <p>
            <strong>The site is secure.</strong>
            <br />
            The <strong>https://</strong> ensures that you are connecting to the
            official website and that any information you provide is encrypted
            and transmitted securely.
          </p>
        </div>
      </div>
    </div>
  </div>
</section>
<div class="usa-overlay"></div>
<header class="ncbi-header" role="banner" data-section="Header">

	<div class="usa-grid">
		<div class="usa-width-one-whole">

            <div class="ncbi-header__logo">
                <a href="https://www.ncbi.nlm.nih.gov/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
                  <img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
                </a>
            </div>

			<div class="ncbi-header__account">
				<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
				<button id="account_info" class="header-button" style="display:none"
						aria-controls="account_popup">
					<span class="fa fa-user" aria-hidden="true"></span>
					<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
					<span class="sr-only">Show account info</span>
				</button>
			</div>

			<div class="ncbi-popup-anchor">
				<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
					<div class="ncbi-popup-head">
						<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu"><span class="fa fa-times"></span><span class="usa-sr-only">Close</span></button>
						<h4>Account</h4>
					</div>
					<div class="account-user-info">
						Logged in as:<br/>
						<b><span class="username" id="uname_long">username</span></b>
					</div>
					<div class="account-links">
						<ul class="usa-unstyled-list">
							<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
							<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
							<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
							<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
						</ul>
					</div>
				</div>
			</div>

		</div>
	</div>
</header>
<div role="navigation" aria-label="access keys">
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
</div>
<section data-section="Alerts">
	<div class="ncbi-alerts-placeholder"></div>
</section>
<!-- ========== END HEADER ========== -->

    
    
        
        <header class="pmc-header usa-header-extended" role="banner">
    <div class="pmc-header__bar">
        <div class="pmc-header__control usa-accordion">
            
                <button class="usa-menu-btn pmc-header--button pmc-header--left">
                    <i class="fa fa-ellipsis-v" aria-hidden="true"></i>
                </button>
            

            <div class="usa-logo pmc-header__logo pmc-header--stretch
                
               " id="extended-mega-logo">
                <div class="usa-logo-text">
                    <a href="/pmc/" title="Home" aria-label="Home" ></a>
                </div>
            </div>
            <button class="usa-accordion-button pmc-header--right pmc-header--button pmc-header__search--control pmc-header--right" aria-expanded="false" aria-controls="a1">
                <i class="fa fa-search" aria-hidden="true"></i>
                <i class="fa fa-times" aria-hidden="true"></i>
            </button>
        </div>
        <div class="pmc-header__search usa-accordion-content" id="a1">
            <div role="search"  class="pmc-header--stretch"  >
    <form class="usa-search " autocomplete="off">
        <div>
              <label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
              <span class="clearable">
                <input
                  required="required"
                  autocomplete-url="/pmc/autocomplete/pmc/"
                  placeholder="Search PMC Full-Text Archive"
                  id="pmc-search" type="search" name="term"/>
                  <i class="clear-btn" ></i>
              </span>
              <button type="submit" formaction="/pmc/">
                <span class="usa-search-submit-text">Search in PMC</span>
              </button>
        </div>
    </form>
</div>


            <ul class="usa-unstyled-list usa-nav-secondary-links pmc-header--offset-two">
                    <li>
                        <a href="https://www.ncbi.nlm.nih.gov/pmc/advanced" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        <a  href="/pmc/about/userguide/" data-ga-action="featured_link"
                        data-ga-label="user guide">
                            User Guide
                        </a>
                    </li>
            </ul>
        </div>
    </div>
     <nav role="navigation" class="usa-nav ">
        <button class="usa-nav-close">
            <i class="fa fa-times" aria-hidden="true"></i>
        </button>
        <div class="usa-breadcrumb usa-breadcrumb--wrap usa-breadcrumb--hack">
             
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/568/">J Lipid Res</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/403962/">v.63(2); 2022 Feb</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8953665
                </li>
            
    </ul>
 

        </div>
        
        
            <div class="pmc-sidebar pmc-sidebar-hack">
                

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8953665/pdf/main.pdf" class="int-view">PDF (1.9M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8953665/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8953665/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8953665" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8953665%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="DF653QqqEB4boJpTnkCaqE0Jowe5i0cF5qhVp28FBS5iiBfistRfoTENoaF7Y5cg">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-header "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-header ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-header "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-header ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8953665%2F&amp;text=Cholesterol%20metabolism%3A%20from%20lipidomics%20to%20immunology" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8953665%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953665/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8953665/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/34953867/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-header" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8953665/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/34953867/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-header"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8953665/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-header"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8953665/" class="usa-accordion-content" id="links-accordion-header" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>
            </div>
        

    </nav>

</header>

    
    

    <div class="usa-overlay"></div>
    
<main id="main-content" class="usa-grid usa-layout-docs pmc-main">
    <article class="usa-width-three-fourths usa-layout-docs-main_content pmc-article">
        <section class="usa-breadcrumb usa-breadcrumb--wrap">
         
    <ul class="usa-breadcrumb__list">
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a href="/pmc/journals/" class="navlink">Journal List</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/journals/568/">J Lipid Res</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                    >
                    <a class="navlink" href="/pmc/issues/403962/">v.63(2); 2022 Feb</a>
                </li>
            
                <li class="usa-breadcrumb__list-item"
                     aria-current="page" >
                    PMC8953665
                </li>
            
    </ul>
 

        </section>
        
  <div class="pmc-article__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/pmc/about/disclaimer/">PMC Disclaimer</a>
    |
    <a data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/pmc/about/copyright/">
        PMC Copyright Notice
    </a>
</div>

        <section class="pmc-page-banner" role="banner">
            
                
                    <div><img src="/corehtml/pmc/pmcgifs/logo-jlr.png" alt="Logo of jlr" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area target="pmc_ext" rel="noopener noreferrer" shape="rect" coords="0,0,500,75" alt="Journal of Lipid Research" title="Journal of Lipid Research" href="http://www.jlr.org" ref="reftype=publisher&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> 
                
            
        </section>
        <section  role="document">
            
                <div id="mc" class=" article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden,.nomenu'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-flexbox"><div class="fm-citation"><div class="citation-default"><div class="part1"><span id="pmcmata">J Lipid Res.</span> 2022 Feb; 63(2): 100165. </div><div class="part2"><span class="fm-vol-iss-date">Published online 2021 Dec 22. </span>  <span class="doi"><span>doi: </span><a href="//doi.org/10.1016%2Fj.jlr.2021.100165" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1016/j.jlr.2021.100165</a></span></div></div></div><div class="fm-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC8953665</span></div><div class="fm-citation-pmid">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34953867">34953867</a></div></div></div><h1 class="content-title">Cholesterol metabolism: from lipidomics to immunology</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Griffiths%20WJ%5BAuthor%5D" id="au1">William J. Griffiths</a><sup>&#x02217;</sup> and  <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang%20Y%5BAuthor%5D" id="au2">Yuqin Wang</a><sup>&#x02217;</sup></div><div style="display:none" class="contrib-group aff-tip"></div></div><div class="half_rhythm"><div class="togglers fm-copyright-license"><a href="#" class="pmctoggle" rid="idm139816983323664_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139816983323664_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139816983323664_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/" style="margin-left: 1em">PMC Disclaimer</a></div><div class="fm-authors-info hide half_rhythm" id="idm139816983323664_ai" style="display:none"><div class="fm-affl" id="aff1">Swansea University Medical School, Swansea, Wales, United Kingdom</div><div><span class="contrib-email" id="au1">William J. Griffiths: <a href="mailto:dev@null" data-email="ku.ca.aesnaws@shtiffirg.j.w" class="oemail">ku.ca.aesnaws@shtiffirg.j.w</a>; </span> <span class="contrib-email" id="au2">Yuqin Wang: <a href="mailto:dev@null" data-email="ku.ca.aesnaws@gnaw.y" class="oemail">ku.ca.aesnaws@gnaw.y</a></span> </div><div id="cor1"><sup>&#x02217;</sup>For correspondence: William J. Griffiths; Yuqin Wang <a href="mailto:dev@null" data-email="ku.ca.aesnaws@shtiffirg.j.w" class="oemail">ku.ca.aesnaws@shtiffirg.j.w</a><span style="unicode-bidi:bidi-override">, </span><a href="mailto:dev@null" data-email="ku.ca.aesnaws@gnaw.y" class="oemail">ku.ca.aesnaws@gnaw.y</a></div></div><div class="fm-article-notes hide half_rhythm" id="idm139816983323664_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2021 Oct 26; Revised 2021 Dec 10</div></div><div class="permissions half_rhythm hide" id="idm139816983323664_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; 2021 The Authors</div><div class="license half_rhythm">This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm hidden" role="complementary" aria-label="Related or updated information about this article."></div></div><div class="sec"></div><div id="ass-data" class="tsec fm-sec whole_rhythm" data-section="Featured_PMC_Datacitation"><h2 class="nomenu">Associated Data</h2><dl data-count="1" class="box-data-suppmats whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-suppmats" data-ga-action="click_feat_toggler" data-ga-label="Supplementary Materials" class="pmctoggle">Supplementary Materials</a></dt><dd id="data-suppmats" style="display: none;"><div class="half_rhythm"><div class="caption half_rhythm no_bottom_margin">Supplemental Figures&#x000a0;S1&#x02013;S3</div><div><a href="/pmc/articles/PMC8953665/bin/mmc1.pptx" data-ga-action="click_feat_suppl">mmc1.pptx</a><span style="color:gray"> (641K)</span></div><div class="small guid">GUID: 7F7BD976-1EEB-448A-8669-35395E2B8BA9</div></div></dd></dl><dl data-length="42" class="box-data-avail whole_rhythm no_bottom_margin"><dt><a href="#" rid="data-avl-stmnt" data-ga-action="click_feat_toggler" data-ga-label="Data Availability Statement" class="pmctoggle">Data Availability Statement</a></dt><dd id="data-avl-stmnt" style="display: none;"><p class="p p-first-last">All data are contained within the article.</p></dd></dl></div><div id="abs0010" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0010title">Abstract</h2><!--article-meta--><div><p class="p p-first-last">Oxysterols, the oxidized forms of cholesterol or of its precursors, are formed in the first steps of cholesterol metabolism. Oxysterols have interested chemists, biologists, and physicians for many decades, but their exact biological relevance in&#x000a0;vivo, other than as intermediates in bile acid biosynthesis, has long been debated. However, in the first quarter of this century, a role for side-chain oxysterols and their C-7 oxidized metabolites has been convincingly established in the immune system. 25-Hydroxycholesterol has been shown to be synthesized by macrophages in response to the activation of Toll-like receptors and to offer protection against microbial pathogens, whereas 7&#x003b1;,25-dihydroxycholesterol has been shown to act as a chemoattractant to lymphocytes expressing the G protein-coupled receptor Epstein-Barr virus-induced gene 2 and to be important in coordinating the action of B cells, T cells, and dendritic cells in secondary lymphoid tissue. There is a growing body of evidence that not only these two oxysterols but also many of their isomers are of importance to the proper function of the immune system. Here, we review recent findings related to the roles of oxysterols in immunology.</p></div><div class="sec"><strong class="kwd-title">Supplementary key words: </strong><span class="kwd-text">oxysterol, hydroxycholesterol, accessible cholesterol, macrophage, B cell, T cell, dendritic cell, virus, bacterial infection, membrane fusion</span></div><div class="sec"><strong class="kwd-title">Abbreviations: </strong><span class="kwd-text">3&#x003b2;,7&#x003b1;-diHCA, 3&#x003b2;,7&#x003b1;-dihydroxycholest-5-en-(25R)26-oic acid, 3&#x003b2;-HCA, 3&#x003b2;-hydroxycholest-5-en-(25R)26-oic acid, 7-DHC, 7-dehydrocholesterol, 7-OC, 7-oxocholesterol, 7&#x003b1;,25-diHC, 7&#x003b1;,25-dihydroxycholesterol, 7&#x003b1;,26-diHC, 7&#x003b1;,26-dihydroxycholesterol, 7&#x003b2;,25-diHC, 7&#x003b2;,25-dihydroxycholesterol, 7&#x003b2;,26-diHC, 7&#x003b2;,26-dihydroxycholesterol, 7&#x003b1;,25-diHCO, 7&#x003b1;,25-dihydroxycholest-4-en-3-one, 7&#x003b1;,26-diHCO, 7&#x003b1;,(25R)26-dihydroxycholest-4-en-3-one, 7&#x003b1;-HC, 7&#x003b1;-hydroxycholesterol, 7&#x003b2;-HC, 7&#x003b2;-hydroxycholesterol, 20S-HC, 20S-hydroxycholesterol, 22R-HC, 22R-hydroxycholesterol, 24S-HC, 24S-hydroxycholesterol, 24S,25-EC, 24S,25-epoxycholesterol, 25-HC, 25-hydroxycholesterol, 26-HC, (25R)26-hydroxycholesterol, ACE2, angiotensin-converting enzyme 2, AID, activation-induced cytidine deaminase, AIM2, absent in melanoma 2, ALO, anthrolysin O, APO, apolipoprotein, BCG, Bacillus Calmette-Gu&#x000e9;rin, BMDM, bone marrow-derived macrophage, CDC, cholesterol-dependent cytolysin, CESD, cholesterol ester storage disease, <em>Ch25h</em>, cholesterol 25-hydroxylase, CNS, central nervous system, COVID-19, coronavirus disease 2019, CSF, cerebrospinal fluid, CYP, cytochrome P450, DC, dendritic cell, DDA, dendrogenin A, DDAB, didodecyldimethylammonium bromide, DHCR7, dehydrocholesterol reductase 7, EAE, experimental autoimmune encephalitis, EBI2, Epstein-Barr virus-induced gene 2, EBP, emopamil binding protein, HEK293T, human embryonic kidney 293T cells, HIV, human immunodeficiency virus, HMGCR, HMG-CoA reductase, HSD, hydroxysteroid dehydrogenase, HSV-1, herpes simplex virus 1, ICZ, itraconazole, IFNAR, IFN&#x003b1; receptor, IgA, immunoglobulin A, IL-2, interleukin 2, INSIG, insulin-induced gene, JAK, Janus kinase, KDO, Kdo2-lipid A, LBD, ligand binding domain, LIPA, lysosomal acid lipase A, LPS, lipopolysaccharide, LXR, liver X receptor, mCMV, mouse cytomegalovirus, mTORC1, mammalian target of rapamycin complex 1, MyD88, myeloid differentiation primary response protein 88, NIH, National Institutes of Health, NLR, nucleotide binding domain and leucine-rich repeat, NLRP3, NOD-, LRR, and pyrin domain-containing protein 3, NPC, Niemann-Pick C, nSREBP-2, the nuclear form of SREBP-2, PFO, perfringolysin O, ROR, retinoic acid-related orphan receptor, ROS, reactive oxygen species, SARS-CoV, severe acute respiratory syndrome coronavirus, SCAP, SREBP cleavage-activating protein, SOAT1, sterol O-acyltransferase 1, SPG5, spastic paraplegia type 5, STAT1, signal transducer and activator of transcription protein 1, TGF-&#x003b2;1, transforming growth factor beta 1, Th, T helper, TLR3, Toll-like receptor 3, TLR4, Toll-like receptor 4, TMPRSS2, transmembrane protease/serine subfamily member 2, TRIF, Toll/IL-1R domain-containing adaptor-inducing IFN&#x003b2;, VSV, vesicular stomatitis Indiana virus</span></div></div><div id="abs0015" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="abs0015title">Graphical abstract</h2><!--article-meta--><div><!--fig ft0--><!--fig @position="anchor" mode=article f4--><!--fig mode="anchored" f5--><div class="fig graphic_only iconblock anchored whole_rhythm" id="undfig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816978717104"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_fx1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is fx1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/fx1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816978717104"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/undfig1/?report=objectonly">Open in a separate window</a></div></div></div></div><div id="body-a.p" class="tsec sec"><h2 class="headless nomenu"></h2><p id="p0010" class="p p-first">Lipidomic studies performed in the last 15 years have revolutionized our understanding of the relationship between cholesterol metabolism and the immune system. In the years 2009&#x02013;2010, Dennis <em>et&#x000a0;al.</em> (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>) reported the biosynthesis of 25-hydroxycholesterol (25-HC, see <a href="#appsec1" rid="appsec1" class=" sec">supplemental data</a> for chemical structures) in macrophages in response to stimulation by Kdo<sub>2</sub>-lipid A (KDO), the active component of lipopolysaccharide (LPS), also known as endotoxin, found on the outer membrane of Gram-negative bacteria, which acts as a Toll-like receptor 4 (TLR4) agonist (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>); Diczfalusy <em>et&#x000a0;al.</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>) found that cholesterol 25-hydroxylase (<em>Ch25h</em>) was strongly upregulated by LPS and that injection of LPS into healthy volunteers increased their plasma 25-HC; whereas Bauman <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) found that treatment of naive B cells with 25-HC (nanomolar) suppressed interleukin 2 (IL-2)-mediated stimulation of B-cell proliferation, repressed activation-induced cytidine deaminase (AID) expression, and suppressed immunoglobulin A (IgA) class switching in B cells. These results demonstrated a mechanism for the negative regulation of the adaptive immune system by the innate immune system in response to bacterial infection (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). Not only is 25-HC generated by macrophages in response to TLR4 ligands but also Park and Scott (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>) showed that <em>Ch25h</em> is upregulated in dendritic cells (DCs), antigen-presenting cells of the immune system, in response to cell surface TLR4 activation by LPS and to intracellular Toll-like receptor 3 (TLR3) ligands. Park and Scott uncovered the pathway for <em>Ch25h</em> regulation to be via the production of type I IFNs and signaling through the IFN&#x003b1; receptor (IFNAR) and the Janus kinase (JAK)/signal transducer and activator of transcription protein 1 (STAT1) pathway. One year later in 2011, studies by Hannedouche <em>et&#x000a0;al.</em> (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>) and Liu <em>et&#x000a0;al.</em> (<a href="#bib6" rid="bib6" class=" bibr popnode">6</a>) identified 7&#x003b1;,25-dihydroxycholesterol (7&#x003b1;,25-diHC) as a chemoattractant for immune cells expressing the G protein-coupled receptor, GPR183, also known as Epstein-Barr virus-induced gene 2 (EBI2). They showed that 7&#x003b1;,25-diHC is required to position activated B cells within the spleen to the outer regions of follicles, and its absence leads to reduced plasma cell response after immune challenge demonstrating a role for 7&#x003b1;,25-diHC in the adaptive immune response (<a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A) (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>). See Ref.&#x000a0;(<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>) for an excellent description of the link between GPR183 and B cells.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig1" co-legend-rid="lgnd_fig1"><a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816961598832"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr1.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr1.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816961598832"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig1"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" rid-figpopup="fig1" rid-ob="ob-fig1">Fig.&#x000a0;1</a></div><!--caption a7--><div class="caption"><p>Pathway map summarizing the involvement of 25-HC in the immune response. The involvement of 26-HC in some of the pathways is also shown. Blue arrows signify a &#x0201c;process,&#x0201d; red arrows a chemical reaction, &#x003a4; signifies inhibition of a process, black arrows indicate transport, arrows with a diamond arrowhead indicate activation of a receptor, and green oval arrowheads indicate catalysis. Oxysterols are on a light green background, enzymes are on a dark green background, nuclear receptors are on a purple background, ILs on a dark salmon background, and end processes on a light salmon background. See <a href="#appsec1" rid="appsec1" class=" sec">supplemental data</a> for oxysterol structures.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig2" co-legend-rid="lgnd_fig2"><a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816986587904"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr2.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr2.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816986587904"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig2"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" rid-figpopup="fig2" rid-ob="ob-fig2">Fig.&#x000a0;2</a></div><!--caption a7--><div class="caption"><p>Pathway map detailing the biosynthesis and metabolism of (A) 7&#x003b1;,25-diHC and (B) 7&#x003b1;,(25R)26-diHC and 7&#x003b1;,(25S)26-diHC. 7&#x003b1;,25-diHC and 7&#x003b1;,(25R)26-diHC are ligands toward GPR183 (shown on a <em>dark gray</em> background) as indicated by a diamond arrowhead; other symbols are as in <a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>. Proposed but unproven enzymes are underlined. Abbreviations for sterols are given in the text.</p></div></div></div><p id="p0015" class="p">Dennis <em>et&#x000a0;al</em>. (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>), Diczfalusy <em>et&#x000a0;al</em>. (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>), Bauman <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>), and Park and Scott (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>) demonstrated the enhanced expression of CH25H in immune cells in response to bacterial infection, whereas two articles published in 2013 further established <em>Ch25h</em> as an IFN-stimulated gene and its product 25-HC to be antiviral against a broad range of enveloped viruses (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>, <a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). In combination, these two studies indicate that 25-HC blocks membrane fusion between the virus and the host cell, ultimately inhibiting viral growth. The exact mechanism is likely to vary from virus to virus and cell to cell, but there is good evidence that it involves inhibition of the processing of SREBP-2 to its active form as a transcription factor for genes of the cholesterol biosynthesis pathway and uptake (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>, <a href="#bib10" rid="bib10" class=" bibr popnode">10</a>). More recently, the replication of both severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 (coronavirus disease 2019 [COVID-19]) has been found to be suppressed by 25-HC (<a href="#bib11" rid="bib11" class=" bibr popnode">11</a>, <a href="#bib12" rid="bib12" class=" bibr popnode">12</a>, <a href="#bib13" rid="bib13" class=" bibr popnode">13</a>, <a href="#bib14" rid="bib14" class=" bibr popnode">14</a>). The suppression of viral replication is likely to be at viral entry with 25-HC repressing membrane fusion between the viral envelope and the lipid bilayers of the cells (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>, <a href="#bib14" rid="bib14" class=" bibr popnode">14</a>).</p></div><div id="sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="sec1title">Side-chain oxysterols</h2><p id="p0020" class="p p-first">25-HC is one of the best studied cholesterol metabolites; this is on account of its commercial availability and low cost. Unlike most other primary cholesterol metabolites, it is not biosynthesized from cholesterol by a cytochrome P450 (CYP) enzyme but by an enzyme, CH25H, that utilizes a diiron cofactor to catalyze hydroxylation (<a href="#bib15" rid="bib15" class=" bibr popnode">15</a>), although some CYP enzymes also have capacity to introduce a hydroxy group to the sterol side chain at C-25 in a side reaction to their main activity (<a href="#bib16" rid="bib16" class=" bibr popnode">16</a>, <a href="#bib17" rid="bib17" class=" bibr popnode">17</a>, <a href="#bib18" rid="bib18" class=" bibr popnode">18</a>, <a href="#bib19" rid="bib19" class=" bibr popnode">19</a>, <a href="#bib20" rid="bib20" class=" bibr popnode">20</a>). In contrast to its formation, the metabolism of 25-HC has been less well studied, although 7&#x003b1;-hydroxylation by CYP7B1 to give 7&#x003b1;,25-diHC followed by oxidation by hydroxysteroid dehydrogenase (HSD) 3B7&#x000a0;to give 7&#x003b1;,25-dihydroxycholest-4-en-3-one (7&#x003b1;,25-diHCO) is a well-established route (<a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A) (<a href="#bib21" rid="bib21" class=" bibr popnode">21</a>, <a href="#bib22" rid="bib22" class=" bibr popnode">22</a>). It is likely that 7&#x003b1;,25-diHCO is further metabolized to the acid, 7&#x003b1;,25-dihydroxy-3-oxocholest-4-en-26-oic acid (<a href="#bib23" rid="bib23" class=" bibr popnode">23</a>).</p><p id="p0025">25-HC is a ligand to the liver X receptors (LXR&#x003b1;, NR1H3; LXR&#x003b2;, NR1H2) (<a href="#bib24" rid="bib24" class=" bibr popnode">24</a>, <a href="#bib25" rid="bib25" class=" bibr popnode">25</a>, <a href="#bib26" rid="bib26" class=" bibr popnode">26</a>). LXR target genes include <em>i</em>) <em>ABC</em> transporters that are important for cholesterol absorption from the intestine via ABCA1-mediated efflux of cholesterol from enterocytes into the circulation, excretion into the intestine via ABCG5/8-mediated efflux from enterocytes into the intestinal lumen, and for cholesterol efflux from cells in general through ABCA1; <em>ii</em>) apolipoproteins (<em>APO</em>s) coding for APOE, APOC1, APOC2, and APOC4 proteins that transport cholesterol between cells, and <em>iii</em>) <em>IDOL</em> (inducible degrader of the LDL receptor or <em>MYLIP,</em> myosin regulatory light chain-interacting protein), which is important in regulating the uptake of cholesterol by cells (<a href="#bib27" rid="bib27" class=" bibr popnode">27</a>). LXRs are involved in the inflammatory response and in the regulation of the lipid composition of membranes (<a href="#bib27" rid="bib27" class=" bibr popnode">27</a>). Besides 25-HC, other side-chain oxysterols similarly activate LXRs, including 24S,25-epoxycholesterol (24S,25-EC), 20S-hydroxycholesterol (20S-HC), 22R-hydroxycholesterol (22R-HC), 20R,22R-dihydroxycholesterol, 24S-hydroxycholesterol (24S-HC), 24R-hydroxycholesterol, 24-oxocholesterol (24-OC, also known as 24-ketocholesterol), (25R)26-hydroxycholesterol (26-HC, also more commonly known by the nonsystematic name 27-hydroxycholesterol (<a href="#bib28" rid="bib28" class=" bibr popnode">28</a>)), 3&#x003b2;-hydroxycholest-5-en-(25R)26-oic acid (3&#x003b2;-HCA), and 3&#x003b2;,7&#x003b1;-dihydroxycholest-5-en-(25R)26-oic acid (3&#x003b2;,7&#x003b1;-diHCA; <a href="/pmc/articles/PMC8953665/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>A) (<a href="#bib24" rid="bib24" class=" bibr popnode">24</a>, <a href="#bib26" rid="bib26" class=" bibr popnode">26</a>, <a href="#bib29" rid="bib29" class=" bibr popnode">29</a>, <a href="#bib30" rid="bib30" class=" bibr popnode">30</a>, <a href="#bib31" rid="bib31" class=" bibr popnode">31</a>). To avoid unnecessary confusion, the reader can assume in this article that unless stated otherwise, products of C-26 oxidation have 25R stereochemistry. It should be noted that some ring-substituted oxysterols also activate LXRs, for example, dendrogenin A (DDA) (<a href="#bib32" rid="bib32" class=" bibr popnode">32</a>). Besides being an agonist toward LXRs, 25-HC and many related oxysterols inhibit the processing of SREBPs (<a href="#bib33" rid="bib33" class=" bibr popnode">33</a>, <a href="#bib34" rid="bib34" class=" bibr popnode">34</a>). SREBP-1c and SREBP-2 are the major forms of SREBP found in liver, SREBP-1c mainly regulates the expression of enzymes involved in the synthesis of fatty acids, whereas SREBP-2 preferentially regulates the expression of cholesterol biosynthetic genes (<a href="#bib35" rid="bib35" class=" bibr popnode">35</a>). SREBP-2 is synthesized in the endoplasmic reticulum where it binds to the transport protein SREBP cleavage-activating protein (SCAP). The function of SCAP is to transport SREBP-2 to the Golgi for processing to its active form as a transcription factor (the nuclear form of SREBP-2 [nSREBP-2]; <a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>). Insulin-induced gene (INSIG) is an endoplasmic reticulum-resident protein, and 25-HC will bind to INSIG causing a conformational change, which results in the binding of INSIG to SCAP and anchoring of the INSIG-SCAP-SREBP-2 complex in the endoplasmic reticulum, thereby preventing SREBP-2 processing to its active form (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>). 25-HC will also interact with INSIG to activate the proteolysis of HMG-CoA reductase (HMGCR) (<a href="#bib33" rid="bib33" class=" bibr popnode">33</a>, <a href="#bib36" rid="bib36" class=" bibr popnode">36</a>). Cholesterol will also regulate its own synthesis via binding to SCAP, causing a conformational change that will result in SCAP binding to INSIG and similarly anchoring the INSIG-SCAP-SREBP-2 complex in the endoplasmic reticulum (<a href="#bib33" rid="bib33" class=" bibr popnode">33</a>). While cholesterol is the main regulator of its own synthesis, 25-HC and other oxysterols can have acute effects on synthesis.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig3" co-legend-rid="lgnd_fig3"><a href="/pmc/articles/PMC8953665/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816958718496"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr3.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr3.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr3.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816958718496"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig3"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig3/" target="figure" rid-figpopup="fig3" rid-ob="ob-fig3">Fig.&#x000a0;3</a></div><!--caption a7--><div class="caption"><p>Oxysterols act as ligands to (A) LXRs, (B) ROR&#x003b3;, (C) INSIG, and (D) GPR183. Ligand interactions are indicated by a diamond arrowhead, whereas a T signifies inverse agonists.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig4" co-legend-rid="lgnd_fig4"><a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816962251840"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr4.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr4.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr4.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816962251840"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig4"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" rid-figpopup="fig4" rid-ob="ob-fig4">Fig.&#x000a0;4</a></div><!--caption a7--><div class="caption"><p>Summary of the mechanisms of cholesterol uptake, synthesis, and storage and the involvement of oxysterols and of cholesterol in cholesterol regulation. The cell can take up cholesterol esters via lipoprotein receptors, or cholesterol can be synthesized via the mevalonate pathway under SREBP-2 regulation. Excess cholesterol can be stored as cholesterol esters in lipid droplets or exported by ABC transporters onto lipoprotein particles. Symbols are as indicated in <a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Figs.&#x000a0;1</span></a> and <a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and2.</span></span><span>2</span></a>. Cell compartments are color coded, endoplasmic reticulum light blue, Golgi light gray, endosome-lysosomal compartment gray, and nucleus pale yellow.</p></div></div></div><p id="p0030" class="p p-last">There is considerable crosstalk between the LXR and SREBP-2 pathways. Activation of the former by oxysterols will lead to elimination of excess cholesterol from cells via ABCA1-mediated export and reverse cholesterol transport, whereas inhibition of the latter will lead to reduced cholesterol synthesis and uptake. The net result will be a reduction in cellular cholesterol.</p></div><div id="sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="sec2title">Bacterial infection, LPS, and oxysterols</h2><div id="sec2.1" class="sec sec-first-last"><h3 id="sec2.1title">Lipidomics</h3><p id="p0035" class="p p-first">As mentioned previously, LPS acts as a TLR4 agonist. LC-MS lipidomic analysis by Dennis <em>et&#x000a0;al.</em> (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>) of the mouse macrophage RAW264.7 activated by KDO, the active component of LPS, revealed a 3-fold increase in intracellular 25-HC accompanying a 4-fold increase in <em>Ch25h</em> mRNA (<a href="#bib37" rid="bib37" class=" bibr popnode">37</a>). Over the 24 h time course of stimulation, the cellular cholesterol level doubled as did that of 24S,25-EC (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>). The increase in 24S,25-EC is likely to reflect the increased synthesis of cholesterol as the two are generated in parallel pathways (<a href="#bib38" rid="bib38" class=" bibr popnode">38</a>). The increase in cellular cholesterol and 24S,25-EC is likely to involve LPS stimulation of mammalian target of rapamycin complex 1 (mTORC1)-driven activation of the SREBP-2 pathway, as discussed later (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>) (<a href="#bib39" rid="bib39" class=" bibr popnode">39</a>, <a href="#bib40" rid="bib40" class=" bibr popnode">40</a>). In a related study, Baumann <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) found a 100-fold and 200-fold increase in <em>Ch25h</em> mRNA in intraperitoneal macrophages and bone marrow-derived macrophages (BMDMs), respectively, when challenged with KDO. CH25H protein was also elevated, and 25-HC levels secreted into the medium rose to about 65&#x000a0;nM (26&#x000a0;ng/ml) and 500&#x000a0;nM (200&#x000a0;ng/ml) by the peritoneal macrophages and BMDM, respectively, from almost zero (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). Note, no saponification step was performed; hence, these concentrations are for the unesterified sterol. Confusion can arise when sterol concentrations are given and, in this review, values given are for the free unesterified molecule unless stated otherwise. Agonists toward TLR2 and TLR3 were similarly found to stimulate <em>Ch25h</em> expression in intraperitoneal macrophages, and intraperitoneal injection of KDO to mice confirmed the in&#x000a0;vivo induction of <em>Ch25h</em> mRNA with the consequent elevation of 25-HC levels in tissues, whereas incubation of macrophages with LPS derived from <em>Escherichia coli</em> and <em>Salmonella enterica</em> confirmed that bacterial LPS induces <em>Ch25h</em> expression (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>).</p><p id="p0040">What might be the function of 25-HC synthesized by macrophages in response to TLR activation? A clue comes from the increased serum IgA levels in the <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mouse (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). In&#x000a0;vitro experiments showed that treatment of naive B cells with 25-HC (nanomolar) blocked class-switch recombination, suppressing IgA secretion. Class-switch recombination is a process by which B cells change Ig production from one type to another, and as part of the adaptive immune response, B cells switch from producing immunoglobulin M to synthesizing and secreting IgA. The switch can be mediated in a T cell-dependent or T cell-independent mechanism. 25-HC was found to inhibit both T cell-dependent (cytokine mediated) and T cell-independent class-switch recombination. IC<sub>50</sub> (half-maximal inhibitory concentration) for 25-HC-mediated suppression of class-switch recombination was found to be about 50&#x000a0;nM (20&#x000a0;ng/ml), a concentration less than that found in the media of KDO-activated macrophages (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). Interestingly, 26-HC suppressed IgA production after cytokine stimulation of B cells, but other&#x000a0;LXR agonists 24S-HC and 22R-HC did not. Dihydrolanosterol, an intermediate in the Kandustch-Russell pathway of cholesterol biosynthesis, and an inhibitor of cholesterol biosynthesis by blocking both the processing of SREBP-2 to its active form and accelerating the INSIG-induced degradation of HMGCR (<a href="#bib41" rid="bib41" class=" bibr popnode">41</a>), was also inactive in the B-cell assay (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). These results suggest that the suppressive effect of 25-HC toward class-switch recombination is independent of total cellular cholesterol levels.</p><p id="p0045">The mechanism by which 25-HC inhibits IgA production in B cells via macrophage stimulation by LPS in combination with the cytokines IL-5 and transforming growth factor beta 1 (TGF-&#x003b2;1) was found to involve AID, a deaminase involved in the initiation of class-switch recombination. 25-HC blocks the induction of <em>AID</em> mRNA in response to a combination of LPS, IL-5, and TGF-&#x003b2;1 but not by LPS alone (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). A second mechanism by which 25-HC, and also 26-HC, inhibits IgA production in B cells is through reducing proliferation of B cells in response to IL-2 but not to TGF-&#x003b2;1 and IL-5 (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). 25-HC also inhibits class-switch recombination in a T-cell-independent manner, as evidenced by inhibiting the effect of APRIL (a proliferation-inducing ligand), which is released by DCs. Importantly, <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice have high levels of IgA in sera, mucosa, and lungs, whereas <em>Cyp7b1</em><sup>&#x02212;/&#x02212;</sup> mice where 25-HC is high have low levels of IgA in sera, mucosa, and lungs (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>). In summary, the study of Bauman <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) showed that activation of the innate immune system through macrophage TLRs induces CH25H and the production of 25-HC. 25-HC then acts as a suppressor of class-switch recombination in B cells to negatively regulate the adaptive immune system.</p><p id="p0050">At about the same time that Bauman <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) were investigating the effects of LPS on mouse macrophages, Diczfalusy <em>et&#x000a0;al.</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>) found that intravenous injection of LPS into humans increased plasma 25-HC levels, measured as total 25-HC following saponification of sterol esters, doubling about 4&#x000a0;h after injection. During these 4&#x000a0;h, there was no increase in 26-HC. The study performed by Diczfalusy <em>et&#x000a0;al.</em> was aimed initially at identifying genes upregulated by LPS in mouse BMDM. Similar to Dennis <em>et&#x000a0;al.</em> (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>), Diczfalusy <em>et&#x000a0;al.</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>) and Bauman <em>et&#x000a0;al</em>. (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) found that LPS, and also live <em>E.&#x000a0;coli</em>, increased the expression of <em>Ch25h</em> in macrophages. As identified by Bauman <em>et&#x000a0;al</em>., the increase in <em>Ch25h</em> was transitory, reaching a maximum at about 4&#x000a0;h and returning to normal by 12&#x000a0;h after treatment. The involvement of TLR4 in <em>Ch25h</em> induction was confirmed in mice deficient in this gene where induction of <em>Ch25h</em> was severely impaired (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>). Importantly, there was an increase neither in the expression of <em>Cyp27a1</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>), the gene coding the enzyme CYP27A1, which can also produce 25-HC as a byproduct to its major product 26-HC (<a href="#bib20" rid="bib20" class=" bibr popnode">20</a>, <a href="#bib42" rid="bib42" class=" bibr popnode">42</a>) nor <em>Cyp7b1</em> coding CYP7B1, which converts 25-HC to 7&#x003b1;,25-diHC (<a href="#bib21" rid="bib21" class=" bibr popnode">21</a>). In agreement with Bauman <em>et&#x000a0;al</em>. (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>), there was a significant increase in 25-HC production in response to LPS 6&#x000a0;h after treatment, which was maintained at 24&#x000a0;h.</p><p id="p0055">In 2010, Park and Scott (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>) made the important discovery that <em>Ch25h</em> production in macrophages and DCs is regulated by type I IFNs and that <em>Ch25h</em> is an IFN-responsive gene. They found that besides upregulating the expression of <em>Ch25h</em>, agonists of intracellular TLR3 and cell surface TLR4 also induced <em>Ifnb1</em> transcription and proposed a pathway in which activation by TLR3 (poly I:C) and TLR4 (LPS) ligands induces <em>Ch25h</em> through TRIF (Toll/IL-1R domain-containing adaptor-inducing IFN&#x003b2;)- mediated production of type I IFNs and signaling through the IFNAR and the JAK/STAT1 pathway (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). They also found that the type II IFN, IFN&#x003b3;, upregulated <em>Ch25h</em> also through STAT1 (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>). As signaling events initiated by TLRs rely on the adaptor proteins, myeloid differentiation primary response protein 88 (MyD88) and TRIF, Park and Scott made use of <em>Myd88</em><sup>&#x02212;/&#x02212;</sup> and <em>Trif</em><sup>&#x02212;/&#x02212;</sup> mice to investigate <em>Ch25h</em> induction. TLR3 and TLR4 agonists failed to activate <em>Ch25h</em> transcription in bone marrow-derived DCs from <em>Trif</em><sup>&#x02212;/&#x02212;</sup> mice, whereas in DCs from <em>Myd88</em><sup>&#x02212;/&#x02212;</sup> mice, the expression of <em>Ch25h</em> was no different, or only modestly reduced, compared with controls treated with TLR3 and TLR4 agonists. These results suggest that TLR-mediated expression of <em>Ch25h</em> is primarily through a TRIF-mediated rather than a MyD88-mediated mechanism (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>). These data agreed with that from Diczfalusy <em>et&#x000a0;al.</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>) who found that BMDM from the <em>Myd88</em><sup>&#x02212;/&#x02212;</sup> mouse responded toward LPS in a similar manner to controls.</p><p id="p0060">In combination, the studies of Dennis <em>et&#x000a0;al</em>. (<a href="#bib1" rid="bib1" class=" bibr popnode">1</a>), Diczfalusy <em>et&#x000a0;al.</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>), Bauman <em>et&#x000a0;al</em>. (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>), and Park and Scott (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>) indicate that the pathway leading to CH25H expression and 25-HC production in macrophages and DCs consists of TLR3/4 &#x02192; TRIF &#x02192; IFN regulatory factor 3/NF-&#x003ba;B &#x02192; IFN&#x003b2; &#x02192; IFNAR &#x02192; JAK/STAT1 &#x02192; CH25H &#x02192; 25-HC (<a href="#bib43" rid="bib43" class=" bibr popnode">43</a>).</p><p id="p0065" class="p p-last">The immune function of CH25H was soon confirmed by Zou <em>et&#x000a0;al.</em> (<a href="#bib44" rid="bib44" class=" bibr popnode">44</a>) in a study of <em>Listeria monocytogenes</em> infection, whereas Liu <em>et&#x000a0;al.</em> (<a href="#bib45" rid="bib45" class=" bibr popnode">45</a>) showed <em>CH25H</em> to be an IFN-stimulated gene with antiviral activity. Although the study by Bauman <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) indicated class-switch recombination to be LXR independent, Tontonoz <em>et&#x000a0;al.</em> (<a href="#bib46" rid="bib46" class=" bibr popnode">46</a>, <a href="#bib47" rid="bib47" class=" bibr popnode">47</a>) have shown that inflammatory signaling induced by LPS through TLR4 can regulate the expression of LXR target genes, and LXR activation can negatively regulate the expression of inflammatory genes. With respect to the innate immune system, Ecker <em>et&#x000a0;al.</em> (<a href="#bib48" rid="bib48" class=" bibr popnode">48</a>) have shown that 25-HC can suppress the differentiation of monocytes to macrophages. Perhaps, providing a negative feedback mechanism to reduce the number of macrophages generating 25-HC (<a href="#bib43" rid="bib43" class=" bibr popnode">43</a>).</p></div></div><div id="sec3" class="tsec sec"><h2 class="head no_bottom_margin" id="sec3title">Oxysterols, cholesterol, and accessible cholesterol</h2><p id="p0070" class="p p-first">25-HC and other side-chain oxysterols can regulate cellular cholesterol through activating LXR receptors (<a href="#bib24" rid="bib24" class=" bibr popnode">24</a>, <a href="#bib25" rid="bib25" class=" bibr popnode">25</a>, <a href="#bib26" rid="bib26" class=" bibr popnode">26</a>), by interacting with INSIG and repressing SREBP-2 processing (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>), accelerating the degradation of the HMGCR (<a href="#bib36" rid="bib36" class=" bibr popnode">36</a>, <a href="#bib49" rid="bib49" class=" bibr popnode">49</a>) and by stimulating the endoplasmic reticulum enzyme acyl-CoA:cholesterol acyl transferase, also known as sterol O-acyltransferase 1 (SOAT1), to esterify cholesterol (<a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>) (<a href="#bib50" rid="bib50" class=" bibr popnode">50</a>). Such activities are used by cells to regulate or manipulate their plasma membrane cholesterol, the major location of cellular cholesterol. 25-HC and other oxysterols cross membranes at a much faster rate than cholesterol (<a href="#bib51" rid="bib51" class=" bibr popnode">51</a>, <a href="#bib52" rid="bib52" class=" bibr popnode">52</a>, <a href="#bib53" rid="bib53" class=" bibr popnode">53</a>), and for hydroxycholesterols, there appears to be a correlation between the separation of the added hydroxy group from the 3&#x003b2;-hydroxy group and the rate of membrane transit (26 &#x0003e; 24S &#x0003e; 4&#x003b2;) (<a href="#bib52" rid="bib52" class=" bibr popnode">52</a>). This suggests that side-chain oxysterols could have a paracrine activity or an autocrine activity in modulating plasma membrane cholesterol levels.</p><p id="p0075">The plasma membrane contains between 60% and 90% of a cells total cholesterol (<a href="#bib54" rid="bib54" class=" bibr popnode">54</a>, <a href="#bib55" rid="bib55" class=" bibr popnode">55</a>), and plasma membrane cholesterol may make up 40&#x02013;50&#x000a0;mol % of plasma membrane lipids (<a href="#bib54" rid="bib54" class=" bibr popnode">54</a>, <a href="#bib56" rid="bib56" class=" bibr popnode">56</a>); however, INSIG, SCAP, SREBP-2, HMGCR, and SOAT1 are all located in the endoplasmic reticulum, an organelle that contains less than 1% of the cell's cholesterol (<a href="#bib57" rid="bib57" class=" bibr popnode">57</a>) and where cholesterol only makes up 5&#x000a0;mol % of the membrane lipids (<a href="#bib58" rid="bib58" class=" bibr popnode">58</a>). This leads to the question, how might a machinery in the endoplasmic reticulum of a cell sense the cholesterol level of a cell when the majority of its cholesterol is located in the plasma membrane? To answer this question, it is important to remember that under homeostatic conditions, cellular cholesterol regulates its own synthesis and import (<a href="#bib33" rid="bib33" class=" bibr popnode">33</a>). When the cholesterol level in the endoplasmic reticulum exceeds 5&#x000a0;mol % of total lipids, cholesterol binds to SCAP, causing a conformational change that results in SCAP binding to INSIG and tethering the INSIG-SCAP-SREBP-2 complex in endoplasmic reticulum, thereby preventing processing of SREBP-2 in the Golgi to its active form (nSREBP-2) as the master regulator of cholesterol biosynthesis and of the expression of the LDL receptor (<a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>) (<a href="#bib33" rid="bib33" class=" bibr popnode">33</a>). To explain how cholesterol in the plasma membrane can regulate cholesterol biosynthesis and uptake through the machinery located in the endoplasmic reticulum, Das <em>et&#x000a0;al.</em> (<a href="#bib59" rid="bib59" class=" bibr popnode">59</a>) in 2014 introduced the concept of three pools of plasma membrane cholesterol. They proposed that in the plasma membrane, there are three pools of cholesterol: <em>i</em>) a pool of cholesterol that is &#x0201c;accessible&#x0201d; to receptor proteins and to transport to the endoplasmic reticulum, <em>ii</em>) a SM sequestered pool that can be released by sphingomyelinase, and <em>iii</em>) a residual pool of cholesterol essential for plasma membrane integrity. The three pools in cholesterol-replete cells correspond to about 16, 15, and 12&#x000a0;mol % of total plasma membrane lipids, respectively (<a href="#bib59" rid="bib59" class=" bibr popnode">59</a>). When cholesterol in the plasma membrane is in excess following LDL uptake by receptor-mediated endocytosis, ester hydrolysis by lysosomal acid lipase A (LIPA), and transport by Niemann-Pick C (NPC)2 and NPC1 proteins to the lysosome outer leaflet and ultimately by transfer to the plasma membrane, the result is a rise in accessible cholesterol, which is then transported to the endoplasmic reticulum to switch off cholesterol synthesis and expression of the LDL receptor (<a href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>) (<a href="#bib59" rid="bib59" class=" bibr popnode">59</a>). Conversely, statin treatment results in inhibition of cholesterol synthesis, concomitant plasma membrane accessible cholesterol depletion, an overall fall in endoplasmic reticulum cholesterol levels, and switching back on the SREBP-2 pathway. The key to this regulatory process is accessible cholesterol, which through transfer to the endoplasmic reticulum via ASTER (GRAM domain containing 1, GRAMD1) proteins (<a href="#bib60" rid="bib60" class=" bibr popnode">60</a>, <a href="#bib61" rid="bib61" class=" bibr popnode">61</a>, <a href="#bib62" rid="bib62" class=" bibr popnode">62</a>), switches the SREBP-2 pathway off and on (<a href="#bib63" rid="bib63" class=" bibr popnode">63</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig5" co-legend-rid="lgnd_fig5"><a href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816984748336"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr5.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr5.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr5.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816984748336"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig5"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" rid-figpopup="fig5" rid-ob="ob-fig5">Fig.&#x000a0;5</a></div><!--caption a7--><div class="caption"><p>The role of accessible cholesterol in regulating cholesterol synthesis and the role of cholesterol in inflammasome activation. Pharmacological mediators are on a royal blue background, other symbols, and cell compartments are as used in earlier figures. Plasma membrane is in light green, and mitochondria is in mustard.</p></div></div></div><p id="p0080">The idea of accessible cholesterol is derived from studies performed by Lange and Steck (<a href="#bib64" rid="bib64" class=" bibr popnode">64</a>, <a href="#bib65" rid="bib65" class=" bibr popnode">65</a>) in Illinois and Radhakrishnan and McConnell (<a href="#bib66" rid="bib66" class=" bibr popnode">66</a>, <a href="#bib67" rid="bib67" class=" bibr popnode">67</a>) in Stanford. Accessible cholesterol can be considered as a descriptive term for cholesterol molecules with a high thermodynamic chemical activity (<a href="#bib68" rid="bib68" class=" bibr popnode">68</a>). Chemical activity being related to the environment of a compound; in this case, cholesterol in a phospholipid bilayer. Cholesterol complexed with phospholipids (sphingolipids and glycerophospholipids) is in a lower energy environment and has lower chemical activity than uncomplexed free cholesterol, which is in a higher energy environment, and accessible to transport from the plasma membrane (<a href="#bib59" rid="bib59" class=" bibr popnode">59</a>, <a href="#bib66" rid="bib66" class=" bibr popnode">66</a>). In a membrane, cholesterol exists in stoichiometric complexes with sphingolipids, glycerophospholipids, and proteins, and when membrane cholesterol exceeds the binding capacity of these membrane components, this free cholesterol has a high thermodynamic chemical activity and becomes accessible cholesterol (<a href="#bib65" rid="bib65" class=" bibr popnode">65</a>).</p><p id="p0085">Accessible cholesterol is measured through its availability to protein probes, for example, bacterial cholesterol oxidase enzymes (<a href="#bib69" rid="bib69" class=" bibr popnode">69</a>), its extraction by cyclodextrins, for example, methyl-&#x003b2;-cyclodextrin (<a href="#bib66" rid="bib66" class=" bibr popnode">66</a>), and by its binding to bacterial pore-forming toxins, that is, the cholesterol-dependent cytolysins (CDCs), perfringolysin O (PFO) and anthrolysin O (ALO) (<a href="#bib70" rid="bib70" class=" bibr popnode">70</a>, <a href="#bib71" rid="bib71" class=" bibr popnode">71</a>). A mutant form of PFO, PFO&#x02217;, binds to accessible cholesterol but does not form pores at 4&#x000b0;C and is widely exploited to probe for accessible cholesterol (<a href="#bib59" rid="bib59" class=" bibr popnode">59</a>, <a href="#bib63" rid="bib63" class=" bibr popnode">63</a>, <a href="#bib70" rid="bib70" class=" bibr popnode">70</a>), whereas a subdomain of ALO, ALOD4, will bind to accessible cholesterol but not form pores (<a href="#bib71" rid="bib71" class=" bibr popnode">71</a>, <a href="#bib72" rid="bib72" class=" bibr popnode">72</a>). All these methods provide a readout for cholesterol accessibility against increasing cholesterol concentration that is sigmoidal or J shaped, that is, there is little change in cellular accessible cholesterol as cholesterol concentration is increased in the membrane until a threshold or equivalence point is reached, at which point cholesterol accessibility rises sharply (<a href="#bib65" rid="bib65" class=" bibr popnode">65</a>, <a href="#bib68" rid="bib68" class=" bibr popnode">68</a>).</p><p id="p0090" class="p p-last">Side-chain oxysterols can be imagined as an autocrine form or a paracrine form of accessible cholesterol. Like accessible cholesterol, they will provide a signal to repress SREBP-2 processing, but they will cross membranes much faster than cholesterol, so may be likened to &#x0201c;fast-acting&#x0201d; accessible cholesterol.</p></div><div id="sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="sec4title">Oxysterols, pore-forming toxins, and bacterial transmission</h2><p id="p0095" class="p p-first">In 2020, two articles appeared, both of which showed 25-HC to be protective against bacterial infection by depleting accessible cholesterol (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>, <a href="#bib74" rid="bib74" class=" bibr popnode">74</a>, <a href="#bib75" rid="bib75" class=" bibr popnode">75</a>). These findings were supported by a third article published in 2021 demonstrating 26-HC to have a similar bioactivity (<a href="#bib76" rid="bib76" class=" bibr popnode">76</a>).</p><div id="sec4.1" class="sec"><h3 id="sec4.1title">CDCs</h3><p id="p0100" class="p p-first">As discussed previously, modified forms of CDCs, that is, bacterial pore-forming toxins, can be used to monitor accessible cholesterol; however, the native forms induce pore formation and ultimately cell death. However, Zhou <em>et&#x000a0;al.</em> (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>) have shown that macrophages and neutrophiles can reprogram their sterol metabolism to provide resistance to CDC pore formation. CDCs bind to cholesterol in the plasma membrane of the target cell, oligomerize, and create pores resulting in loss of membrane integrity and ultimately cell death. Zhou <em>et&#x000a0;al.</em> (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>) discovered that PFO activation of TLR3 provides protection against pore formation. As discussed previously, activation of TLR3 in macrophages leads to IFN&#x003b2; formation, and both IFN&#x003b2; and IFN&#x003b3; were found to induce resistance to PFO. IFN&#x003b2; and IFN&#x003b3; also provided resistance against the pore-forming toxins streptolysin O and ALO. Both IFNs also protected neutrophils against PFO. Both IFN&#x003b2; and IFN&#x003b3; treatments of macrophages decreased ALOD4 binding (a measure of accessible cholesterol); this linked the protective effects of IFNs to a reduction of plasma membrane accessible cholesterol, although no decrease was found in overall cell cholesterol (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>).</p><p id="p0105">What might be the link between activation of TLR3, IFN, accessible cholesterol, and resistance against CDC pore-forming toxins? As <em>Ch25h</em> is an IFN-stimulated gene (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>, <a href="#bib43" rid="bib43" class=" bibr popnode">43</a>), 25-HC, the product of the translated enzyme, might provide such a link. Zhou <em>et&#x000a0;al.</em> (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>) found that macrophages when treated with 25-HC (3&#x000a0;&#x003bc;M, 1.2&#x000a0;&#x003bc;g/ml, 4&#x000a0;h) showed reduced ALOD4 binding, but when <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages were treated with IFNs, ALOD4 binding was not reduced, and <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages were not protected against PFO or streptolysin O challenge. However, when 25-HC itself was added to <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> or control macrophages, they were protected from PFO challenge. In addition, simvastatin reduced ALOD4 binding to otherwise unstimulated macrophages and protected against CDC-mediated membrane damage. As 25-HC is derived from cholesterol, in combination, these results led to the proposal that endogenous production of cholesterol and its metabolism is involved in macrophage susceptibility to, and protection against, CDCs (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>).</p><p id="p0110">25-HC can reduce cholesterol biosynthesis and uptake by inhibiting SREBP-2 processing (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>), it can activate LXRs and enhance cholesterol export (<a href="#bib26" rid="bib26" class=" bibr popnode">26</a>, <a href="#bib27" rid="bib27" class=" bibr popnode">27</a>, <a href="#bib77" rid="bib77" class=" bibr popnode">77</a>), and mediate cholesterol ester formation (<a href="#bib50" rid="bib50" class=" bibr popnode">50</a>). Using <sup>13</sup>C-isotope tracer studies, IFN&#x003b2; stimulation of control macrophages led to a drastic fall in cholesterol synthesis; in contrast, in <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages, there was only a small although significant attenuation in cholesterol synthesis. Although IFN treatment of <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> does not attenuate ALDO4 binding, addition of simvastatin does, supporting the concept that IFN-mediated protection against CDC is via 25-HC inhibition of cholesterol biosynthesis (<a href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>). <em>Abca1</em> and <em>Abcg1</em> are LXR target genes and code for cholesterol efflux transporters (<a href="#bib27" rid="bib27" class=" bibr popnode">27</a>). However, <em>Abca1</em><sup>&#x02212;/&#x02212;</sup> macrophages are no more susceptible to PFO than control macrophages, and IFN treatment provided similar protection to both genotypes. In addition, ALOD4 binding was found to be similarly reduced in control, <em>Abca1</em><sup>&#x02212;/&#x02212;</sup>, and <em>Abcg1</em><sup>&#x02212;/&#x02212;</sup> macrophages upon IFN treatment (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>). This led to the conclusion that under the experimental conditions employed, protection against PFO conveyed by IFN&#x003b2; and IFN&#x003b3; in mouse BMDM was not dependent on cholesterol efflux. However, the synthetic LXR agonist GW3965 provided protection to control and <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages against PFO challenge and also against ALOD4 binding (a measure of accessible cholesterol), implying that LXR activation might have a support role in protection against CDCs (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig6" co-legend-rid="lgnd_fig6"><a href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816964204000"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr6.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr6.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr6.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816964204000"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig6"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" rid-figpopup="fig6" rid-ob="ob-fig6">Fig.&#x000a0;6</a></div><!--caption a7--><div class="caption"><p>Oxysterols, accessible cholesterol, and protection against microbial infection. Symbols and color coding are as in earlier figures. enz corresponds to enzymes of the cholesterol biosynthesis pathway.</p></div></div></div><p id="p0115">Included among the IFN-stimulated genes expressed by macrophages are <em>Soat1</em> and <em>Soat2</em>. Surprisingly, however, the presence of cholesterol in cell media was not required for increased cholesterol esterification in macrophages in response to IFNs. This suggests that the source of cholesterol for esterification is from host cell membranes (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>) or directly from synthesis in the endoplasmic reticulum. Zhou <em>et&#x000a0;al.</em> (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>) went on to provide strong evidence that cholesterol ester formation contributes to IFN-mediated resistance to CDCs in macrophages by showing that a pharmacological inhibitor (Sandoz 58-035) of SOAT1 and SOAT2 attenuates protection provided by IFNs against PFO.</p><p id="p0120">Zhou <em>et&#x000a0;al.</em> (<a href="#bib73" rid="bib73" class=" bibr popnode">73</a>) were able to confirm the protective effect of 25-HC against infection by CDC in&#x000a0;vivo. They found that <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice were more susceptible to infection by CDC injected in skin than WT animals, but preinjection of 25-HC reduced subsequent tissue damage.</p><p id="p0125" class="p p-last">In combination, the data of Zhou <em>et&#x000a0;al.</em> favor a model where IFNs via 25-HC reduce cholesterol synthesis and increase esterification of cholesterol, resulting in a reduction of accessible cholesterol required for CDC binding (<a href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>). This mechanism is exploited by immune cells to evade pathogens and protect the host from damage and is likely to be exploited by cells other than macrophages including those of epithelial tissue.</p></div><div id="sec4.2" class="sec sec-last"><h3 id="sec4.2title">Epithelial cell infection</h3><p id="p0130" class="p p-first">In fact, soon after the publication of the data by Zhou <em>et&#x000a0;al.</em>, Ormsby <em>et&#x000a0;al.</em> (<a href="#bib76" rid="bib76" class=" bibr popnode">76</a>) showed that bovine endometrial epithelial cells generate 25-HC in response to challenge by LPS and pyolysin, the CDC from <em>Trueperella pyogenes</em>, a bacterium that targets endometrial cells. Ormsby <em>et&#x000a0;al.</em> (<a href="#bib76" rid="bib76" class=" bibr popnode">76</a>) found that 25-HC protected endometrial epithelial and stromal cells against pyolysin and also against &#x003b1;-hemolysin, a CDC from <em>Staphylococcus aureus</em>. The endometrium is the innermost lining layer of the uterus, and to investigate further the potential source of cytoprotective oxysterols, Ormsby <em>et&#x000a0;al.</em> profiled using LC-MS, the oxysterol content of epithelial cells, stromal cells, and also uterine and ovarian follicular fluids. Even without bacterial challenge, epithelial cells were found to secrete 25-HC (about 1&#x000a0;ng/10<sup>5</sup>&#x000a0;cells) and also 7&#x003b1;,25-diHCO at about the same level. Following pyolysin challenge, these values more than doubled. Stromal cells were not found to secrete either oxysterol before or after pyolysin challenge. Uterine and follicular fluids collected from cattle with no evidence of infection were found to contain not only 25-HC (3.9 &#x000b1; 0.6&#x000a0;ng/ml uterine, 26.8 &#x000b1; 11.4&#x000a0;ng/ml follicular) and its metabolite 7&#x003b1;,25-diHC (1.3 &#x000b1; 0.7&#x000a0;ng/ml uterine, 2.0 &#x000b1; 1.5&#x000a0;ng/ml follicular) but also high levels of 26-HC (19.9 &#x000b1; 4.9&#x000a0;ng/ml uterine, 244.6 &#x000b1; 99.5&#x000a0;ng/ml follicular) and its metabolites 3&#x003b2;-HCA (12.7 &#x000b1; 6.8&#x000a0;ng/ml uterine, 295.8 &#x000b1; 118.4&#x000a0;ng/ml follicular), 3&#x003b2;,7&#x003b1;-diHCA (4.9 &#x000b1; 2.5&#x000a0;ng/ml uterine, 6.5 &#x000b1; 4.2&#x000a0;ng/ml follicular), and 7&#x003b1;-hydroxy-3-oxocholest-4-en-(25R/S)26-oic acid (81.3&#x000a0;ng/ml uterine, 258.9 &#x000b1; 136.8&#x000a0;ng/ml follicular). 26-HC, like 25-HC, was found to be cytoprotective toward epithelial and stromal cells against both pyolysin and &#x003b1;-hemolysin, although unlike 25-HC, 26-HC was not released by endometrial cells in response to pathogen challenge (<a href="#bib76" rid="bib76" class=" bibr popnode">76</a>). Based on studies using the SOAT inhibitor Sandoz 58-035, knockdown of LXR&#x003b1; and LXR&#x003b2;, and measurement of plasma membrane accessible cholesterol binding to pyolysin, Ormsby <em>et&#x000a0;al.</em> (<a href="#bib76" rid="bib76" class=" bibr popnode">76</a>) concluded that cytoprotection against pyolysin by 26-HC, and by inference 25-HC, was by activation of LXRs and SOAT resulting in a reduction in plasma membrane accessible cholesterol and thereby binding of CDCs to the plasma membrane. Importantly, the concentrations of 25-HC and 26-HC required for cytoprotection of endometrial cells, 5 and 25&#x000a0;ng/ml, respectively, were similar to concentrations of these oxysterols found in uterine fluid, lending weight to a hypothesis that oxysterols provide protection against pathogens in the uterus. Two further points of consideration are that besides 25-HC and 26-HC, 3&#x003b2;-HCA and 3&#x003b2;,7&#x003b1;-diHCA are LXR ligands (<a href="#bib24" rid="bib24" class=" bibr popnode">24</a>, <a href="#bib29" rid="bib29" class=" bibr popnode">29</a>, <a href="#bib30" rid="bib30" class=" bibr popnode">30</a>, <a href="#bib31" rid="bib31" class=" bibr popnode">31</a>) and are present in uterine fluid and could potentially offer additional protection against CDCs via LXR activation, perhaps through an additive effect, whereas Griffin <em>et&#x000a0;al.</em> (<a href="#bib78" rid="bib78" class=" bibr popnode">78</a>) have shown that statins and knockdown of <em>HMGCR</em> partially protect bovine endometrial cells against polylysin implicating inhibition of the SREBP-2 pathway in protection against CDCs.</p><p id="p0135">IFN&#x003b3; is an important component of the mucosal epithelium immune system, which provides a barrier to bacteria protecting underlying tissue, and deficiency in IFN&#x003b3; increases host susceptibility to <em>L.&#x000a0;monocytogenes</em> and <em>Mycobacterium tuberculosis</em> (<a href="#bib79" rid="bib79" class=" bibr popnode">79</a>). In their recent study, Abrams <em>et&#x000a0;al.</em> (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>) exploited the <em>L.&#x000a0;monocytogenes</em> to investigate how IFN&#x003b3;-activated macrophages protect the barrier epithelium from bacterial infection. <em>L.&#x000a0;monocytogenes</em> penetrates mucosal membranes of the gut, spreads to other organs, and it is often used as a model enteric pathogen to study the immune response to bacterial infection (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). IFN&#x003b3;-stimulated macrophages secrete 25-HC in response to induction of <em>Ch25h</em> (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>), and Abrams <em>et&#x000a0;al.</em> (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>) found that conditioned media containing elevated levels of 25-HC suppressed <em>L.&#x000a0;monocytogenes</em> infection of epithelial cells. Importantly, conditioned media from <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophage cultures, where 25-HC is absent, failed to suppress <em>L.&#x000a0;monocytogenes</em> infection of epithelia cells. These data led to the suggestion that 25-HC is the active molecule secreted by IFN&#x003b3;-activated macrophages that inhibits <em>L.&#x000a0;monocytogenes</em> infection of epithelial cells. This hypothesis was confirmed by further in&#x000a0;vitro and in&#x000a0;vivo experiments where 25-HC added to culture media suppressed bacterial colonization of a wide range of immortalized cells, and when 25-HC was injected into mice infected with <em>L.&#x000a0;monocytogenes</em>, the bacterial burden was reduced (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). Importantly, and in agreement with earlier studies (<a href="#bib44" rid="bib44" class=" bibr popnode">44</a>), 25-HC did not protect BMDM from <em>L.&#x000a0;monocytogenes</em> infection (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). However, the antibacterial activity of 25-HC in epithelial cells against <em>L.&#x000a0;monocytogenes</em> was explained by suppression of contact-dependent cell-to-cell spread across host cells; this could be reconciled with 25-HC depleting plasma membrane accessible cholesterol (<a href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>) (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). Although Abrams <em>et&#x000a0;al.</em> (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>) did not find a reduction in total cholesterol in 25-HC-treated cells (CHO cells), accessible cholesterol in the plasma membrane was reduced as revealed by reduced ALOD4 binding. <em>Shigella flexneri</em> is a Gram-negative bacterium and infects the intestine, and like <em>L.&#x000a0;monocytogenes</em>, its intercellular dissemination is inhibited by reducing accessible cholesterol.</p><p id="p0140">To uncover the mechanism by which 25-HC reduces accessible cholesterol, Abrams <em>et&#x000a0;al.</em> (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>) performed investigations on CHO-K1 cells, a subclone of the original CHO cell line. They found that besides 25-HC, 20S-HC and 26-HC also reduce accessible cholesterol in these cells as determined by ALOD4 binding. These three oxysterols will inhibit the processing of SREBP-2 to its active form and thereby downregulate cholesterol biosynthesis and uptake (<a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>) (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>, <a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). 22R-HC will also suppress SREBP-2 processing but surprisingly did not reduce ALOD4 binding in CHO-K1 cells (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). 22R-HC will also activate the LXR receptors (<a href="#bib25" rid="bib25" class=" bibr popnode">25</a>), arguing that neither reducing cholesterol biosynthesis nor enhancing cholesterol efflux via activation of LXRs provide a general mechanism for side-chain oxysterol mobilization of accessible cholesterol in CHO-K1 cells.</p><p id="p0145">As discussed previously, 25-HC enhances the activity of SOAT, the endoplasmic reticulum enzymes that catalyze the formation of cholesterol esters (<a href="#bib50" rid="bib50" class=" bibr popnode">50</a>). Interestingly, the SOAT-specific inhibitor, Sandoz 58-035, prevented the elimination of accessible cholesterol stimulated by 25-HC, 20S-HC, and 26-HC and also suppressed the antibacterial activity of 25-HC in CHO-7&#x000a0;cells. These data point to cholesterol ester formation, to be the primary driver for plasma membrane remodeling induced by 25-HC, although this may in addition be sustained by inhibition of SREBP-2 processing (<a href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>) (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). Perhaps surprisingly in light of the activity of 25-HC in protecting macrophages against pore-forming toxins produced by bacteria, 25-HC was found to make macrophages more susceptible to <em>L.&#x000a0;monocytogenes</em> infection (<a href="#bib44" rid="bib44" class=" bibr popnode">44</a>, <a href="#bib74" rid="bib74" class=" bibr popnode">74</a>).</p><p id="p0150" class="p p-last">In summary, Abrams <em>et&#x000a0;al.</em> found that in response to IFN&#x003b3; epithelia, cells are protected against both <em>L.&#x000a0;monocytogenes</em> and <em>S.&#x000a0;flexneri</em>. Protection is by way of mobilizing accessible cholesterol away from the plasma membrane and enhancing its esterification by 25-HC-mediated activation of SOAT and on a longer time scale by 25-HC inhibiting new cholesterol synthesis and uptake preventing the replenishment of membrane accessible cholesterol (<a href="/pmc/articles/PMC8953665/figure/fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig6" rid-ob="ob-fig6" co-legend-rid="lgnd_fig6"><span>Fig.&#x000a0;6</span></a>).</p></div></div><div id="sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="sec5title">Anti-inflammatory activity of 25-HC</h2><div id="sec5.1" class="sec sec-first"><h3 id="sec5.1title">Inflammasomes and IL-1&#x003b2;</h3><p id="p0155" class="p p-first">Considering that <em>Ch25h</em> is an IFN-stimulated gene (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>, <a href="#bib9" rid="bib9" class=" bibr popnode">9</a>, <a href="#bib43" rid="bib43" class=" bibr popnode">43</a>) and that its metabolic product, 25-HC, has multiple activities that regulate cellular sterols (<a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>) (<a href="#bib27" rid="bib27" class=" bibr popnode">27</a>, <a href="#bib33" rid="bib33" class=" bibr popnode">33</a>, <a href="#bib50" rid="bib50" class=" bibr popnode">50</a>) raises the question: are the known suppressive effects of type I IFNs on the immune system (<a href="#bib80" rid="bib80" class=" bibr popnode">80</a>, <a href="#bib81" rid="bib81" class=" bibr popnode">81</a>) mediated by 25-HC and its regulation of sterols?</p><p id="p0160">Type I IFNs are known to downregulate inflammasome activity and IL-1&#x003b2; production (<a href="#bib82" rid="bib82" class=" bibr popnode">82</a>), IL-1&#x003b2; being a cytokine produced by activated macrophages as a proprotein, which is cleaved by caspase-1 to the mature inflammatory mediator, whereas inflammasomes are multiprotein complexes that function to activate caspase-1 for its proteolytic action. Inflammasome activation is triggered by a sensor protein from the nucleotide binding domain and leucine-rich repeat (NLR) family, from the absent in melanoma 2 (AIM2) (absent in melanoma-like receptor) family or by pyrin protein (Mediterranean fever innate immunity regulator). Upon ligand binding, inflammasome sensor proteins oligomerize, recruit the adaptor protein ASC (apoptosis-associated speck-like adaptor protein containing a C-terminal caspase recruitment domain), which oligomerizes and recruit procaspase-1, which undergoes autoproteolysis to release active caspase-1, which can proteolyze pro-IL-1-family cytokines (IL-1&#x003b2; and IL-18) to their active forms (<a href="#bib83" rid="bib83" class=" bibr popnode">83</a>).</p><p id="p0165">In a groundbreaking study, Reboldi <em>et&#x000a0;al.</em> (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>) showed that <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages overproduce IL-1 family cytokines in response to LPS; this increase is transient peaking after 8&#x000a0;h of stimulation. IL-1 cytokine overproduction was explained by 25-HC having an inhibitory effect on <em>Il1b</em> expression and on the activation of IL-1&#x003b2; protein by inflammasomes. A mechanism was proposed whereby bacterial infection, or LPS treatment, of macrophages leads to upregulation of IFN expression and CH25H-mediated 25-HC formation (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). 25-HC represses SREBP-2 processing and expression of enzymes of the cholesterol biosynthesis pathway, which ultimately leads to downregulation of inflammasome-mediated proteolysis of pro-IL-1&#x003b2; to its active form; 25-HC also represses <em>Il1b</em> expression (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>). The overall effect being suppressed inflammation. A downside of suppressed inflammation is reduced resistance against bacterial infection, and Reboldi <em>et&#x000a0;al.</em> (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>) showed that <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice have less bacterial growth in spleen and liver than <em>Ch25h</em><sup><em>+/&#x02212;</em></sup> littermate controls following infection by <em>L.&#x000a0;monocytogenes</em>. <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice also showed elevated IL-1&#x003b2; and IL-18 in serum and BMDM cultures. These data are in agreement with earlier data of Zou <em>et&#x000a0;al.</em> who showed that 25-HC failed to protect BMDM from <em>L.&#x000a0;monocytogenes</em> infection (<a href="#bib44" rid="bib44" class=" bibr popnode">44</a>) and the later report by Abrams <em>et&#x000a0;al.</em> showing that 25-HC makes macrophages more susceptible to <em>L.&#x000a0;monocytogenes</em> infection (<a href="#bib74" rid="bib74" class=" bibr popnode">74</a>). Interestingly, Reboldi <em>et&#x000a0;al.</em> (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>) found <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice to have elevated IL-17A<sup>+</sup> T cells in spleen and lymph nodes and also an increased neutrophil count; these cell populations often promote inflammation. An increase in IL-17A<sup>+</sup> T cells is likely to be mediated by elevated IL-1&#x003b2;, one of the cytokines involved in the differentiation of T helper (T<sub>h</sub>) 17 cells. Experimental autoimmune encephalitis (EAE) is a mouse model of multiple sclerosis driven by IL-17 (<a href="#bib80" rid="bib80" class=" bibr popnode">80</a>), and Reboldi <em>et&#x000a0;al.</em> (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>) found that <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice show exacerbated EAE compared with controls. Thus, 25-HC is likely to be protective against EAE by limiting IL-1&#x003b2; and IL-17A<sup>+</sup> cell populations (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). The conclusion of this study was that 25-HC acts as a mediator in a negative-feedback pathway of IFN on IL-1 family cytokine production and inflammasome activity (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>).</p><p id="p0170">In a follow-on study, Dang <em>et&#x000a0;al.</em> (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>) discovered how 25-HC prevents inflammasome activation. They uncovered a link between mTORC1 stimulation by LPS, expression of SREBP-2 target genes, and cholesterol over accumulation in <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages and proposed that 25-HC functions to restrain cholesterol biosynthesis and thereby inhibit inflammasome activation and IL-1&#x003b2; secretion (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>) (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>). After 8&#x000a0;h stimulation with LPS, <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages were found by LC-MS to have elevated levels of desmosterol, 7-dehydrocholesterol (7-DHC), and lanosterol compared with control cells, suggesting that both the Bloch and Kandustch-Russell pathways of cholesterol biosynthesis are repressed by 25-HC. Unsurprisingly in light of these data, cholesterol levels in <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages were elevated after 8&#x000a0;h stimulation. Interestingly, at 4&#x000a0;h of LPS stimulation, macrophages of both genotypes showed a decrease in their cholesterol content; this is consistent with <em>Ch25h</em> transcripts peaking at 4&#x000a0;h (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>, <a href="#bib3" rid="bib3" class=" bibr popnode">3</a>) and transcripts of HMG-CoA synthase 1 (<em>Hmgcs1</em>), squalene synthase (<em>Sqs</em>, farnesyl-diphosphate farnesyltransferase 1, <em>Fdft1</em>), lanosterol synthase (<em>Lss</em>), and dehydrocholesterol reductase 24 (<em>Dhcr24</em>) being repressed at 2&#x000a0;h in both <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> and control macrophages. However, the mRNAs had increased after 8&#x000a0;h of LPS stimulation in <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages. In summary, these data indicate that 25-HC is required by macrophages following 8&#x000a0;h of LPS stimulation to repress mTORC1-induced activation of the SREBP-2 pathway and to avoid overaccumulation of cholesterol (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>).</p><p id="p0175" class="p p-last">Dang <em>et&#x000a0;al.</em> (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>) also showed that it is the AIM2 inflammasome that is involved in cholesterol-dependent IL-1&#x003b2; secretion in response to LPS or <em>L.&#x000a0;monocytogenes</em> infection of macrophages. AIM2 is a DNA sensor protein, and Dang <em>et&#x000a0;al.</em> (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>) discovered that cholesterol overload of mitochondria can lead to mitochondrial DNA release into the cytosol and AIM2-inflammasone activation leading to proteolysis of pro-IL-1&#x003b2; to the active cytokine. In summary, the work of Reboldi <em>et&#x000a0;al.</em> (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>) and Dang <em>et&#x000a0;al.</em> (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>) revealed a mechanism by which 25-HC protects macrophages from overstimulation of the immune system. The pathway involves LPS activation of the TLR receptors leading to mTORC1 signaling, which in the absence of 25-HC leads to enhanced expression of SREBP-2 target genes and cholesterol synthesis resulting in mitochondrial cholesterol overload and AIM2-inflammasome activation with subsequent enhanced IL-1&#x003b2; secretion (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). TLR activation will also mediate IFN production and induction of IFN-stimulated genes, which include <em>Ch25h</em>. In turn, this will lead to the production of 25-HC, which will repress the processing of SREBP-2 and restrain mTORC1-mediated overproduction of cholesterol, thereby preventing AIM2-inflammasome activation, limiting the magnitude of the inflammatory response (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). It is likely that NLR pyrin domain-containing protein 3 (NLRP3) inflammasomes, which are activated by a diverse array of stimuli (<a href="#bib86" rid="bib86" class=" bibr popnode">86</a>), including cholesterol crystals (<a href="#bib87" rid="bib87" class=" bibr popnode">87</a>), also contribute redundantly to IL-1&#x003b2; production, perhaps via oxidized mitochondrial DNA (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>). It is also possible that activation of LXR may have a role in restraining the pathological secretion of IL-1&#x003b2;, as the synthetic LXR agonist GW3965 was found to be protective against mitochondrial dysfunction in macrophages overexpressing <em>Hmgcr</em> or <em>Dhcr24</em>, although 25-HC still blocked IL-1&#x003b2; release in <em>LXR&#x003b1;</em><sup>&#x02212;/&#x02212;</sup>&#x003b2;<sup>&#x02212;/&#x02212;</sup> macrophages, arguing against a dominant role for LXR in restraining IL-1&#x003b2; secretion (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>, <a href="#bib85" rid="bib85" class=" bibr popnode">85</a>). 25-HC can enhance the removal of free cholesterol by activating SOAT1 and converting it to cholesterol esters; this could also be a mechanism to protect against cholesterol overload in macrophages. Although the studies of Reboldi <em>et&#x000a0;al.</em> (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>) and Dang <em>et&#x000a0;al.</em> (<a href="#bib85" rid="bib85" class=" bibr popnode">85</a>) focused on the pathological consequence of LPS stimulation of macrophages in a setting of infection (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>, <a href="#bib85" rid="bib85" class=" bibr popnode">85</a>), cholesterol overload may have a role in driving in chronic diseases, such as obesity, metabolic syndrome, and atherosclerosis (<a href="#bib83" rid="bib83" class=" bibr popnode">83</a>).</p></div><div id="sec5.2" class="sec"><h3 id="sec5.2title">Efferocytosis, LIPA, and 25-HC</h3><p id="p0180" class="p p-first">Efferocytosis is the process by which macrophages phagocytose billions of host cells per day, preventing inflammatory consequences of apoptotic debris. It is in&#x000a0;this context that Viaud <em>et&#x000a0;al.</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>) showed 25-HC to have a role in protecting macrophages against mitochondrial-induced NLRP3 inflammasome activation and defective cell clearance. A consequence of ingestion of apoptotic cells is the import of large amounts of cholesterol esters to the macrophage. These are hydrolyzed within the lysosome by the enzyme LIPA to free cholesterol and fatty acids. One of the metabolic routes for released cholesterol is conversion to an oxysterol. Using LC-MS, Viaud <em>et&#x000a0;al.</em> found that 3&#x000a0;h post efferocytosis, THP-1-derived macrophages treated with the LIPA inhibitor lalistat had greatly reduced levels of 25-HC, 26-HC and 4&#x003b2;-hydroxycholesterol (4&#x003b2;-HC), 70%, 50%, and 50% reduced respectively, compared with controls (<a href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>). These changes in oxysterol abundance were a consequence as reduced substrate availability as opposed to reduced expression of mRNA of the respective biosynthetic genes <em>Ch25h</em>, <em>Cyp27a1</em>, and <em>Cyp3a4</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>). LIPA inhibition led to reduced efferocytotic capacity of macrophages, NLRP3 inflammasome activation, and higher IL-1&#x003b2; and IL-18 secretions. In control macrophages, ingestion of apoptotic cells leads to downregulation of <em>Srebf-2</em> (the gene coding SREBP-2) and <em>Hmgcr</em> 3&#x000a0;h after efferocytosis, effects absent in lalistat-treated macrophages but restored by addition of 25-HC. Addition of 25-HC reduced inflammasome activation after efferocytosis in lalistat-treated macrophages and restored an efficient efferocytic response. This led to the conclusion that inhibition of LIPA results in reduced 25-HC formation, accentuated cholesterol synthesis, mitochondrial-induced inflammasome activation, and reduced clearance of apoptotic cells (<a href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>). While 25-HC has an effect on inflammasome activation within 3&#x000a0;h of efferocytosis, surprisingly, 26-HC does not prevent inflammasome activation, but acting as an LXR ligand can partially restore efferocytic capacity of lalistat-treated macrophages. Viaud <em>et&#x000a0;al.</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>) showed that reduced LXR activation in lalistat-treated macrophages impaired cholesterol efflux and reduced efferocytic capacity. The study by Viaud <em>et&#x000a0;al.</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>) provides a link between cholesterol hydrolysis, LIPA, oxysterols, macrophage efferocytic capacity, and metabolic inflammation. These results imply that it is cholesterol newly synthesized in the endoplasmic reticulum that is responsible for mitochondrial-induced inflammasome activation rather than cholesterol released by LIPA, and that hydrolysis of cholesterol esters will provide a source of 25-HC, and presumably cholesterol, to inhibit the biosynthesis of new cholesterol. A possible explanation for the actual source of cholesterol affecting mitochondrial-induced inflammasome activation comes from its availability for transport to the mitochondria. The data of Viaud <em>et&#x000a0;al.</em> suggest that newly synthesized cholesterol is in a more accessible environment than that passing through the lysosome, which first needs to be transported to the plasma membrane before reaching the endoplasmic reticulum and mitochondria (<a href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>).</p><p id="p0185">In human, LIPA deficiency results in two major phenotypes of cholesterol ester storage disease (CESD; Mendelian Inheritance in Man, MIM, number: 278000): infant-onset Wolman disease, where there is no or &#x0003c;1% of normal LIPA activity, and late-onset CESD. Infants with Wolman disease often do not survive beyond 12&#x000a0;months of life. Late-onset CESD is often undiagnosed and can present in infancy, childhood, or in adults. CESD presents with hepatomegaly, splenomegaly, dyslipidemia, and accelerated atherosclerosis (<a href="#bib89" rid="bib89" class=" bibr popnode">89</a>). Patients with Wolman's disease often present with an inflammatory phenotype, including hemophagocytic lymphohistiocytosis, where the body makes too many activated immune cells. A new treatment introduced by Potter <em>et&#x000a0;al.</em> (<a href="#bib89" rid="bib89" class=" bibr popnode">89</a>) in Royal Manchester Children's Hospital in the United Kingdom is enzyme replacement therapy with dietary substrate reduction followed by hematopoietic stem cell transplant. As of 2021, of the five patients treated in Manchester in this manner, four are still alive more than 40&#x000a0;months after multimodal treatment, and both phenotype and laboratory parameters are improved compared with treatment with enzyme replacement therapy alone; histologically, there are reduced cholesterol clefts and fewer foamy macrophages (<a href="#bib89" rid="bib89" class=" bibr popnode">89</a>). Cholestane-3&#x003b2;,5&#x003b1;,6&#x003b2;-triol is a marker of presentation and the worsening of Wolman's disease (<a href="#bib90" rid="bib90" class=" bibr popnode">90</a>); it is likely to be formed by cholesterol epoxide hydrolase (a dimer of 7-DHC reductase [DHCR7] and &#x00394;<sup>8</sup>-&#x00394;<sup>7</sup> isomerase and emopamil binding protein sterol isomerase [EBP]), two enzymes of the cholesterol biosynthesis pathway, catalyzed hydration of 3&#x003b2;-hydroxycholestane-5,6-epoxide (5,6-epoxycholesterol) (<a href="#bib91" rid="bib91" class=" bibr popnode">91</a>), a nonenzymatic product of cholesterol (<a href="#bib92" rid="bib92" class=" bibr popnode">92</a>, <a href="#bib93" rid="bib93" class=" bibr popnode">93</a>), potentially formed in mitochondria under oxidative stress in Wolman's disease. After multimodal treatment, all five patients showed greatly reduced plasma cholestane-3&#x003b2;,5&#x003b1;,6&#x003b2;-triol as measured by LC-MS (<a href="#bib89" rid="bib89" class=" bibr popnode">89</a>). Two of the five patients had presented before treatment with hemophagocytic lymphohistiocytosis, which is reported in many cases of Wolman's disease, and is suggested to involve inflammasome activation (<a href="#bib94" rid="bib94" class=" bibr popnode">94</a>). This provides a link between the clinical work of Potter <em>et&#x000a0;al.</em> (<a href="#bib89" rid="bib89" class=" bibr popnode">89</a>) on patients with defective LIPA, the in&#x000a0;vivo experiments of Viaud <em>et&#x000a0;al.</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>) using the LIPA inhibitor lalistat, which resulted in inflammasome activation of macrophages, and reduced efferocytic capacity, which can be corrected by addition of 25-HC (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>, <a href="#bib89" rid="bib89" class=" bibr popnode">89</a>). It is not unreasonable to speculate that inflammasome activation in Wolman's disease is a consequence of mitochondrial cholesterol overload by newly synthesized cholesterol (<a href="/pmc/articles/PMC8953665/figure/fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig5" rid-ob="ob-fig5" co-legend-rid="lgnd_fig5"><span>Fig.&#x000a0;5</span></a>).</p><p id="p0190" class="p p-last">Using LC-MS, we have performed a sterolomic profile of Wolman's disease patients from the Royal Manchester Children&#x02019;s Hospital prior to stem cell transplantation as part of a larger study of unusual oxysterols produced in lysosomal storage disorders (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>). At the time of this study, we were unaware of the work of Viaud <em>et&#x000a0;al.</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>) and were surprised to find an absence of 25-HC in plasma from Wolman's disease patients (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>). Plasma levels of this oxysterol are usually low at 0.5&#x02013;2&#x000a0;ng/ml (nonesterified) in healthy individuals as are those of cholestane-3&#x003b2;,5&#x003b1;,6&#x003b2;-triol (0.5&#x02013;5&#x000a0;ng/ml, nonesterified); however, as reported by Potter <em>et&#x000a0;al.</em> (<a href="#bib89" rid="bib89" class=" bibr popnode">89</a>), levels of the latter oxysterol are elevated in plasma from Wolman's disease patients (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>). These sterolomic data are compatible with the hypothesis that an absence of LIPA activity leads to reduced production of 25-HC, consequently removing a brake on mitochondrial-induced inflammasome activation with the ultimate result of an inflammatory phenotype. Viaud <em>et&#x000a0;al.</em> (<a href="#bib88" rid="bib88" class=" bibr popnode">88</a>) linked inflammasome activation with signaling through reactive oxygen species (ROS) (<a href="#bib86" rid="bib86" class=" bibr popnode">86</a>, <a href="#bib88" rid="bib88" class=" bibr popnode">88</a>); this is supported by lalistat-treated macrophages showing increased mitochondrial ROS generation. Enhanced mitochondrial production of ROS could explain increased levels of cholestane-3&#x003b2;,5&#x003b1;,6&#x003b2;-triol in Wolman&#x02019;s disease patients and would also fit the hypothesis of enhanced cholesterol biosynthesis in macrophages with insufficient LIPA activity. Importantly, we found levels of 5,6-epoxycholesterol, the immediate autoxidation product of cholesterol and precursor of cholestane-3&#x003b2;,5&#x003b1;,6&#x003b2;-triol, to be elevated in Wolman's disease plasma (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>).</p></div><div id="sec5.3" class="sec sec-last"><h3 id="sec5.3title">Human patients with a deletion in both LIPA and CH25H</h3><p id="p0195" class="p p-first-last">In 2017, Goenka <em>et&#x000a0;al.</em> (<a href="#bib96" rid="bib96" class=" bibr popnode">96</a>) reported the first case of patients with deletions of both <em>LIPA</em> and <em>CH25H</em>, two adjacent genes on chromosome 10. These patients showed susceptibility to Bacillus Calmette-Gu&#x000e9;rin (BCG) vaccine-associated abscesses. BCG is a vaccine primarily used against tuberculosis; it was developed from <em>Mycobacterium bovis</em>, and this bacterium was isolated by Goenka <em>et&#x000a0;al.</em> (<a href="#bib96" rid="bib96" class=" bibr popnode">96</a>) from infected lymph nodes (axillary lymphadenitis) of one of these double-deletion patients. In their report, Goenka <em>et&#x000a0;al.</em> (<a href="#bib96" rid="bib96" class=" bibr popnode">96</a>) described five patients with the double deletion, and four of five of these infants presented with localized BCG abscess. In contrast, no BCG abscesses were reported in eight children with <em>LIPA</em>-only mutation. We confirmed a complete absence of 25-HC in the plasma of the double-deletion patients. Significantly, there is no other report of a deficiency in CH25H in human. What might be the explanation for the susceptibility of patients with the double mutation toward BCG abscess? An abscess is defensive reaction against infectious material with the release of cytokines triggering an inflammatory response, so one explanation for these abscesses may be a consequence of a failure of 25-HC to repress inflammasome activation in macrophages. BCG is known to activate TLR4 and stimulate IFN&#x003b3; production (<a href="#bib97" rid="bib97" class=" bibr popnode">97</a>, <a href="#bib98" rid="bib98" class=" bibr popnode">98</a>), which will lead to macrophage biosynthesis of 25-HC in normal macrophages; however, an absence of CH25H enzyme will prevent this, resulting perhaps in overactivation of inflammasomes. Significantly, genetic deficiency in IFN&#x003b3; or its receptor IFNGR (IFN&#x003b3; receptor) enhances host susceptibility to <em>M.&#x000a0;tuberculosis</em> (<a href="#bib79" rid="bib79" class=" bibr popnode">79</a>, <a href="#bib99" rid="bib99" class=" bibr popnode">99</a>). This may be explained by a failure of macrophages to produce 25-HC and hence remove paracrine protection of epithelial cells from <em>M.&#x000a0;tuberculosis</em> spread. This may be a second reason for BCG abscesses in the double-deletion infants, where a failure in 25-HC production could result in cell-to-cell spread of bacteria. Whatever the mechanism, the report by Goenka <em>et&#x000a0;al.</em> (<a href="#bib96" rid="bib96" class=" bibr popnode">96</a>) irrefutably links <em>CH25H</em> and 25-HC to resistance against bacterial infection in human.</p></div></div><div id="sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="sec6title">Antiviral activity of oxysterols</h2><div id="sec6.1" class="sec sec-first"><h3 id="sec6.1title">IFN CH25H and 25-HC in the antiviral response</h3><p id="p0200" class="p p-first">In 2011, soon after the seminal articles of Baumann <em>et&#x000a0;al.</em> (<a href="#bib3" rid="bib3" class=" bibr popnode">3</a>), Diczfalusy <em>et&#x000a0;al.</em> (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>), and Park and Scott (<a href="#bib4" rid="bib4" class=" bibr popnode">4</a>) linking TLR, IFN, CH25H, and 25-HC to the immune response against bacterial infection (<a href="#bib2" rid="bib2" class=" bibr popnode">2</a>, <a href="#bib3" rid="bib3" class=" bibr popnode">3</a>, <a href="#bib4" rid="bib4" class=" bibr popnode">4</a>), Blanc <em>et&#x000a0;al.</em> (<a href="#bib10" rid="bib10" class=" bibr popnode">10</a>) proposed a mechanism by which the host defends itself against viral infection through IFN-mediated downregulation of sterol biosynthesis. In genome-wide lipid-associated gene expression experiments on macrophages, they found negative regulation of the sterol pathway upon viral infection or treatment with IFN&#x003b3; or IFN&#x003b2;. nSREBP-2 was reduced upon viral infection or IFN&#x003b2; treatment as were cholesterol levels after 48&#x000a0;h. Thus, in response to viral infection, IFN produced as part of the innate immune response downregulates the expression of genes of the cholesterol biosynthesis pathway, ultimately leading to reduced cholesterol synthesis (<a href="#bib10" rid="bib10" class=" bibr popnode">10</a>). In a follow-on study, Blanc <em>et&#x000a0;al.</em> (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>) uncovered the link between IFN and reduced cholesterol biosynthesis to be 25-HC (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). They showed that upon viral infection or IFN treatment of macrophages, stimulation of either IFNAR or IFNGR led to STAT1 activation, <em>Ch25h</em> transcription, and 25-HC synthesis and secretion. 25-HC was found to be a paracrine inhibitor of a broad range of viral infections, and the mechanism by which 25-HC limits viral infections was confirmed to involve in downregulation of the cholesterol biosynthesis pathway (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). Importantly, oxysterol profiling of mouse BMDM infected with mouse cytomegalovirus (mCMV), a double-stranded enveloped virus, or treated with IFN&#x003b2; or IFN&#x003b3; showed 25-HC to be the only hydroxycholesterol secreted into the medium or found in the cell pellet (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). Following IFN stimulation, the majority of 25-HC was secreted in the first 8&#x000a0;h of incubation, and <em>Ch25h</em> was found to be upregulated after 6&#x000a0;h. Neither <em>Cyp27a1</em> nor <em>Cyp7a1</em> was upregulated in response to IFN&#x003b3; or mCMV explaining the absence of 26-HC and 7&#x003b1;-hydroxycholesterol (7&#x003b1;-HC) from stimulated macrophages. However, desmosterol and cholesterol levels in cells were found to fall with time indicating reduced flux through the cholesterol biosynthesis pathway in response to 25-HC. IC<sub>50</sub> values for the antiviral role of 25-HC as measured by viral growth inhibition were found to vary between 20&#x000a0;nM (8&#x000a0;ng/ml) and 750&#x000a0;nM (300&#x000a0;ng/ml) depending on the virus and host cell. Enveloped viruses found to be inhibited include influenza A (H1N1), herpes simplex virus 1 (HSV-1), varicella-zoster virus, and murine gamma herpes virus 68. 25-HC was not found to inhibit adenovirus 5 or 19a, which are nonenveloped viruses (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). Interestingly, two other oxysterols that inhibit the processing of SREBP-2 and hence cholesterol biosynthesis, 26-HC and 24S,25-EC (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>), also inhibit mCMV growth but at a higher IC<sub>50</sub> than 25-HC (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). This observation highlights the importance of performing detailed sterolomic studies when studying oxysterol involvement in the immune response as multiple oxysterols may have additive effects on the response.</p><p id="p0205">Beyond the effect of 25-HC on downregulating the expression of SREBP-2 target genes in infected cells, it is not clear how this translates into viral growth inhibition beyond reducing cellular cholesterol. Experiments with mCMV-infected mouse embryonic fibroblasts (National Institutes of Health [NIH]-3T3) treated with the potent synthetic LXR ligands GW3965 and T090317 indicated that LXR activation is not part of the antiviral response, at least against this virus and by this host cell. In contrast, the antiviral effect of 25-HC toward NIH-3T3 cells infected by mCMV was partially blocked by <a id="__tag_1056007823" class="tag_hotlink" href="/nuccore/Ly295427" ref="/nuccore/Ly295427"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"Ly295427","term_id":"1258031645","term_text":"LY295427"}}</span>Ly295427</a> (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>), a synthetic agent that blocks the suppression of SREBP processing mediated by oxysterols (<a href="/pmc/articles/PMC8953665/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>) (<a href="#bib100" rid="bib100" class=" bibr popnode">100</a>). The enantiomer of 25-HC was largely ineffective as a viral inhibitor (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>), arguing that inhibition of viral growth is via interaction with proteins, for example, INSIG (<a href="/pmc/articles/PMC8953665/figure/fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig4" rid-ob="ob-fig4" co-legend-rid="lgnd_fig4"><span>Fig.&#x000a0;4</span></a>) (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>), rather than a direct effect of 25-HC interfering with membrane structure, that is, through its incorporation into the membrane. In the mCMV-NIH-3T3 context, the level of internalized mCMV genome was unaffected by 25-HC, arguing against viral entry as the primary mode of mCMV inhibition. Blanc <em>et&#x000a0;al.</em> suggested that inhibition of early steps in sterol synthesis may be important for the antiviral effect of 25-HC, as in mCMV-infected mouse embryonic fibroblasts', viral growth inhibited by 25-HC (1&#x000a0;&#x003bc;M, 400&#x000a0;ng/ml) could be restored by addition by mevalonolactone, the lactone form of mevalonate, and by C<sub>20</sub> geranylgeraniol, but not by C<sub>15</sub> farnesol. This implicates protein prenylation by geranylgeraniol during viral infection with the antiviral effect mediated by 25-HC. However, at 5&#x000a0;&#x003bc;M 25-HC, the antiviral effect of 25-HC was maintained (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). A further important point uncovered in the studies of Blanc <em>et&#x000a0;al.</em> was that the antiviral potency of 25-HC increased for most infections under lipid-depleted conditions, supporting the involvement of the cholesterol synthesis pathway (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>). In lipid-replete media, cells can receive cholesterol by lipoprotein uptake reducing the requirement for new synthesis. Interestingly, the finding of Blanc <em>et&#x000a0;al.</em> mirrors those of Potena <em>et&#x000a0;al.</em> (<a href="#bib101" rid="bib101" class=" bibr popnode">101</a>) who found that statins inhibit the replication of CMV in human endothelial cells, and that addition of mevalonate to treated cultures rescued statin-mediated inhibition of viral growth.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig7" co-legend-rid="lgnd_fig7"><a href="/pmc/articles/PMC8953665/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816982674928"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr7.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr7.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr7.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816982674928"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig7/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig7"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig7/" target="figure" rid-figpopup="fig7" rid-ob="ob-fig7">Fig.&#x000a0;7</a></div><!--caption a7--><div class="caption"><p>Membrane fusion and the antiviral activity of 25-HC. Symbols and colors are as in previous figures.</p></div></div></div><p id="p0210" class="p p-last">In summary, Blanc <em>et&#x000a0;al.</em> (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>) concluded that activation of pattern recognition receptors by the viral particle is sufficient to activate the transcription of the IFN-stimulated gene <em>Ch25h</em> via STAT-1 binding to the <em>Ch25h</em> promoter leading to 25-HC production and secretion and that it was likely that 25-HC mediates its antiviral effects through multiple levels of entry and growth depending on the host system and virus.</p></div><div id="sec6.2" class="sec"><h3 id="sec6.2title">IFN, CH25H, 25-HC, and membrane fusion</h3><p id="p0215" class="p p-first">In an article published back to back with that of Blanc <em>et&#x000a0;al.</em> (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>), Liu <em>et&#x000a0;al.</em> (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>) proposed that 25-HC inhibits growth of enveloped viruses by blocking membrane fusion between the virus and host cell. Liu <em>et&#x000a0;al.</em> confirmed that <em>Ch25h</em> is induced in mouse BMDM by TLR agonists, most potently by TLR3 and TLR4 agonists, and that both IFN&#x003b1; and IFN&#x003b3; stimulate <em>Ch25h</em> expression (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). When cells were preincubated with 25-HC at 1&#x000a0;&#x003bc;M (400&#x000a0;ng/ml), 25-HC was found to be antiviral against vesicular stomatitis Indiana virus (VSV), human immunodeficiency virus (HIV), Ebola virus, Nipah virus, Russian spring-summer encephalitis virus and Rift Valley fever virus, as well as HSV and murine gamma herpes virus 68 (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>). In agreement with Blanc <em>et&#x000a0;al.</em> (<a href="#bib9" rid="bib9" class=" bibr popnode">9</a>), 25-HC was not found to inhibit growth of nonenveloped viruses (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>). Liu <em>et&#x000a0;al.</em> (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>) reasoned that the antiviral effects of 25-HC were independent of LXR activation based on experiments in human embryonic kidney 293T (HEK293T) cells where the LXR ligand 22R-HC failed to have an antiviral effect against VSV. 22R-HC is also an inhibitor of SREBP-2 processing (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>), so this finding also argues against the inhibition of the cholesterol biosynthesis pathway in the antiviral response, at least against VSV in HEK293T cells.</p><p id="p0220" class="p p-last">The studies by Liu <em>et&#x000a0;al.</em> favored a hypothesis that 25-HC inhibits viral entry to the host cell by inhibiting fusion of the viral and host membranes, an essential step for an enveloped virus to replicate (<a href="/pmc/articles/PMC8953665/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>). Using VSV as a model virus, they showed that 25-HC inhibited virus-cell fusion at 1&#x000a0;&#x003bc;M (400&#x000a0;ng/ml) in HEK293T cells. They found that the longer the preincubation time with medium derived from cells overexpressing <em>Ch25h</em> the greater the viral inhibition. Surprisingly, overexpression of SREBP-2 did not reverse the antiviral effect of 25-HC, nor did addition of mevalonate prior to 25-HC treatment (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>). VSV undergoes pH-dependent viral entry, via obligatory endocytosis of the virus-receptor complex with exposure to acidic pH in the endosomal/lysosomal vesicle and fusion with the endosomal/lysosomal membrane, whereas HIV undergoes pH-independent entry (<a href="#bib102" rid="bib102" class=" bibr popnode">102</a>). With pH-independent viral entry, the viral membrane directly fuses with the plasma membrane at neutral pH. Liu <em>et&#x000a0;al.</em> found 25-HC to inhibit HIV entry to CEM cells, a lymphoblastic cell line, and concluded that 25-HC modifies cell membranes to impede viral infection. An important aspect of the study of Liu <em>et&#x000a0;al.</em> was the demonstration in&#x000a0;vivo of the antiviral activity of 25-HC. Humanized mice were given intraperitoneal injection of 25-HC (50&#x000a0;mg/kg) 12&#x000a0;h prior to infection with HIV, 25-HC was administered daily, and after 7 days, serum HIV RNA was reduced by 80% compared with control mice, which were given vehicle (<a href="#bib8" rid="bib8" class=" bibr popnode">8</a>).</p></div><div id="sec6.3" class="sec"><h3 id="sec6.3title">25-HC, 26-HC, IL-6, and the antiviral response</h3><p id="p0225" class="p p-first-last">Although in this review we have so far focused on the anti-inflammatory action of oxysterols (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>, <a href="#bib85" rid="bib85" class=" bibr popnode">85</a>, <a href="#bib88" rid="bib88" class=" bibr popnode">88</a>), certain oxysterols have also been assigned proinflammatory roles (<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>, <a href="#bib103" rid="bib103" class=" bibr popnode">103</a>, <a href="#bib104" rid="bib104" class=" bibr popnode">104</a>). Taking note of this, Cagno <em>et&#x000a0;al.</em> (<a href="#bib105" rid="bib105" class=" bibr popnode">105</a>) suggested that oxysterols may work as inducers of proinflammatory cytokines, which themselves may have an antiviral effect. To test this hypothesis, Cango <em>et&#x000a0;al.</em> exploited HSV-1 infection as a model system in which an antiviral cytokine reaction is triggered in host cells by the virus itself. Cango <em>et&#x000a0;al.</em> found that 25-HC and 26-HC had antiviral effects if added before or after viral infection. In fact, when added to Vero cells (African green monkey kidney cells) before infection, the half maximal effective concentration (EC<sub>50</sub>) determined for the antiviral effect of the two oxysterols was 5&#x000a0;&#x003bc;M (2&#x000a0;&#x003bc;g/ml) and 17&#x000a0;&#x003bc;M (6.8&#x000a0;&#x003bc;g/ml), respectively. However, when using a different assay, where 25-HC and 26-HC were added postinfection, the respective EC<sub>50</sub> values were much lower at 180&#x000a0;nM (72&#x000a0;ng/ml) and 220&#x000a0;nM (88&#x000a0;ng/ml). Based on the knowledge that the proinflammatory cytokine IL-6 is produced in response to HSV-1 infection and evidence that it has an antiviral effect, Cango <em>et&#x000a0;al.</em> tested if 25-HC or 26-HC pretreatment of cells would induce IL-6 secretion. Both oxysterols had this effect, as did viral treatment alone, and preincubation with either oxysterol followed by viral treatment proved to be additive toward IL-6 secretion in HeLa cells (<a href="#bib105" rid="bib105" class=" bibr popnode">105</a>). Cango <em>et&#x000a0;al.</em> then confirmed that IL-6 was antiviral against HSV-1 and proposed that one mechanism by which 25-HC and 26-HC may be protective against viral infection is through upregulation of antiviral IL-6 (<a href="/pmc/articles/PMC8953665/figure/fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig1" rid-ob="ob-fig1" co-legend-rid="lgnd_fig1"><span>Fig.&#x000a0;1</span></a>). The explanation of the antiviral effect of these oxysterols postinfection was not obvious but could be due to sustained production of IL-6. Interestingly, earlier work from the same group had indicated that both 25-HC and 26-HC had antiviral activity against the nonenveloped viruses human papillomavirus-16, human rotavirus, and human rhinovirus, which argued against a general mechanism for antiviral activity of 25-HC involving membrane fusion, but rather these oxysterols may inhibit the viral replication machinery postviral entry (<a href="#bib106" rid="bib106" class=" bibr popnode">106</a>).</p></div><div id="sec6.4" class="sec sec-last"><h3 id="sec6.4title">25-HC and coronaviruses</h3><p id="p0230" class="p p-first">IFNs are induced by coronaviruses (<a href="#bib107" rid="bib107" class=" bibr popnode">107</a>), and IFN-stimulated genes expressed by cells infected with SARS-CoV and SARS-CoV-2 include <em>CH25H</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>, <a href="#bib14" rid="bib14" class=" bibr popnode">14</a>). SARS-CoV-2 infects lung epithelial cells, and <em>CH25H</em> has been shown to be upregulated in both epithelial cells and macrophages found in bronchioalveolar lavage fluid from COVID-19 patients (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>). SARS-CoV-2 also infects intestinal epithelial cells (<a href="#bib108" rid="bib108" class=" bibr popnode">108</a>), and Zang <em>et&#x000a0;al.</em> (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>) confirmed <em>CH25H</em> to be an IFN-stimulated gene in human enteroids. Importantly, 25-HC has been found to be elevated in some patients suffering from COVID-19 (<a href="#bib12" rid="bib12" class=" bibr popnode">12</a>, <a href="#bib109" rid="bib109" class=" bibr popnode">109</a>). Zu <em>et&#x000a0;al.</em> (<a href="#bib12" rid="bib12" class=" bibr popnode">12</a>) performed a longitudinal study on a single COVID-19 patient analyzing serum samples for 25-HC by LC-MS (without hydrolysis) at four time points. 25-HC was stable at a level similar to controls (&#x0003c;10&#x000a0;ng/ml) for the first three time points but jumped to about 60&#x000a0;ng/ml, 2 days before the patient deceased. In a more detailed study of 144 adults with SARS-CoV-2, Marcello <em>et&#x000a0;al.</em> (<a href="#bib109" rid="bib109" class=" bibr popnode">109</a>) found that a group of patients with mild symptoms showed a modest but significant increase in serum 25-HC (9.7 &#x000b1; 2.5&#x000a0;ng/ml, mean &#x000b1; SD) compared with controls (8.5 &#x000b1; 2.6&#x000a0;ng/ml), whereas the other patient groups displaying moderate (8.4 &#x000b1; 2.6&#x000a0;ng/ml) or severe symptoms (7.6 &#x000b1; 2.5&#x000a0;ng/ml) showed a small decrease in 25-HC levels. This study was performed by GC-MS for total 25-HC following hydrolysis of sterol esters. Interestingly, the serum concentration of 26-HC fell from 171.5 &#x000b1; 34.6&#x000a0;ng/ml in controls to 142.3 &#x000b1; 33.2&#x000a0;ng/ml in patients with mild symptoms to 119.6 &#x000b1; 52.4 and 87.8 &#x000b1; 31.9&#x000a0;ng/ml in patients with moderate and severe symptoms, respectively (<a href="#bib109" rid="bib109" class=" bibr popnode">109</a>). Marcello <em>et&#x000a0;al.</em> (<a href="#bib109" rid="bib109" class=" bibr popnode">109</a>) suggested treatment with 26-HC as a possible course of action against severe COVID-19.</p><p id="p0235">SARS-CoV-2 infection proceeds via the viral spike protein binding to the angiotensin-converting enzyme 2 (ACE2) receptor on the plasma membrane of host cells, followed by priming of the spike protein by the serine protease transmembrane protease/serine subfamily member 2 (TMPRSS2) prior to membrane fusion of the viral envelope with the plasma membrane of the host cell and release of viral RNA into the cell (<a href="#bib110" rid="bib110" class=" bibr popnode">110</a>, <a href="#bib111" rid="bib111" class=" bibr popnode">111</a>). This is known as the early fusion pathway that dominates SARS-CoV-2 infection. An alternative pathway in cells not expressing membrane-bound TMPRSS2 is the endosomal pathway in which viral particles are endocytosed and the spike protein is primed for membrane fusion with the membrane of the lysosomal-endosomal compartment by a cathepsin cysteine protease, itself activated by the low pH in the lysosomal-endosomal compartment (<a href="/pmc/articles/PMC8953665/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>) (<a href="#bib110" rid="bib110" class=" bibr popnode">110</a>, <a href="#bib111" rid="bib111" class=" bibr popnode">111</a>).</p><p id="p0240">Because of the high safety requirement of handling SARS-CoV-2, a replication-restricted pseudovirus, which bares the viral coat proteins, is often used in laboratory experiments of viral entry, and Wang <em>et&#x000a0;al.</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>) exploited a SARS-CoV-2 pseudovirus in a study of viral entry into lung epithelial cells. SARS-CoV-2 entry to lung epithelial cells is primarily through the early fusion pathway rather than by endocytosis, and Wang <em>et&#x000a0;al.</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>) found that pseudovirus entry to Calu-3&#x000a0;cells, an epithelial cell line expressing ACE2 and TMPRSS2, to be inhibited by 25-HC at an IC<sub>50</sub> of 550&#x000a0;nM (220&#x000a0;ng/ml). They then showed that 25-HC acts at the level of spike-mediated membrane fusion rather than receptor binding, and by exploiting ALOD4 showed that 25-HC blocks viral entry to Calu-3&#x000a0;cells by mobilizing accessible cholesterol away from the plasma membrane. Significantly, supplementation of cholesterol using a cyclodextrin vehicle restored SARS-CoV-2 fusion and entry (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>). Similar effects were observed with SARS-CoV and Middle East respiratory syndrome-related CoV pseudoviruses (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>).</p><p id="p0245">As discussed previously, multiple mechanisms exist by which 25-HC can alter the level of plasma membrane accessible cholesterol. Wang <em>et&#x000a0;al.</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>) favored a mechanism by which 25-HC activated SOAT, by removing nonesterified cholesterol from the endoplasmic reticulum and encouraging net transport of accessible cholesterol from the plasma membrane to the endoplasmic reticulum. They found that the SOAT inhibitor, Sandoz 58-035, increased the amount of accessible cholesterol in the plasma membrane of 25-HC-conditioned Calu-3&#x000a0;cells, and importantly rescued SARS-CoV-2 pseudovirus entry, as did SOAT knockdown by shRNA (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>). These experiments were performed in lipid-depleted medium; hence, cholesterol uptake via the LDL receptor was restricted, so its regulation by SREBP-2 was not considered. In summary, the results of Wang <em>et&#x000a0;al.</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>) indicate that the early membrane fusion pathway involves plasma membrane accessible cholesterol, and its depletion by 25-HC-mediated activation of SOAT restricts viral entry and viral genome release (<a href="/pmc/articles/PMC8953665/figure/fig7/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig7" rid-ob="ob-fig7" co-legend-rid="lgnd_fig7"><span>Fig.&#x000a0;7</span></a>).</p><p id="p0250">Zang <em>et&#x000a0;al.</em> (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>) also utilized a SARS-CoV-2 pseudovirus to demonstrate the antiviral properties of 25-HC. They found that 25-HC inhibited pseudovirus infection of MA104&#x000a0;cells, a Rhesus monkey epithelial cell line, at an EC<sub>50</sub> of 1.5&#x000a0;&#x003bc;M (600&#x000a0;ng/ml) and that WT SARS-CoV-2 was also inhibited by 25-HC in an assay of HEK293-hACE2 cells (HEK293&#x000a0;cells expressing the human ACE2 receptor) (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>). To study the mechanism of 25-HC antiviral activity against SARS-CoV-2, they exploited an in&#x000a0;vitro cell fusion assay and found that both <em>CH25H</em> expression and addition of 25-HC reduced membrane fusion. Fluorescent-labeled 25-HC (C4 TopFluor-25-HC) was found to have almost identical antiviral activity against the SARS-CoV-2 pseudovirus in HEK293&#x000a0;cells as 25-HC and similarly blocked membrane fusion. Interestingly, C4 TopFluor-25-HC was found to accumulate in the late endosome-lysosome compartment when added to HEK cells in medium containing fetal bovine serum. 25-HC treatment of these cells led to intracellular accumulation of TopFluor-cholesterol and of nonesterified cholesterol as measured by filipin staining, a similar effect to that mediated by the NPC1 inhibitors U18666A and itraconazole (ICZ). Importantly, ICZ significantly reduced SARS-CoV-2 pseudovirus titers, and the antiviral activities of 25-HC and ICZ were found to be diminished in serum-free media. In combination, these data suggested to Zang <em>et&#x000a0;al.</em> that 25-HC inhibits the endosomal pathway of viral infection and that nonesterified cholesterol accumulates in the endosomal/lysosomal compartment as a consequence of NPC1 inhibition. Cholesterol accumulation in the interior of the compartment was reasoned to mediate the antiviral activity of both 25-HC and ICZ (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>). A complication to this mechanism is that in cellular assays, 25-HC travels directly to the endoplasmic reticulum without traversing the lysosome on its way to inhibiting SREBP-2 processing (<a href="#bib34" rid="bib34" class=" bibr popnode">34</a>, <a href="#bib112" rid="bib112" class=" bibr popnode">112</a>); however, in&#x000a0;vivo, it is likely that when derived from the circulation, where the majority of 25-HC is esterified (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib114" rid="bib114" class=" bibr popnode">114</a>), the ester as part of lipoprotein particles is taken up by receptor-mediated endocytosis and travels to the lysosome where it is hydrolyzed to the nonesterified molecule. Zang <em>et&#x000a0;al.</em> (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>) concluded that 25-HC reduces SARS-CoV-2 spike-mediated fusion via a mechanism that involves altered cholesterol levels leading to inhibition of viral replication. The data by Zang <em>et&#x000a0;al.</em> (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>) suggest that inhibition of NPC1 by 25-HC leads to a reduction in accessible cholesterol in the membrane of the endosomal/lysosomal compartment, which results in reduced membrane fusion with the viral envelope and thereby preventing release of viral RNA.</p><p id="p0255">In summary, the studies of Wang <em>et&#x000a0;al.</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>) and Zang <em>et&#x000a0;al.</em> (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>) suggest a model in which viral infection leads to activation of pattern recognition receptors on macrophages, IFN secretion, upregulation of <em>CH25H</em>, and synthesis and secretion of 25-HC. Paracrine or autocrine, or even hormonal signaling, by 25-HC leads to reduced accessible cholesterol in the plasma membrane and/or endosomal/lysosomal membrane of host cells restricting SARS-CoV-2 spike protein-mediated fusion and viral replication.</p><p id="p0260">Following on from the work of Zu <em>et&#x000a0;al.</em> (<a href="#bib12" rid="bib12" class=" bibr popnode">12</a>), Wang <em>et&#x000a0;al.</em> (<a href="#bib13" rid="bib13" class=" bibr popnode">13</a>), Zang <em>et&#x000a0;al.</em> (<a href="#bib14" rid="bib14" class=" bibr popnode">14</a>), and Marcello <em>et&#x000a0;al.</em> (<a href="#bib109" rid="bib109" class=" bibr popnode">109</a>) connecting 25-HC with the mechanism of SARS-CoV-2 infection, others have suggested therapeutics based on the 25-HC structure (<a href="#bib115" rid="bib115" class=" bibr popnode">115</a>, <a href="#bib116" rid="bib116" class=" bibr popnode">116</a>). Kim <em>et&#x000a0;al.</em> (<a href="#bib115" rid="bib115" class=" bibr popnode">115</a>) prepared nanovesicles made of 25-HC and didodecyldimethylammonium bromide (DDAB), that is, 25-HC@DDAB, DDAB being a cationic lipid that forms liposome-like structures. 25-HC@DDAB was found to selectively accumulate in lung tissue and downregulate the NF-&#x003ba;B and SREBP-2 pathways and in peripheral blood mononuclear cells derived from COVID-19 patients, reducing inflammatory cytokine levels (<a href="#bib115" rid="bib115" class=" bibr popnode">115</a>). Ohashi <em>et&#x000a0;al.</em> (<a href="#bib116" rid="bib116" class=" bibr popnode">116</a>) screened a panel of naturally occurring and semisynthetic oxysterols for anti-SARS-CoV-2 activity using a cell culture infection assay. They found that 7-oxocholesterol (7-OC, also called 7-ketocholesterol), 22R-HC, 24S-HC, and 26-HC inhibited SARS-CoV-2 propagation in cultured cells. Two semisynthetic oxysterols based on the 20-HC skeleton, but <em>i</em>) with a C<sub>4</sub> side chain (rather than the C<sub>8</sub> as in cholesterol) attached at the terminal carbon to a pyridine ring through the carbon at position 3 of the aromatic heterocycle (Oxy210, see <a href="#appsec1" rid="appsec1" class=" sec">supplemental data</a>) and <em>ii</em>) with a 5&#x003b1;-reduced B-ring and a C<sub>5</sub> side chain with a C-21 ethyl rather than methyl group (Oxy232), were found to display more robust anti-SARS-CoV-2 activities, reducing viral replication more than 90% at 10&#x000a0;&#x003bc;M and 99% at 15&#x000a0;&#x003bc;M, respectively (<a href="#bib116" rid="bib116" class=" bibr popnode">116</a>). These studies suggest a therapeutic value for side-chain oxysterols and their derivatives in the treatment of SARS-CoV-2.</p><p id="p0265" class="p p-last">With respect to 7-OC, Ghzaiel <em>et&#x000a0;al.</em> (<a href="#bib117" rid="bib117" class=" bibr popnode">117</a>) proposed that 7-OC may be involved in the pathophysiology of SARS-CoV-2 by promoting acute respiratory distress syndrome, and therapies countering the toxic effects of 7-OC may have therapeutic merit.</p></div></div><div id="sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="sec7title">Proinflammatory oxysterols</h2><p id="p0270" class="p p-first">As mentioned previously, 25-HC can have a proinflammatory as well as an anti-inflammatory role. It can augment macrophage and epithelial cell secretion of the inflammatory cytokines IL-6, IL-8, and macrophage colony-stimulating factor in a mechanism involving stimulation of TLR, but which is otherwise ill defined (<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>, <a href="#bib104" rid="bib104" class=" bibr popnode">104</a>, <a href="#bib118" rid="bib118" class=" bibr popnode">118</a>). As mentioned previously, 26-HC may also augment inflammatory cytokine production (<a href="#bib105" rid="bib105" class=" bibr popnode">105</a>), one mechanism may involve its action as a selective estrogen receptor modulator (<a href="#bib119" rid="bib119" class=" bibr popnode">119</a>). The concentration of available oxysterols is likely to dictate whether they behave in a proinflammatory manner or an anti-inflammatory manner, and it is possible that multiple oxysterols have additive effects. It is noteworthy that 25-HC repressed the expression of <em>Il1b</em> in LPS-stimulated <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> macrophages at a level of 100&#x000a0;nM (40&#x000a0;ng/ml) (<a href="#bib84" rid="bib84" class=" bibr popnode">84</a>), whereas some proinflammatory effects of 25-HC are observed at micromolar concentrations (<a href="#bib104" rid="bib104" class=" bibr popnode">104</a>, <a href="#bib118" rid="bib118" class=" bibr popnode">118</a>).</p><p id="p0275" class="p p-last">Besides side-chain oxysterols, ring oxysterols also have modulatory effects on the immune system. 7&#x003b2;-Hydroxycholesterol (7&#x003b2;-HC) has been found to enhance IL-8 mRNA in, and secretion from, U937 human promonocytic leukemia cells (<a href="#bib120" rid="bib120" class=" bibr popnode">120</a>), whereas 4&#x003b2;-HC has been implicated in colon inflammation (<a href="#bib121" rid="bib121" class=" bibr popnode">121</a>). However, it is oxysterols modified in both the ring and side chain that have attracted most attention in immunology and which are discussed later.</p></div><div id="sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="sec8title">7&#x003b1;,25-diHC and EBI2 (GPR183)</h2><p id="p0280" class="p p-first">EBI2 is a G protein-coupled receptor (GPR183); it is widely expressed in the immune system by multiple cell types, including macrophages, neutrophiles, B cells, T cells, and DCs (<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>, <a href="#bib122" rid="bib122" class=" bibr popnode">122</a>). The ligands for GPR183 were discovered independently by scientists from Novartis and Johnson &#x00026; Johnson to be dihydroxycholesterols with the most potent being 7&#x003b1;,25-diHC and 7&#x003b1;,26-dihydroxycholesterol (7&#x003b1;,26-diHC), presumably the 25R-epimer, although it is not clear whether the 25S-epimer also has biological activity (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>). The reader can, however, assume 25R stereochemistry unless stated otherwise, as this is normally the dominant epimer in human and mouse. While the ligand identifications made by Hannedouche <em>et&#x000a0;al.</em> (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>) were made based on chromatographic separations and detailed MS analysis of biologically active fractions from sheep liver, the identifications made by Liu <em>et&#x000a0;al.</em> (<a href="#bib6" rid="bib6" class=" bibr popnode">6</a>) were perhaps fortuitous as GC-MS identification from porcine spleen were of 7&#x003b1;-HC and 7&#x003b2;-HC, the true ligands only being identified following screening of a panel of synthetic oxysterols. Liu <em>et&#x000a0;al.</em> (<a href="#bib6" rid="bib6" class=" bibr popnode">6</a>) went on to measure by GC-MS the level of 7&#x003b1;,25-diHC to be 1.4 &#x000b1; 0.2&#x000a0;ng/g of spleen tissue, which increased to 9.4 &#x000b1; 1.3&#x000a0;ng/g after LPS challenge and determined a dissociation constant for 7&#x003b1;,25-HC from GPR183 to be 450 pM (180 pg/ml). For comparison, 100&#x000a0;&#x003bc;g of 7&#x003b1;,25-diHC was isolated by Hannedouche <em>et&#x000a0;al.</em> (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>) from 35&#x000a0;kg of pig liver; this translates to a 7&#x003b1;,25-diHC concentration of 2.9&#x000a0;ng/g of tissue. Both groups found 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC to be chemoattractants to cells expressing GPR183, with 7&#x003b1;,25-diHC as the more potent ligand (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>).</p><div id="sec8.1" class="sec"><h3 id="sec8.1title">B cells</h3><p id="p0285" class="p p-first">An important function of 7&#x003b1;,25-diHC, 7&#x003b1;,26-diHC, and GPR183 is in the guidance of immune cells required for mounting an adaptive immune response (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>, <a href="#bib7" rid="bib7" class=" bibr popnode">7</a>). The first described biological activity of GPR183-expressing cells toward these oxysterols was of B cells responding to antigen encounter (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>, <a href="#bib7" rid="bib7" class=" bibr popnode">7</a>). This is eloquently described by Cyster <em>et&#x000a0;al.</em> (<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>) and will be precised here. In the spleen, following antigen encounter and receptor engagement, B cells upregulate expression of GPR183. Activated B cells then migrate toward 7&#x003b1;,25-diHC, which is suggested to be most abundant, based on enzyme expression data, in the inter and outer follicular regions of lymph tissue (<a href="/pmc/articles/PMC8953665/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Fig.&#x000a0;8</span></a>). Within a few hours of antigen encounter, GPR183 promotes B-cell positioning toward the outer region of the follicle, close to where antigens enter the follicle. After about 6&#x000a0;h, activated B cells are distributed along the interface between the B-cell follicle and the T-cell zone in the spleen in response to the chemokine ligands CCL19 and CCL21 in the T-cell zone and upregulation of their receptor CCR7 in the B cells. The interface between the B-cell follicle and T-cell zone is a region in which B cells encounter cognate T<sub>h</sub> cells. Signals from T<sub>h</sub> cells maintain GPR183 expression but downregulate the chemokine receptor CCR7 for CCL19 and CCL21. Next after 2&#x02013;3&#x000a0;days, B cells are positioned in a GPR183-dependent manner toward the outer regions of the follicle, with a preference for interfollicular regions. It is suggested that 7&#x003b1;,25-HC is most abundant in these regions. The reason for this B-cell positioning may be to increase exposure to newly arriving antigen and/or for DCs in these areas to augment plasmablast responses and plasma cell formation. During differentiation into germinal center B cells, GPR183 is downregulated important for movement to the follicle center. In the germinal center, B cells undergo rounds of proliferation. Importantly, deficiency in GPR183 leads to a reduced plasma cell response and antibody secretion (<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>). GPR183 deficiency in mice leads to reduced immunoglobulin G and immunoglobulin M antibody response (<a href="#bib123" rid="bib123" class=" bibr popnode">123</a>, <a href="#bib124" rid="bib124" class=" bibr popnode">124</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig8" co-legend-rid="lgnd_fig8"><a href="/pmc/articles/PMC8953665/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816977131888"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr8.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr8.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr8.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816977131888"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig8/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig8"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig8/" target="figure" rid-figpopup="fig8" rid-ob="ob-fig8">Fig.&#x000a0;8</a></div><!--caption a7--><div class="caption"><p>GPR183 and 7&#x003b1;,25-diHC guide B-cell positioning within lymphoid tissue. Figure&#x000a0;inspired by Refs.&#x000a0;(<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>, <a href="#bib7" rid="bib7" class=" bibr popnode">7</a>). On a time course from antigen encounter at time 0 to 4 days post exposure, the guidance of activated B cells towards 7&#x003b1;,25-diHC and chemokines CCL19 and CCL21 according to expression of their respective receptors GPR183 and CCR7 is displayed.</p></div></div></div><p id="p0290" class="p p-last">The distribution of naive B cells within the follicle is also influenced by GPR183, favoring migration to the outer follicle edge. Besides B cells, CD4<sup>+</sup> T cells also express GPR183 and migrate toward 7&#x003b1;,25-diHC (<a href="#bib6" rid="bib6" class=" bibr popnode">6</a>).</p></div><div id="sec8.2" class="sec"><h3 id="sec8.2title">DCs</h3><p id="p0295" class="p p-first">DCs, the antigen-presenting cells of the innate and adaptive immune systems, express GPR183 and in&#x000a0;vitro migrate toward 7&#x003b1;,25-diHC (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>, <a href="#bib125" rid="bib125" class=" bibr popnode">125</a>, <a href="#bib126" rid="bib126" class=" bibr popnode">126</a>). In 2013, articles by Gatto <em>et&#x000a0;al.</em> (<a href="#bib125" rid="bib125" class=" bibr popnode">125</a>) and Yi and Cyster (<a href="#bib126" rid="bib126" class=" bibr popnode">126</a>) established that DCs in the spleen require GPR183 and 7&#x003b1;,25-diHC for proper positioning in marginal zone bridging channels, a specialized type of interfollicular region, and are important for mounting T cell-dependent antibody responses against some blood-borne antigens (<a href="#bib7" rid="bib7" class=" bibr popnode">7</a>). In the spleen, there are two types of DC cells, cDC2 cells important for presenting antigen to CD4<sup>+</sup> T cells and cDC1 cells that present antigen to CD8<sup>+</sup> T cells. Naive cDC2 cells are mostly located in the marginal zone bridging channels (<a href="/pmc/articles/PMC8953665/figure/fig9/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig9" rid-ob="ob-fig9" co-legend-rid="lgnd_fig9"><span>Fig.&#x000a0;9</span></a>). Recently, Lu <em>et&#x000a0;al.</em> (<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>) provided evidence that not only 7&#x003b1;,25-diHC but also 7&#x003b1;,26-diHC is important in positioning of cDC2 cells. <em>Cyp27a1</em> is expressed in the marginal zone bridging channels along with <em>Ch25h</em>, and Lu <em>et&#x000a0;al.</em> (<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>) proposed that under stable or homeostatic conditions, 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC in combination attract cDC2 cells to these channels. After cDC2 cell activation, GPR183 and CCR7, the receptor for the T-cell zone chemokines, CCL19 and CCL21, are upregulated directing activated cDC2 cells toward in the T-cell zone where 7&#x003b1;,25-diHC helps position the cells at the B-T zone interface, where they can interact with early activated T cells and promote differentiation to T follicular helper cells (<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>). T follicular helper cells help B cells produce antibodies against foreign pathogens and are found in the B-cell zone of secondary lymphoid organs. Lu <em>et&#x000a0;al.</em> (<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>) measured the 7&#x003b1;,26-diHC content of spleen extracts by LC-MS and found it to be present at a level of 12&#x000a0;ng/g (30&#x000a0;nM) in WT mice, whereas 7&#x003b1;,26-diHC was absent in extracts from <em>Cyp27a1</em><sup>&#x02212;/&#x02212;</sup> mice. In confirmation of the importance of <em>Cyp27a1</em> in DC positioning, <em>Cyp27a1/Ch25h</em> double knockout mice showed a more severe cDC2 deficiency than <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mice and more comparable to <em>Gpr183</em><sup>&#x02212;/&#x02212;</sup> mice. cDC1 cells may also be important for the proper positioning of activated cDC2 cells toward the outer T-cell zone by acting as a sink for 7&#x003b1;,25-diHC (and 7&#x003b1;,26-diHC) more centrally within the T-cell zone through conversion of the dihydroxycholesterols to their 3-oxo-4-ene derivatives and inducing a gradient of 7&#x003b1;,25-diHC maximizing at the outer T-cell zone. Interestingly, type I IFNs can negatively regulate DC positioning in the outer T-cell zone by upregulating <em>Ch25h</em> expression and presumably disturbing 7&#x003b1;,25-diHC gradients in the T-cell zone (<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig9" co-legend-rid="lgnd_fig9"><a href="/pmc/articles/PMC8953665/figure/fig9/" target="figure" rid-figpopup="fig9" rid-ob="ob-fig9"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816972379888"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr9.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr9.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr9.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816972379888"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig9/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig9"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig9/" target="figure" rid-figpopup="fig9" rid-ob="ob-fig9">Fig.&#x000a0;9</a></div><!--caption a7--><div class="caption"><p>Positioning of naive and activated cDC2 cells to promote T follicular helper (Tfh) cell differentiation. Naive cDC2 cells are positioned in marginal zone bridging channels by the GPR183 ligands 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC. Upon activation, CCR7 is expressed, and cDC2 cells are guided by 7&#x003b1;,25-diHC to the B-T cell zone interface where they interact with early activated T cells to promote Tfh cell differentiation. Tfh cells help B cells produce antibodies against foreign pathogens. Figure&#x000a0;inspired by Ref.&#x000a0;(<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>).</p></div></div></div><p id="p0300" class="p p-last">In summary, GPR183-mediated positioning of B and DC cells and possibly CD4+ T cells in the interfollicular region may promote interactions between cells that together augment the antibody response (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>, <a href="#bib7" rid="bib7" class=" bibr popnode">7</a>).</p></div><div id="sec8.3" class="sec"><h3 id="sec8.3title">7&#x003b1;,25-diHC, 7&#x003b1;,26-diHC, enzymes, and genes</h3><p id="p0305" class="p p-first">While Hannedouche <em>et&#x000a0;al.</em> (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>) and Liu <em>et&#x000a0;al.</em> (<a href="#bib6" rid="bib6" class=" bibr popnode">6</a>) made MS-based measurements of 7&#x003b1;,25-diHC from liver (pig liver 3&#x000a0;ng/g) and lymphoid tissue (mouse spleen 1&#x02013;10&#x000a0;ng/g) (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib6" rid="bib6" class=" bibr popnode">6</a>), there are few other quantitative measurements in the literature of this or of the other major GPR183 ligand 7&#x003b1;,26-diHC in tissue or fluids (<a href="#bib121" rid="bib121" class=" bibr popnode">121</a>, <a href="#bib127" rid="bib127" class=" bibr popnode">127</a>, <a href="#bib128" rid="bib128" class=" bibr popnode">128</a>, <a href="#bib129" rid="bib129" class=" bibr popnode">129</a>, <a href="#bib130" rid="bib130" class=" bibr popnode">130</a>). Lu <em>et&#x000a0;al.</em> (<a href="#bib127" rid="bib127" class=" bibr popnode">127</a>) measured 7&#x003b1;,26-diHC by LC-MS to be at a level of 12&#x000a0;ng/g in mouse spleen tissue, whereas Wanke <em>et&#x000a0;al.</em> (<a href="#bib128" rid="bib128" class=" bibr popnode">128</a>) found 7&#x003b1;,25-diHC to be elevated in central nervous system (CNS) tissue from an EAE mouse model but did not provide concentration units; similarly, Mutemberezi <em>et&#x000a0;al.</em> (<a href="#bib129" rid="bib129" class=" bibr popnode">129</a>) measured 7&#x003b1;,25-diHC in the context of neuroinflammation but failed to provide concentration units. Guillemot-Legris <em>et&#x000a0;al.</em> (<a href="#bib121" rid="bib121" class=" bibr popnode">121</a>) performed extensive oxysterol profiling by LC-MS of colon and liver tissue in the context of a mouse model of colitis and found 7&#x003b1;,25-diHC to be at a level of 100&#x02013;200 pmol/g tissue (40&#x02013;80&#x000a0;ng/g) in colon and about 20 pmol/g (8&#x000a0;ng/g) in liver. Raselli <em>et&#x000a0;al.</em> (<a href="#bib131" rid="bib131" class=" bibr popnode">131</a>) measured oxysterol levels in human and mouse livers by LC-MS but failed to detect 7&#x003b1;,25-diHC. The level of 7&#x003b1;,26-diHC in human liver was about 3&#x000a0;ng/g, but in liver from patients with nonalcoholic steatohepatitis, the downstream metabolite 7&#x003b1;,(25R)26-dihydroxycholest-4-en-3-one (7&#x003b1;,26-diHCO) was significantly elevated above control values, that is, 21&#x000a0;ng/g cf. 4 ng/g. Interestingly, these results were not replicated in a mouse model of nonalcoholic steatohepatitis, where levels of 7&#x003b1;,26-diHC and 7&#x003b1;,26-diHCO were about 25 and 50&#x000a0;ng/g, respectively, in both WT and treated animals (<a href="#bib131" rid="bib131" class=" bibr popnode">131</a>). It is important to note that both 7&#x003b1;,26-diHC and 7&#x003b1;,26-diHCO are found in man and mouse as 25R-epimer and 25S-epimer where the stereochemistry at C-25 is different (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib132" rid="bib132" class=" bibr popnode">132</a>), and that Raselli <em>et&#x000a0;al.</em> (<a href="#bib131" rid="bib131" class=" bibr popnode">131</a>) specifically quantified the 25R-epimer. Very few other studies define the specific epimer(s) measured; however, the 25R-epimers is usually dominant except in the case of CYP27A1 deficiency (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib132" rid="bib132" class=" bibr popnode">132</a>, <a href="#bib133" rid="bib133" class=" bibr popnode">133</a>), where the 25S-epimer dominates. By default, and unless explicitly stated here, it can be assumed that the stereochemistry at C-25 is R, and the concentrations presented are for the 25R-epimer or for a combination of C-25R and C-25S epimers. This is also true with respect to measurements of biological activity where few if any reports define the stereochemistry at C-25, and the reader is left to assume 25R stereochemistry. Even the patent filed by Novartis of the invention of 7&#x003b1;,26-diHC as a ligand of EBI2 (GPR183) failed to define the stereochemistry at C-25 (WO 2010/066689 A2). To the best of our knowledge, the biological activity of 7&#x003b1;,(25S)26-diHC has not been tested toward GPR183.</p><p id="p0310">Both 7&#x003b1;,25-diHC (1&#x000a0;ng/ml) and 7&#x003b1;,26-diHC (6&#x02013;10&#x000a0;ng/ml) can be detected by LC-MS in human plasma following ester hydrolysis as the sum of esterified and nonesterified sterols (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib134" rid="bib134" class=" bibr popnode">134</a>), but their levels as free nonesterified molecules are very low (7&#x003b1;,25-diHC, 0.2&#x000a0;ng/ml; 7&#x003b1;,26-diHC, 0.5&#x000a0;ng/ml (<a href="#bib135" rid="bib135" class=" bibr popnode">135</a>)). However, the nonesterified 3-oxo-4-ene metabolites (produced through the action of HSD3B7) are more abundant (7&#x003b1;,25-diHCO, 1&#x02013;2&#x000a0;ng/ml; 7&#x003b1;,26-diHCO, 3&#x02013;8&#x000a0;ng/ml (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib135" rid="bib135" class=" bibr popnode">135</a>)). In mouse plasma, the situation is similar with levels of nonesterified 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC being very low at about 0.1&#x000a0;ng/ml, with 7&#x003b1;,25-diHCO and 7&#x003b1;,26-diHCO at about 1&#x000a0;ng/ml (<a href="#bib132" rid="bib132" class=" bibr popnode">132</a>). Nonesterified 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC are hardly detectable by LC-MS in &#x0201c;control&#x0201d; human cerebrospinal fluid (CSF) (&#x0003c;0.01&#x000a0;ng/ml), although their levels are measurable at about 0.05&#x000a0;ng/ml in CSF from people with pathogen-based infections of the CNS (<a href="#bib135" rid="bib135" class=" bibr popnode">135</a>). The HSD3B7-derived metabolites 7&#x003b1;,25-diHCO and 7&#x003b1;,26-diHCO are detectable in control CSF at about 0.03&#x000a0;ng/ml, and from patients with pathogen-based infections, 7&#x003b1;,26-diHCO is elevated significantly to 0.05&#x000a0;ng/ml (<a href="#bib135" rid="bib135" class=" bibr popnode">135</a>). In hydrolyzed &#x0201c;control&#x0201d; CSF, the sum of esterified and nonesterified 7&#x003b1;,25-diHC is about 0.05&#x000a0;ng/ml, whereas that of 7&#x003b1;,(25R/S)26-diHC is about 0.2&#x000a0;ng/ml (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>). Note that concentrations of 7,25-diHCO and 7,26-diHCO are difficult to measure by LC-MS in hydrolyzed samples as the 7-hydroxy-3-oxo-4-ene structure dehydrates under the basic conditions of hydrolysis. In mouse CSF, unesterified 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC have only been measured by LC-MS in combination with their 3-oxo-4-ene analogs, concentration being in the region of 0.01&#x02013;0.04&#x000a0;ng/ml (<a href="#bib136" rid="bib136" class=" bibr popnode">136</a>).</p><p id="p0315">The deficit in measurement of GPR183 ligand concentrations, particularly in tissue samples, has meant that gradients of 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC have been assumed based on expression of genes or enzymes required for their synthesis from cholesterol. These assumptions have been based on the hypothesis that CH25H and CYP7B1 are the dominant enzymes for 7&#x003b1;,25-diHC formation (<a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A) and CYP27A1 and CYP7B1 for the formation of 7&#x003b1;,26-diHC (<a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>B). While this may be true in spleen (<a href="#bib126" rid="bib126" class=" bibr popnode">126</a>), this is not necessarily correct in other lymphoid tissues as 7&#x003b1;,26-diHC can be synthesized from cholesterol via CYP7A1 to generate 7&#x003b1;-HC hepatically and then by CYP27A1 to generate 7&#x003b1;,26-diHC in the periphery (<a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>B), and it should be noted that 7&#x003b1;-HC is abundant in the circulation as the nonesterified molecule (5&#x02013;20&#x000a0;ng/ml) (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib114" rid="bib114" class=" bibr popnode">114</a>, <a href="#bib135" rid="bib135" class=" bibr popnode">135</a>) and can cross plasma membranes (<a href="#bib52" rid="bib52" class=" bibr popnode">52</a>). Similarly, 7&#x003b1;,25-diHC can be generated from 7&#x003b1;-HC, the 25-hydroxylase being by CYP3A4 (<a href="#bib132" rid="bib132" class=" bibr popnode">132</a>).</p><p id="p0320">With respect to positioning of B cells in lymphoid tissue, Yi <em>et&#x000a0;al.</em> (<a href="#bib137" rid="bib137" class=" bibr popnode">137</a>) found that lymphoid stromal cells were the main CH25H-expressing and CYP7B1-expressing cells required for B-cell positioning, and that CH25H and CYP7B1 were abundant in interfollicular and outer follicular stromal cells but low in the central region of the follicle, thereby explaining movement of GPR183-expressing B cells to the outer and interfollicular regions when mounting the adaptive immune response (<a href="/pmc/articles/PMC8953665/figure/fig8/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig8" rid-ob="ob-fig8" co-legend-rid="lgnd_fig8"><span>Fig.&#x000a0;8</span></a>). CH25H, CYP7B1, and HSD3B7 were also found to be expressed in the T-cell zone of lymphoid tissue providing a route to 7&#x003b1;,25-diHC formation, then removal, and to the generation of 7&#x003b1;,25-diHC gradients (<a href="#bib126" rid="bib126" class=" bibr popnode">126</a>).</p><p id="p0325">Both <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> and <em>Cyp7b1</em><sup>&#x02212;/&#x02212;</sup> mice phenocopy <em>Gpr183</em><sup>&#x02212;/&#x02212;</sup> mice with respect to B-cell positioning and to a reduced T cell-dependent antibody response (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>, <a href="#bib137" rid="bib137" class=" bibr popnode">137</a>) and also show a reduction in CD4<sup>+</sup> DC numbers (<a href="#bib125" rid="bib125" class=" bibr popnode">125</a>,&#x000a0;<a href="#bib137" rid="bib137" class=" bibr popnode">137</a>). Interestingly, <em>Hsd3b7</em><sup>&#x02212;/&#x02212;</sup> mice have similar defects in B and DC cells as <em>Gpr183</em><sup>&#x02212;/&#x02212;</sup> mice emphasizing that it is molecular gradients that are the key to the T cell-dependent antibody response (<a href="#bib137" rid="bib137" class=" bibr popnode">137</a>).</p><p id="p0330">In human, CYP7B1 deficiency can present as oxysterol 7&#x003b1;-hydroxylase deficiency in the infant and spastic paraplegia type 5 (SPG5) in the adult (<a href="#bib138" rid="bib138" class=" bibr popnode">138</a>). Oxysterol 7&#x003b1;-hydroxylase deficiency presents with liver disease, which can be successfully treated by bile acid replacement therapy (<a href="#bib139" rid="bib139" class=" bibr popnode">139</a>), whereas SPG5 is a disorder with progressive degeneration of upper motor neurones leading to lower extremity weakness and spasticity. Neither SPG5 nor oxysterol 7&#x003b1;-hydroxylase deficiency has been explicitly associated with a defective antibody response; however, the first infant diagnosed with oxysterol 7&#x003b1;-hydroxylase deficiency died after liver transplant of Epstein-Barr virus-associated disseminated lymphoproliferative disease in all body tissues (<a href="#bib140" rid="bib140" class=" bibr popnode">140</a>). It is perhaps noteworthy that lymphoproliferative disease is a B-lymphocyte growth and that GPR183 was first identified in a screen of upregulated genes in human B cells infected with Epstein-Barr virus (<a href="#bib141" rid="bib141" class=" bibr popnode">141</a>).</p><p id="p0335" class="p p-last">Cerebrotendinous xanthomatotisis (CTX) is the human disorder resulting from CYP27A1 deficiency (<a href="#bib133" rid="bib133" class=" bibr popnode">133</a>, <a href="#bib138" rid="bib138" class=" bibr popnode">138</a>). In infants, it can present with cholestatic liver disease and in later life as a neurological disease. There appear to be no specific associations between CTX and a compromised antibody response. HSD3B7 deficiency presents with cholestasis, but like CTX, it can be treated successfully by bile acid replacement therapy (<a href="#bib138" rid="bib138" class=" bibr popnode">138</a>). The absence of a defective antibody response in people with deficiency in CYP7B1, CYP27A1, or HSD3B7 presents a conundrum, and once again, a major difference between human and mouse is evident. Significantly, in this context, neither <em>Cyp27a1</em><sup>&#x02212;/&#x02212;</sup> nor <em>Cyp7b1</em><sup>&#x02212;/&#x02212;</sup> mice phenocopy the human enzyme deficiencies other than in oxysterol patterns.</p></div><div id="sec8.4" class="sec sec-last"><h3 id="sec8.4title">Biology of GPR183 and 7&#x003b1;,25-diHC</h3><p id="p0340" class="p p-first">There is good evidence that GPR183 and 7&#x003b1;,25-diHC are linked to inflammation of the colon (<a href="#bib121" rid="bib121" class=" bibr popnode">121</a>, <a href="#bib130" rid="bib130" class=" bibr popnode">130</a>). In a study of colitis in human and mouse models of the disease, Wyss <em>et&#x000a0;al.</em> (<a href="#bib130" rid="bib130" class=" bibr popnode">130</a>) established that genes coding for GPR183, CH25H, and CYP7B1 were upregulated in colon tissue, with CYP27A1 also being upregulated in inflamed tissue from patients with ulcerative colitis. Concentrations of 7&#x003b1;,25-diHC and 7&#x003b1;,26-diHC were determined by LC-MS to be elevated in tissue from mouse colon and liver in an acute disease model, although it was unclear what units of concentration were exactly reported (<a href="#bib130" rid="bib130" class=" bibr popnode">130</a>). It is interesting to note that Wyss <em>et&#x000a0;al.</em> (<a href="#bib130" rid="bib130" class=" bibr popnode">130</a>) found that 25-HC, 7&#x003b1;,25-diHC, and 7&#x003b2;,25-dihydroxycholesterol (7&#x003b2;,25-diHC) were present in <em>Ch25h</em><sup>&#x02212;/&#x02212;</sup> mouse tissue, explained by the sterol 25-hydroxylase activity of other enzymes besides CH25H (<a href="/pmc/articles/PMC8953665/figure/fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig2" rid-ob="ob-fig2" co-legend-rid="lgnd_fig2"><span>Fig.&#x000a0;2</span></a>A). Wyss <em>et&#x000a0;al.</em> (<a href="#bib130" rid="bib130" class=" bibr popnode">130</a>) also established that <em>Gpr183</em><sup>&#x02212;/&#x02212;</sup> mice had fewer lymphoid structures than control animals, and defects in inflammation induced lymphoid structures, leading to the conclusion that the GPR183-oxysterol axis promotes the development of lymphoid structures and colitis. This agreed with work by Emg&#x000e5;rd <em>et&#x000a0;al.</em> (<a href="#bib142" rid="bib142" class=" bibr popnode">142</a>) who showed that expression of <em>Gpr183</em> and oxysterol-synthesizing genes <em>Ch25h</em> and <em>Cyp7b1</em> promoted the formation of colonic lymphoid tissues in the steady state and during inflammation. In an independent study of colitis, Guillemot-Legris <em>et&#x000a0;al.</em> (<a href="#bib121" rid="bib121" class=" bibr popnode">121</a>) found both 25-HC and 7&#x003b1;,25-diHC to be elevated in colon from mice models of colitis as was 4&#x003b2;-HC. In chronic mouse models of colitis, levels of 7&#x003b1;,25-diHC and 4&#x003b2;-HC were at a level of about 200 pmol/g (80&#x000a0;ng/g), about double that found in control animals.</p><p id="p0345">Multiple sclerosis is an autoimmune disease where circulating autoreactive T cells escape immune regulation and enter the brain resulting in inflammation and demyelination. Interestingly, Chalmin <em>et&#x000a0;al.</em> (<a href="#bib143" rid="bib143" class=" bibr popnode">143</a>) found the migration of GPR183-expressing memory CD4<sup>+</sup> T cells toward 7&#x003b1;,25-diHC to be linked with EAE, the mouse model of multiple sclerosis. In the context of the human biology, Clottu <em>et&#x000a0;al.</em> (<a href="#bib144" rid="bib144" class=" bibr popnode">144</a>) have shown that the functional GPR183 protein is expressed on human lymphocytes and that memory CD4<sup>+</sup> T and B cells express more GPR183 than their naive counterparts (which unlike memory cells have not encountered antigen) and that in transwell assays memory CD4<sup>+</sup> T cells are most responsive toward 7&#x003b1;,25-diHC. Interestingly, Clottu <em>et&#x000a0;al.</em> (<a href="#bib144" rid="bib144" class=" bibr popnode">144</a>) found a positive correlation between GPR183 expression and migration toward 7&#x003b1;,25-diHC in relapsing remitting multiple sclerosis in CD4<sup>+</sup> and CD8<sup>+</sup> memory T cells, a correlation not observed in the corresponding cells from healthy donors. This led to the suggestion that a difference in migration could indicate a difference in GPR183 expression during autoimmunity. However, Crick <em>et&#x000a0;al.</em> (<a href="#bib135" rid="bib135" class=" bibr popnode">135</a>) using LC-MS failed to find an elevation in the 7&#x003b1;,25-diHC or 7&#x003b1;,26-diHC in CSF or plasma of patients suffering from either relapsing remitting multiple sclerosis or clinically isolated syndrome. They did, however, find a reduction in the plasma content of 25-HC, perhaps disturbing the production of 7&#x003b1;,25-diHC in lymphoid tissue and disorientating homeostatic concentration gradients (<a href="#bib135" rid="bib135" class=" bibr popnode">135</a>).</p><p id="p0350">In the context of multiple sclerosis and EAE, Wanke <em>et&#x000a0;al.</em> (<a href="#bib128" rid="bib128" class=" bibr popnode">128</a>) found that GPR183 is highly expressed in inflamed white matter lesions in human multiple sclerosis brain, whereas in EAE mouse models, GPR183 promotes early migration of inflammatory CD4<sup>+</sup> T cells into the CNS. They found that the majority of naive CD4<sup>+</sup> T cells express GPR183, and that inflammatory Th17 (or T<sub>h</sub>17) cells derived from naive CD4<sup>+</sup> T under IL-1&#x003b2;-induced and IL-23-induced differentiation maintain GPR183 expression. Their results suggest a role for GPR183 in early migration of encephalitogenic Th17&#x000a0;cells from peripheral lymphoid organs to the CNS. In the EAE mouse model, <em>Ch25h</em> and <em>Cyp7b1</em> were found to be upregulated in spinal cord, whereas <em>Hsd3b7</em> to be downregulated; this led to an increase in the GPR183 ligand and chemoattractant 7&#x003b1;,25-diHC in EAE animals (<a href="#bib128" rid="bib128" class=" bibr popnode">128</a>). Using LC-MS, it was found that besides 7&#x003b1;,25-diHC, 7&#x003b1;,26-diHC and 7&#x003b1;,24-dihydroxycholesterol were also elevated in spinal cord from EAE animals, as was 25-HC, but levels of 24-HC and 26-HC were reduced (<a href="#bib128" rid="bib128" class=" bibr popnode">128</a>). Interestingly, during EAE, microglia the macrophages of the brain, strongly express <em>Ch25h</em>, whereas <em>Cyp7b1</em> is expressed by infiltrating lymphocytes and monocytes but not microglia. <em>Hsd3b7</em> was found to be expressed in both groups of cells. Importantly, human Th17&#x000a0;cells express GPR183, and CD4<sup>+</sup> T cells migrate toward 7&#x003b1;,25-diHC in a dose-dependent manner. In summary, the work of Wanke <em>et&#x000a0;al.</em> (<a href="#bib128" rid="bib128" class=" bibr popnode">128</a>) supports the hypothesis that in multiple sclerosis GPR183 and 7&#x003b1;,25-diHC promote the redistribution of inflammatory Th17&#x000a0;cells from secondary lymphoid organs to sites of inflammation.</p><p id="p0355" class="p p-last">It should also be noted that besides B cells, T cells, and DCs, GPR183 is also expressed in human astrocytes and promotes their in&#x000a0;vitro migration (<a href="#bib145" rid="bib145" class=" bibr popnode">145</a>) and also in primary human macrophages (<a href="#bib146" rid="bib146" class=" bibr popnode">146</a>).</p></div></div><div id="sec9" class="tsec sec"><h2 class="head no_bottom_margin" id="sec9title">ROR&#x003b3;1 and ROR&#x003b3;2 nuclear receptors</h2><p id="p0360" class="p p-first">There are three retinoic acid-related orphan receptors (RORs): ROR&#x003b1; (NR1F1), ROR&#x003b2; (NR1F2), and ROR&#x003b3; (NR1F3). ROR&#x003b3; has two isoforms, ROR&#x003b3;1 and ROR&#x003b3;2, the first isoform is simply called ROR&#x003b3;, whereas the second one is often called ROR&#x003b3;t. ROR&#x003b3;t has a shorter N terminus than ROR&#x003b3;, but otherwise, the domains are identical. ROR&#x003b3;t is highly expressed in thymus and is an essential transcription factor for the development of proinflammatory IL-17-expressing Th17&#x000a0;cells. As discussed previously, Th17&#x000a0;cells are implicated in multiple sclerosis and its mouse model EAE. Although ROR&#x003b3;t is expressed in multiple organs, they do not include the brain, but ROR&#x003b3;t immunoreactive cells have been found in the meninges of multiple sclerosis patients, perhaps by infiltrating immune cells (<a href="#bib147" rid="bib147" class=" bibr popnode">147</a>).</p><p id="p0365">Although LXRs are generally considered as the oxysterol nuclear receptors, oxysterols can also bind to the ligand binding domain (LBD) of ROR&#x003b3; and ROR&#x003b3;t. In 2010, Wang <em>et&#x000a0;al.</em> (<a href="#bib148" rid="bib148" class=" bibr popnode">148</a>) found 7&#x003b1;-HC, 7&#x003b2;-HC, and 7-OC to be inverse agonists of ROR&#x003b3;t (<a href="/pmc/articles/PMC8953665/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>B). These three oxysterols can all be formed by autoxidation (<a href="#bib92" rid="bib92" class=" bibr popnode">92</a>, <a href="#bib93" rid="bib93" class=" bibr popnode">93</a>), which may be not only ex&#x000a0;vivo but also in&#x000a0;vivo, as evidenced by their presence, and that of their downstream metabolites, in plasma from patients suffering from the cholesterol transport disorder NPC1 disease and also other lysosomal storage disorders (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>). These three oxysterols can also be formed enzymatically: 7&#x003b1;-HC by CYP7A1 catalyzed oxidation of cholesterol (<a href="#bib149" rid="bib149" class=" bibr popnode">149</a>); 7-OC by CYP7A1-mediated oxidation of 7-DHC (<a href="#bib150" rid="bib150" class=" bibr popnode">150</a>, <a href="#bib151" rid="bib151" class=" bibr popnode">151</a>); and 7&#x003b2;-HC by reduction of 7-OC by HSD11B1 (<a href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Fig.&#x000a0;10</span></a>) (<a href="#bib152" rid="bib152" class=" bibr popnode">152</a>, <a href="#bib153" rid="bib153" class=" bibr popnode">153</a>, <a href="#bib154" rid="bib154" class=" bibr popnode">154</a>). The latter two oxysterols can be generated enzymatically in Smith-Lemli-Opitz syndrome, where 7-DHC is abundant on account of a deficiency in DHCR7 (<a href="#bib155" rid="bib155" class=" bibr popnode">155</a>). Wang <em>et&#x000a0;al.</em> (<a href="#bib148" rid="bib148" class=" bibr popnode">148</a>) also found 24S-HC and 24S,25-EC to be inverse agonists of ROR&#x003b3;, but Jin <em>et&#x000a0;al.</em> (<a href="#bib156" rid="bib156" class=" bibr popnode">156</a>) also in 2010 reported 20S-HC, 22R-HC, and 25-HC to be agonists toward ROR&#x003b3; (<a href="/pmc/articles/PMC8953665/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>B).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm" id="fig10" co-legend-rid="lgnd_fig10"><a href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" rid-figpopup="fig10" rid-ob="ob-fig10"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div class="figure" data-largeobj="" data-largeobj-link-rid="largeobj_idm139816982565296"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8953665_gr10.jpg" target="tileshopwindow" rel="noopener"><div class="ts_bar small" title="Click on image to zoom"></div><img loading="lazy" alt="An external file that holds a picture, illustration, etc.&#10;Object name is gr10.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC8953665/bin/gr10.jpg" /></a></div><div class="largeobj-link align_right" id="largeobj_idm139816982565296"><a target="object" rel="noopener" href="/pmc/articles/PMC8953665/figure/fig10/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_fig10"><div><a class="figpopup" href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" rid-figpopup="fig10" rid-ob="ob-fig10">Fig.&#x000a0;10</a></div><!--caption a7--><div class="caption"><p>Pathway map detailing the biosynthesis and metabolism of the ROR&#x003b3; agonists 7&#x003b1;,26-diHC and 7&#x003b2;,26-diHC. Nonenzymatic oxidation is indicated by [O] on a pink background. 7&#x003b1;-HC, 7&#x003b2;-HC, and 7-OC have been found to be inverse agonists of ROR&#x003b3;.</p></div></div></div><p id="p0370">While 7&#x003b1;,26-diHC and 7&#x003b2;,26-dihydroxycholesterol (7&#x003b2;,26-diHC) are both ligands toward GPR183 (<a href="#bib5" rid="bib5" class=" bibr popnode">5</a>), they have also been shown to be agonists toward RORyt (<a href="/pmc/articles/PMC8953665/figure/fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig3" rid-ob="ob-fig3" co-legend-rid="lgnd_fig3"><span>Fig.&#x000a0;3</span></a>B) (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>). Interestingly, while 7&#x003b1;,26-diHC is the more potent ligand toward GPR183, the reverse is true with respect to activation of ROR&#x003b3;t, where 7&#x003b2;,26-diHC is more potent. Soroosh <em>et&#x000a0;al.</em> (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>) found that both ligands, presumably the 25R-epimers, reversed the inhibitory effects of ursolic acid in a cell-based reporter assay and in primary cells enhanced the differentiation of IL-17-producing cells in an ROR&#x003b3;t-dependent manner. They found that in&#x000a0;vivo administration of 7&#x003b2;,26-diHC to mice enhanced IL-17 production and that differentiating Th17 but not Th1 cells generate these two oxysterols (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>). Soroosh <em>et&#x000a0;al.</em> found <em>Cyp27a1</em> to be enriched in mouse Th17&#x000a0;cells, and when treated with [<sup>3</sup>H]7&#x003b2;-HC or [<sup>3</sup>H]7&#x003b1;-HC, these cells produced [<sup>3</sup>H]7&#x003b2;,26-diHC and [<sup>3</sup>H]7&#x003b1;,26-diHC, respectively, the reaction product [<sup>3</sup>H]7&#x003b2;,26-diHC being more readily formed (<a href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Fig.&#x000a0;10</span></a>). Both 7&#x003b2;,26-diHC and 7&#x003b1;,26-diHC were shown using LC-MS to be endogenous molecules in mouse spleen, the level of the former isomer to be about 3% of the latter. 26-Hydroxy-7-oxocholesterol (26H,7O-C, also called 7-keto-27-hydroxycholesterol) was not detected in mouse spleen (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>) but is a difficult molecule to detect by LC-MS (<a href="#bib158" rid="bib158" class=" bibr popnode">158</a>); however, it also reverses the inhibitory effects of ursolic acid in a cell-based ROR&#x003b3;t LBD reporter assay, but unlike 7&#x003b1;,26-diHC and 7&#x003b2;,26-diHC, 26H,7O-C was found to be largely inactive in full-length ROR&#x003b3; or ROR&#x003b3;t reporter assays. Although not targeted by LC-MS analysis of mouse spleen, the CYP27A1 downstream metabolites of 7&#x003b1;,26-diHC and 7&#x003b2;,26-diHC, that is, the cholestenoic acids 3&#x003b2;,7&#x003b1;-diHCA and 3&#x003b2;,7&#x003b2;-diHCA (<a href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Fig.&#x000a0;10</span></a>) were found to display minimal agonist activity in the LBD reporter assay; however, in this assay, the HSD3B7-derived metabolite 7&#x003b1;,26-diHCO showed similar activity to 7&#x003b1;,26-diHC (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>). In support of the lack of activity of 26H,7O-C in the full-length ROR&#x003b3;t reporter assay, 26H,7O-C was much less efficacious than 7&#x003b2;,26-diHC or 7&#x003b1;,26-diHC in promoting IL-17 producing mouse or human Th17&#x000a0;cells (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>). These data suggest that conversion of dihydroxycholesterols to their 7-one equivalents may be a route to inactivation of ROR&#x003b3;t ligands, as may further CYP27A1-mediated metabolism to cholestenoic acids.</p><p id="p0375">Soroosh <em>et&#x000a0;al.</em> (<a href="#bib157" rid="bib157" class=" bibr popnode">157</a>) suggested that 7&#x003b1;,26-diHC, 7&#x003b2;,26-diHC, and 26H,7O-C were derived from 26-HC, the former by CYP7B1-mediated 7&#x003b1;-hydroxylation and the latter two via somewhat unlikely autoxidation reactions. An alternative route to the formation of 7&#x003b1;,26-diHC is via CYP27A1-mediated oxidation of 7&#x003b1;-HC, which is prevalent in the circulation, whereas the latter two oxysterols can be formed by CYP27A1-mediated oxidation of 7&#x003b2;-HC and 7-OC (<a href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Fig.&#x000a0;10</span></a>) (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>, <a href="#bib155" rid="bib155" class=" bibr popnode">155</a>).</p><p id="p0380">A study by Beck <em>et&#x000a0;al.</em> (<a href="#bib159" rid="bib159" class=" bibr popnode">159</a>) in 2019 shed further light on the metabolism of 7&#x003b2;,26-diHC in the context of ROR&#x003b3;t signaling. Following on from earlier work, which showed that 7&#x003b2;-HC and 7-OC are interconvertible by HSD11B enzymes, the 11B1 enzyme driving reduction and the 11B2 enzyme oxidation (<a href="#bib152" rid="bib152" class=" bibr popnode">152</a>, <a href="#bib153" rid="bib153" class=" bibr popnode">153</a>, <a href="#bib154" rid="bib154" class=" bibr popnode">154</a>), Beck <em>et&#x000a0;al.</em> (<a href="#bib159" rid="bib159" class=" bibr popnode">159</a>) found that 7&#x003b2;,26-diHC and 26H,7O-C were interconvertible by the same enzymes in the same manner (<a href="/pmc/articles/PMC8953665/figure/fig10/" target="figure" class="fig-table-link figpopup" rid-figpopup="fig10" rid-ob="ob-fig10" co-legend-rid="lgnd_fig10"><span>Fig.&#x000a0;10</span></a>). HSD11B2 was shown to provide a route to the deactivation of the ROR&#x003b3;t agonist 7&#x003b2;,26-diHC, and this was confirmed in a ROR&#x003b3; reporter system where HSD11B2-mediated oxidation of 7&#x003b2;,26-diHC led reduced activation of the receptor (<a href="#bib159" rid="bib159" class=" bibr popnode">159</a>). Beck <em>et&#x000a0;al.</em> (<a href="#bib159" rid="bib159" class=" bibr popnode">159</a>) also showed that CYP27A1 can convert 7&#x003b2;-HC to 7&#x003b2;,26-diHC, whereas earlier studies have shown that 7-OC can be metabolized to 26H,7O-C by CYP27A1 (<a href="#bib160" rid="bib160" class=" bibr popnode">160</a>). Beck <em>et&#x000a0;al.</em> (<a href="#bib159" rid="bib159" class=" bibr popnode">159</a>) did not investigate the alternative deactivation route of 7&#x003b2;,26-diHC to the cholestenoic acid 3&#x003b2;,7&#x003b2;-diHCA, although the presence of this acid in plasma from patients suffering from Smith-Lemli-Opitz syndrome and NPC1 disease and also healthy people suggests that this reaction proceeds in human (<a href="#bib95" rid="bib95" class=" bibr popnode">95</a>, <a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib155" rid="bib155" class=" bibr popnode">155</a>).</p><p id="p0385">These mechanisms for deactivation of 7&#x003b2;,26-diHC are also relevant to its potential role as a ligand toward GPR183. In this context, Beck <em>et&#x000a0;al.</em> (<a href="#bib161" rid="bib161" class=" bibr popnode">161</a>) in a separate study demonstrated that 7&#x003b2;,25-diHC, which like 7&#x003b2;,26-diHC, is a ligand toward GPR183, is oxidized by HSD11B2 to inactive 25-hydroxy-7-oxocholesterol (25H,7O-C), which can be reduced back to 7&#x003b2;,25-diHC by HSD11B1. In this study, Beck <em>et&#x000a0;al.</em> (<a href="#bib161" rid="bib161" class=" bibr popnode">161</a>) also showed that 7-OC could be hydroxylated by CH25H to 25H,7-OC, providing a further route to GPR183 ligands this time from 7-OC by CH25H-mediated 25-hydroxylation followed by HSD11B1-catalyzed reduction of the 7-oxo group to a 7&#x003b2;-hydroxy group.</p><p id="p0390" class="p p-last">Besides oxysterols, it should be noted that cholesterol precursors including desmosterol and 4,4-disubstituted sterols have been proposed as mammalian ligands to ROR&#x003b3;t (<a href="#bib162" rid="bib162" class=" bibr popnode">162</a>, <a href="#bib163" rid="bib163" class=" bibr popnode">163</a>).</p></div><div id="sec10" class="tsec sec"><h2 class="head no_bottom_margin" id="sec10title">Final considerations</h2><p id="p0395" class="p p-first">In this review, we have tried to demonstrate the importance of oxysterols in the immune response. We have discussed in some details specific articles that we find to be particularly significant and interesting. During our preparation for this review, a number of thoughts relating to experimental conditions came to mind and are worthy of brief discussion here, as are considerations relating to the interpretation of data.</p><div id="sec10.1" class="sec"><h3 id="sec10.1title">Replete or delipidated medium, vehicle, esterified or nonesterified sterols</h3><p id="p0400" class="p p-first-last">During in&#x000a0;vitro experiments, how does the nature of the cell culture medium influence the result? Very often, studies of oxysterol activity are performed in lipid-depleted medium; this is to avoid the uncontrolled addition of oxysterols to cells. However, under these conditions, receptor-mediated endocytosis is not active, and the SREBP-2 pathway is turned on providing the cell with cholesterol exclusively via this route. Under these conditions, cholesterol is not in excess, and oxysterol synthesis in the cell will be restricted. Alternatively, under conditions where the medium is not lipid depleted, receptor-mediated cholesterol uptake is active leading to the plasma membrane being replete with accessible cholesterol, and the excess becomes available for oxysterol formation. This leads to the unanswered question: does oxysterol synthesis depends on the source of the cholesterol substrate? Another aspect to be considered is the vehicle in which the oxysterol is added to cells. A vehicle is necessary on account of the low solubility of oxysterols in aqueous media. Very often, ethanol or methanol is used as the vehicle, and the free sterol is assumed to cross the plasma membrane. Care must be taken to maintain sufficient solubility of oxysterol but to avoid any effects specific to the vehicle itself. But how relevant is the use of a vehicle? The majority of oxysterols are present in the circulation in their esterified forms, so if oxysterol action is considered as hormonal, or prohormonal, then it may be more appropriate to add the esterified oxysterol to the cell in lipoprotein particles. This leads to the next question, when oxysterol data are presented, do the data refer to the free unesterified oxysterol or to the combination of esterified and nonesterified molecules determined following base hydrolysis? The analytical chemist will be able in most cases to answer this question by tracing the experimental method, but this may not be the case for the biologist who may easily be misled unless data are clearly represented. The value for an oxysterol concentration determined following base hydrolysis can be as much as 10-fold greater than for the nonesterified molecule. In this review, values given are those of the unesterified molecules unless stated otherwise.</p></div><div id="sec10.2" class="sec sec-last"><h3 id="sec10.2title">Nomenclature, isomers, mouse, and human</h3><p id="p0405" class="p p-first">The nomenclature resulting from substitution at the terminal carbons of the cholesterol side chain can be confusing (<a href="#bib28" rid="bib28" class=" bibr popnode">28</a>). For example, the product of the CYP27A1-catalyzed hydroxylation of cholesterol is according to systematic rules 26-HC, [(25R)26-HC], although it is most commonly referred to as 27-HC. Similarly, 7&#x003b1;-hydroxylation of (25R)26-HC by CYP7B1 leads 7&#x003b1;,(25R)26-dihydroxycholesterol, which again is often referred to by the nonsystematic name 7&#x003b1;,27-dihydroxycholesterol. Confusion is further heightened as 7&#x003b1;,26-diHC is found in man and mouse as both the 25R-epimer and 25S-epimer (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib132" rid="bib132" class=" bibr popnode">132</a>, <a href="#bib133" rid="bib133" class=" bibr popnode">133</a>) and rarely is the stereochemistry at C-25 defined although the isomers are diastereomeric and can be chromatographically resolved (<a href="#bib113" rid="bib113" class=" bibr popnode">113</a>).</p><p id="p0410">A further point of consideration is that many results are presented, and conclusions drawn, from experiments made on knockout mice. It is important to realize that while the basic sterol biochemistry in mouse and human is generally similar, as are oxysterol patterns, the phenotype of knockout animals can be very different from the disease symptoms resulting from the corresponding enzyme deficiencies in human. This is especially evident in the case of deficiency in the enzymes CYP7B1 and CYP27A1.</p><p id="p0415" class="p p-last">In a similar context, an early report of <em>Ch25h</em> expression in mouse indicated <em>low</em> levels in heart, lung, and kidney, whereas in human, <em>CH25H</em> was more generally expressed but at <em>very low</em> levels (<a href="#bib15" rid="bib15" class=" bibr popnode">15</a>). More recent reports indicate <em>Ch25h</em> to be more ubiquitously expressed in mouse than first described (<a href="#bib164" rid="bib164" class=" bibr popnode">164</a>), whereas <em>CH25H</em> was found to be enhanced in brain and lymphoid tissue of human (<a href="#bib165" rid="bib165" class=" bibr popnode">165</a>). It is difficult to extrapolate to protein expression and whether it is greater in mouse than man or vice versa, but the levels of nonesterified 25-HC in mouse and human plasma are not drastically different at about 1 and 1&#x02013;5&#x000a0;ng/ml, respectively (<a href="#bib31" rid="bib31" class=" bibr popnode">31</a>, <a href="#bib113" rid="bib113" class=" bibr popnode">113</a>, <a href="#bib132" rid="bib132" class=" bibr popnode">132</a>, <a href="#bib166" rid="bib166" class=" bibr popnode">166</a>), which would imply that at least in the absence of infection, CH25H protein levels are quite similar. This is backed up by 25-HC levels in plasma from <em>Cyp7b1</em><sup>&#x02212;/&#x02212;</sup> mice and SPG5 patients being at 40&#x02013;50&#x000a0;ng/ml in both species (<a href="#bib31" rid="bib31" class=" bibr popnode">31</a>, <a href="#bib166" rid="bib166" class=" bibr popnode">166</a>).</p></div></div><div id="sec11" class="tsec sec"><h2 class="head no_bottom_margin" id="sec11title">Conclusion</h2><p id="p0420" class="p p-first-last">Our understanding of the involvement of oxysterols in immunology was revolutionized with the discovery that <em>Ch25h</em> is an IFN-stimulated gene and that macrophages synthesize 25-HC in response to activation of TLRs. The related discovery that 25-HC is generated by macrophages in response to viral and bacterial infections and that 25-HC is protective against both viral and bacterial spread further highlighted the importance of this family of sterols in immunology. The involvement of 7-hydroxylated derivatives of both 25-HC and 26-HC in the adaptive immune response acting as chemoattractants to GPR183-expressing immune cells and of 7&#x003b1;/&#x003b2;,26-diHC epimers as ligands to ROR&#x003b3;t has opened more avenues for investigation, particularly with respect to autoimmune diseases. Interestingly, it appears that while 25-HC and its 7-hydroxy metabolites are synthesized specifically in response to infection, 26-HC and its metabolites, which have similar biological activity to those of 25-HC but are continuously present under steady-state conditions, may play a more protective role against infection.</p></div><div id="sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="sec12title">Data availability</h2><p id="p0425" class="p p-first-last">All data are contained within the article.</p></div><div id="sec-a.p.p" class="tsec sec"><h2 class="head no_bottom_margin" id="sec-a.p.ptitle">Conflict of interest</h2><p id="p0435" class="p p-first-last">W. J. G. and Y. W. are listed as inventors on the patent &#x0201c;Kit and method for quantitative detection of steroids&#x0201d; (US9851368B2). W. J. G. and Y. W. are shareholders in CholesteniX Ltd.</p></div><div id="sec13" class="tsec sec"><a id="supplementary-material-sec"></a><h2 class="head no_bottom_margin" id="sec13title">Supplemental data</h2><!--/article/body/sec/--><p id="p0430" class="p p-first-last">This article contains <a href="#appsec1" rid="appsec1" class=" sec">supplemental data</a>.</p></div><div id="ack0010" class="tsec sec"><h2 class="head no_bottom_margin" id="ack0010title">Acknowledgments</h2><div class="sec"><p id="p0440">The authors thank members of the European Network for Oxysterol Research (<a href="http://oxysterols.com/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://oxysterols.com/</a>) for informative discussions.</p><div id="sec14" class="sec"><h3 id="sec14title">Author contributions</h3><p id="p0445" class="p p-first-last">W. J. G. and Y. W. writing&#x02013;original draft; W. J. G. and Y. W. writing&#x02013;review &#x00026; editing; W. J. G. and Y. W. funding acquisition.</p></div><div id="sec15" class="sec sec-last"><h3 id="sec15title">Funding and additional information</h3><p id="p0450" class="p p-first-last">This work was supported by the UK Research and Innovation,
Biotechnology and Biological Sciences Research Council (grant numbers BB/I001735/1 and BB/N015932/1 to W. J. G. and BB/L001942/1 to Y. W.).</p></div></div></div><div id="appsec1" class="tsec bk-sec"><h2 class="head no_bottom_margin" id="appsec1title">Supplemental data</h2><!--/article/back/sec/--><p id="p0455" class="p p-first-last">
</p><div class="sec suppmat" id="mmc1"><!--caption a9--><strong>Supplemental Figures&#x000a0;S1&#x02013;S3:</strong><div class="sup-box half_rhythm" id="media-a.q.b.b.a.b"><a href="/pmc/articles/PMC8953665/bin/mmc1.pptx" data-ga-action="click_feat_suppl">Click here to view.</a><sup>(641K, pptx)</sup></div></div><p>
</p></div><div id="cebib0010" class="tsec sec"><h2 class="head no_bottom_margin" id="cebib0010title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="bib1">1. <span class="element-citation" id="sref1">Dennis E.A., Deems R.A., Harkewicz R., Quehenberger O., Brown H.A., Milne S.B., Myers D.S., Glass C.K., Hardiman G., Reichart D., Merrill A.H., Jr., Sullards M.C., Wang E., Murphy R.C., Raetz C.R., et al. A&#x000a0;mouse macrophage lipidome. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2010;<span class="ref-vol">285</span>:39976–39985.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3000979/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20923771" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=A&#x000a0;mouse+macrophage+lipidome&amp;author=E.A.+Dennis&amp;author=R.A.+Deems&amp;author=R.+Harkewicz&amp;author=O.+Quehenberger&amp;author=H.A.+Brown&amp;volume=285&amp;publication_year=2010&amp;pages=39976-39985&amp;pmid=20923771&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib2">2. <span class="element-citation" id="sref2">Diczfalusy U., Olofsson K.E., Carlsson A.M., Gong M., Golenbock D.T., Rooyackers O., Flaring U., Bjorkbacka H. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2009;<span class="ref-vol">50</span>:2258–2264.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2759831/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19502589" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Marked+upregulation+of+cholesterol+25-hydroxylase+expression+by+lipopolysaccharide&amp;author=U.+Diczfalusy&amp;author=K.E.+Olofsson&amp;author=A.M.+Carlsson&amp;author=M.+Gong&amp;author=D.T.+Golenbock&amp;volume=50&amp;publication_year=2009&amp;pages=2258-2264&amp;pmid=19502589&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib3">3. <span class="element-citation" id="sref3">Bauman D.R., Bitmansour A.D., McDonald J.G., Thompson B.M., Liang G., Russell D.W. 25-Hydroxycholesterol secreted by macrophages in response to toll-like receptor activation suppresses immunoglobulin A production. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2009;<span class="ref-vol">106</span>:16764–16769.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2757821/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19805370" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=25-Hydroxycholesterol+secreted+by+macrophages+in+response+to+toll-like+receptor+activation+suppresses+immunoglobulin+A+production&amp;author=D.R.+Bauman&amp;author=A.D.+Bitmansour&amp;author=J.G.+McDonald&amp;author=B.M.+Thompson&amp;author=G.+Liang&amp;volume=106&amp;publication_year=2009&amp;pages=16764-16769&amp;pmid=19805370&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib4">4. <span class="element-citation" id="sref4">Park K., Scott A.L. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. <span><span class="ref-journal">J.&#x000a0;Leukoc. Biol. </span>2010;<span class="ref-vol">88</span>:1081–1087.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2996899/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20699362" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Leukoc.+Biol.&amp;title=Cholesterol+25-hydroxylase+production+by+dendritic+cells+and+macrophages+is+regulated+by+type+I+interferons&amp;author=K.+Park&amp;author=A.L.+Scott&amp;volume=88&amp;publication_year=2010&amp;pages=1081-1087&amp;pmid=20699362&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib5">5. <span class="element-citation" id="sref5">Hannedouche S., Zhang J., Yi T., Shen W., Nguyen D., Pereira J.P., Guerini D., Baumgarten B.U., Roggo S., Wen B., Knochenmuss R., Noel S., Gessier F., Kelly L.M., Vanek M., et al. Oxysterols direct immune cell migration via EBI2. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">475</span>:524–527.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4297623/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21796212" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Oxysterols+direct+immune+cell+migration+via+EBI2&amp;author=S.+Hannedouche&amp;author=J.+Zhang&amp;author=T.+Yi&amp;author=W.+Shen&amp;author=D.+Nguyen&amp;volume=475&amp;publication_year=2011&amp;pages=524-527&amp;pmid=21796212&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib6">6. <span class="element-citation" id="sref6">Liu C., Yang X.V., Wu J., Kuei C., Mani N.S., Zhang L., Yu J., Sutton S.W., Qin N., Banie H., Karlsson L., Sun S., Lovenberg T.W. Oxysterols direct B-cell migration through EBI2. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">475</span>:519–523.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21796211" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Oxysterols+direct+B-cell+migration+through+EBI2&amp;author=C.+Liu&amp;author=X.V.+Yang&amp;author=J.+Wu&amp;author=C.+Kuei&amp;author=N.S.+Mani&amp;volume=475&amp;publication_year=2011&amp;pages=519-523&amp;pmid=21796211&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib7">7. <span class="element-citation" id="sref7">Cyster J.G., Dang E.V., Reboldi A., Yi T. 25-Hydroxycholesterols in innate and adaptive immunity. <span><span class="ref-journal">Nat. Rev. Immunol. </span>2014;<span class="ref-vol">14</span>:731–743.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25324126" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Immunol.&amp;title=25-Hydroxycholesterols+in+innate+and+adaptive+immunity&amp;author=J.G.+Cyster&amp;author=E.V.+Dang&amp;author=A.+Reboldi&amp;author=T.+Yi&amp;volume=14&amp;publication_year=2014&amp;pages=731-743&amp;pmid=25324126&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib8">8. <span class="element-citation" id="sref8">Liu S.Y., Aliyari R., Chikere K., Li G., Marsden M.D., Smith J.K., Pernet O., Guo H., Nusbaum R., Zack J.A., Freiberg A.N., Su L., Lee B., Cheng G. Interferon-inducible cholesterol-25-hydroxylase broadly inhibits viral entry by production of 25-hydroxycholesterol. <span><span class="ref-journal">Immunity. </span>2013;<span class="ref-vol">38</span>:92–105.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3698975/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23273844" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Interferon-inducible+cholesterol-25-hydroxylase+broadly+inhibits+viral+entry+by+production+of+25-hydroxycholesterol&amp;author=S.Y.+Liu&amp;author=R.+Aliyari&amp;author=K.+Chikere&amp;author=G.+Li&amp;author=M.D.+Marsden&amp;volume=38&amp;publication_year=2013&amp;pages=92-105&amp;pmid=23273844&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib9">9. <span class="element-citation" id="sref9">Blanc M., Hsieh W.Y., Robertson K.A., Kropp K.A., Forster T., Shui G., Lacaze P., Watterson S., Griffiths S.J., Spann N.J., Meljon A., Talbot S., Krishnan K., Covey D.F., Wenk M.R., et al. The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response. <span><span class="ref-journal">Immunity. </span>2013;<span class="ref-vol">38</span>:106–118.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3556782/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23273843" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=The+transcription+factor+STAT-1+couples+macrophage+synthesis+of+25-hydroxycholesterol+to+the+interferon+antiviral+response&amp;author=M.+Blanc&amp;author=W.Y.+Hsieh&amp;author=K.A.+Robertson&amp;author=K.A.+Kropp&amp;author=T.+Forster&amp;volume=38&amp;publication_year=2013&amp;pages=106-118&amp;pmid=23273843&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib10">10. <span class="element-citation" id="sref10">Blanc M., Hsieh W.Y., Robertson K.A., Watterson S., Shui G., Lacaze P., Khondoker M., Dickinson P., Sing G., Rodr&#x000ed;guez-Mart&#x000ed;n S., Phelan P., Forster T., Strobl B., M&#x000fc;ller M., Riemersma R., et al. Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis. <span><span class="ref-journal">PLoS Biol. </span>2011;<span class="ref-vol">9</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3050939/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21408089" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Biol.&amp;title=Host+defense+against+viral+infection+involves+interferon+mediated+down-regulation+of+sterol+biosynthesis&amp;author=M.+Blanc&amp;author=W.Y.+Hsieh&amp;author=K.A.+Robertson&amp;author=S.+Watterson&amp;author=G.+Shui&amp;volume=9&amp;publication_year=2011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib11">11. <span class="element-citation" id="sref11">Yuan S., Chan C.C., Chik K.K., Tsang J.O., Liang R., Cao J., Tang K., Cai J.P., Ye Z.W., Yin F., To K.K., Chu H., Jin D.Y., Hung I.F., Yuen K.Y., et al. Broad-spectrum host-based antivirals targeting the interferon and lipogenesis pathways as potential treatment options for the pandemic coronavirus disease 2019 (COVID-19) <span><span class="ref-journal">Viruses. </span>2020;<span class="ref-vol">12</span>:628.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7354423/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32532085" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Viruses&amp;title=Broad-spectrum+host-based+antivirals+targeting+the+interferon+and+lipogenesis+pathways+as+potential+treatment+options+for+the+pandemic+coronavirus+disease+2019+(COVID-19)&amp;author=S.+Yuan&amp;author=C.C.+Chan&amp;author=K.K.+Chik&amp;author=J.O.+Tsang&amp;author=R.+Liang&amp;volume=12&amp;publication_year=2020&amp;pages=628&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib12">12. <span class="element-citation" id="sref12">Zu S., Deng Y.Q., Zhou C., Li J., Li L., Chen Q., Li X.F., Zhao H., Gold S., He J., Li X., Zhang C., Yang H., Cheng G., Qin C.F. 25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor. <span><span class="ref-journal">Cell Res. </span>2020;<span class="ref-vol">30</span>:1043–1045.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7431750/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32811977" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Res.&amp;title=25-Hydroxycholesterol+is+a+potent+SARS-CoV-2+inhibitor&amp;author=S.+Zu&amp;author=Y.Q.+Deng&amp;author=C.+Zhou&amp;author=J.+Li&amp;author=L.+Li&amp;volume=30&amp;publication_year=2020&amp;pages=1043-1045&amp;pmid=32811977&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib13">13. <span class="element-citation" id="sref13">Wang S., Li W., Hui H., Tiwari S.K., Zhang Q., Croker B.A., Rawlings S., Smith D., Carlin A.F., Rana T.M. Cholesterol 25-hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol. <span><span class="ref-journal">EMBO J. </span>2020;<span class="ref-vol">39</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7537045/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32944968" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=EMBO+J.&amp;title=Cholesterol+25-hydroxylase+inhibits+SARS-CoV-2+and+other+coronaviruses+by+depleting+membrane+cholesterol&amp;author=S.+Wang&amp;author=W.+Li&amp;author=H.+Hui&amp;author=S.K.+Tiwari&amp;author=Q.+Zhang&amp;volume=39&amp;publication_year=2020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib14">14. <span class="element-citation" id="sref14">Zang R., Case J.B., Yutuc E., Ma X., Shen S., Gomez Castro M.F., Liu Z., Zeng Q., Zhao H., Son J., Rothlauf P.W., Kreutzberger A.J.B., Hou G., Zhang H., Bose S., et al. Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2020;<span class="ref-vol">117</span>:32105–32113.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7749331/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33239446" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Cholesterol+25-hydroxylase+suppresses+SARS-CoV-2+replication+by+blocking+membrane+fusion&amp;author=R.+Zang&amp;author=J.B.+Case&amp;author=E.+Yutuc&amp;author=X.+Ma&amp;author=S.+Shen&amp;volume=117&amp;publication_year=2020&amp;pages=32105-32113&amp;pmid=33239446&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib15">15. <span class="element-citation" id="sref15">Lund E.G., Kerr T.A., Sakai J., Li W.P., Russell D.W. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytopic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1998;<span class="ref-vol">273</span>:34316–34327.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9852097" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=cDNA+cloning+of+mouse+and+human+cholesterol+25-hydroxylases,+polytopic+membrane+proteins+that+synthesize+a+potent+oxysterol+regulator+of+lipid+metabolism&amp;author=E.G.+Lund&amp;author=T.A.+Kerr&amp;author=J.+Sakai&amp;author=W.P.+Li&amp;author=D.W.+Russell&amp;volume=273&amp;publication_year=1998&amp;pages=34316-34327&amp;pmid=9852097&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib16">16. <span class="element-citation" id="sref16">Griffiths W.J., Wang Y. Oxysterols as lipid mediators: their biosynthetic genes, enzymes and metabolites. <span><span class="ref-journal">Prostaglandins Other Lipid Mediat. </span>2020;<span class="ref-vol">147</span>:106381.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7081179/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31698146" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prostaglandins+Other+Lipid+Mediat.&amp;title=Oxysterols+as+lipid+mediators:+their+biosynthetic+genes,+enzymes+and+metabolites&amp;author=W.J.+Griffiths&amp;author=Y.+Wang&amp;volume=147&amp;publication_year=2020&amp;pages=106381&amp;pmid=31698146&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib17">17. <span class="element-citation" id="sref17">Honda A., Miyazaki T., Ikegami T., Iwamoto J., Maeda T., Hirayama T., Saito Y., Teramoto T., Matsuzaki Y. Cholesterol 25-hydroxylation activity of CYP3A. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2011;<span class="ref-vol">52</span>:1509–1516.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3137016/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21576599" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Cholesterol+25-hydroxylation+activity+of+CYP3A&amp;author=A.+Honda&amp;author=T.+Miyazaki&amp;author=T.+Ikegami&amp;author=J.+Iwamoto&amp;author=T.+Maeda&amp;volume=52&amp;publication_year=2011&amp;pages=1509-1516&amp;pmid=21576599&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib18">18. <span class="element-citation" id="sref18">Mast N., Norcross R., Andersson U., Shou M., Nakayama K., Bjorkhem I., Pikuleva I.A. Broad substrate specificity of human cytochrome P450 46A1 which initiates cholesterol degradation in the brain. <span><span class="ref-journal">Biochemistry. </span>2003;<span class="ref-vol">42</span>:14284–14292.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14640697" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Broad+substrate+specificity+of+human+cytochrome+P450+46A1+which+initiates+cholesterol+degradation+in+the+brain&amp;author=N.+Mast&amp;author=R.+Norcross&amp;author=U.+Andersson&amp;author=M.+Shou&amp;author=K.+Nakayama&amp;volume=42&amp;publication_year=2003&amp;pages=14284-14292&amp;pmid=14640697&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib19">19. <span class="element-citation" id="sref19">Lund E.G., Guileyardo J.M., Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>1999;<span class="ref-vol">96</span>:7238–7243.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC22064/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10377398" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=cDNA+cloning+of+cholesterol+24-hydroxylase,+a+mediator+of+cholesterol+homeostasis+in+the+brain&amp;author=E.G.+Lund&amp;author=J.M.+Guileyardo&amp;author=D.W.+Russell&amp;volume=96&amp;publication_year=1999&amp;pages=7238-7243&amp;pmid=10377398&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib20">20. <span class="element-citation" id="sref20">Li X., Pandak W.M., Erickson S.K., Ma Y., Yin L., Hylemon P., Ren S. Biosynthesis of the regulatory oxysterol, 5-cholesten-3beta,25-diol 3-sulfate, in hepatocytes. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2007;<span class="ref-vol">48</span>:2587–2596.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17890683" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Biosynthesis+of+the+regulatory+oxysterol,+5-cholesten-3beta,25-diol+3-sulfate,+in+hepatocytes&amp;author=X.+Li&amp;author=W.M.+Pandak&amp;author=S.K.+Erickson&amp;author=Y.+Ma&amp;author=L.+Yin&amp;volume=48&amp;publication_year=2007&amp;pages=2587-2596&amp;pmid=17890683&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib21">21. <span class="element-citation" id="sref21">Schwarz M., Lund E.G., Lathe R., Bj&#x000f6;rkhem I., Russell D.W. Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cDNA. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1997;<span class="ref-vol">272</span>:23995–24001.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9295351" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Identification+and+characterization+of+a+mouse+oxysterol+7alpha-hydroxylase+cDNA&amp;author=M.+Schwarz&amp;author=E.G.+Lund&amp;author=R.+Lathe&amp;author=I.+Bj&#x000f6;rkhem&amp;author=D.W.+Russell&amp;volume=272&amp;publication_year=1997&amp;pages=23995-24001&amp;pmid=9295351&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib22">22. <span class="element-citation" id="sref22">Schwarz M., Wright A.C., Davis D.L., Nazer H., Bj&#x000f6;rkhem I., Russell D.W. The bile acid synthetic gene 3beta-hydroxy-delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis. <span><span class="ref-journal">J.&#x000a0;Clin. Invest. </span>2000;<span class="ref-vol">106</span>:1175–1184.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC301421/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11067870" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Clin.+Invest.&amp;title=The+bile+acid+synthetic+gene+3beta-hydroxy-delta(5)-C(27)-steroid+oxidoreductase+is+mutated+in+progressive+intrahepatic+cholestasis&amp;author=M.+Schwarz&amp;author=A.C.+Wright&amp;author=D.L.+Davis&amp;author=H.+Nazer&amp;author=I.+Bj&#x000f6;rkhem&amp;volume=106&amp;publication_year=2000&amp;pages=1175-1184&amp;pmid=11067870&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib23">23. <span class="element-citation" id="sref23">Abdel-Khalik J., Crick P.J., Yutuc E., DeBarber A.E., Duell P.B., Steiner R.D., Laina I., Wang Y., Griffiths W.J. Identification of 7alpha,24-dihydroxy-3-oxocholest-4-en-26-oic and 7alpha,25-dihydroxy-3-oxocholest-4-en-26-oic acids in human cerebrospinal fluid and plasma. <span><span class="ref-journal">Biochimie. </span>2018;<span class="ref-vol">153</span>:86–98.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6171785/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29960034" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochimie&amp;title=Identification+of+7alpha,24-dihydroxy-3-oxocholest-4-en-26-oic+and+7alpha,25-dihydroxy-3-oxocholest-4-en-26-oic+acids+in+human+cerebrospinal+fluid+and+plasma&amp;author=J.+Abdel-Khalik&amp;author=P.J.+Crick&amp;author=E.+Yutuc&amp;author=A.E.+DeBarber&amp;author=P.B.+Duell&amp;volume=153&amp;publication_year=2018&amp;pages=86-98&amp;pmid=29960034&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib24">24. <span class="element-citation" id="sref24">Lehmann J.M., Kliewer S.A., Moore L.B., Smith-Oliver T.A., Oliver B.B., Su J.L., Sundseth S.S., Winegar D.A., Blanchard D.E., Spencer T.A., Willson T.M. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1997;<span class="ref-vol">272</span>:3137–3140.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9013544" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Activation+of+the+nuclear+receptor+LXR+by+oxysterols+defines+a+new+hormone+response+pathway&amp;author=J.M.+Lehmann&amp;author=S.A.+Kliewer&amp;author=L.B.+Moore&amp;author=T.A.+Smith-Oliver&amp;author=B.B.+Oliver&amp;volume=272&amp;publication_year=1997&amp;pages=3137-3140&amp;pmid=9013544&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib25">25. <span class="element-citation" id="sref25">Janowski B.A., Grogan M.J., Jones S.A., Wisely G.B., Kliewer S.A., Corey E.J., Mangelsdorf D.J. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>1999;<span class="ref-vol">96</span>:266–271.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC15128/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9874807" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Structural+requirements+of+ligands+for+the+oxysterol+liver+X+receptors+LXRalpha+and+LXRbeta&amp;author=B.A.+Janowski&amp;author=M.J.+Grogan&amp;author=S.A.+Jones&amp;author=G.B.+Wisely&amp;author=S.A.+Kliewer&amp;volume=96&amp;publication_year=1999&amp;pages=266-271&amp;pmid=9874807&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib26">26. <span class="element-citation" id="sref26">Forman B.M., Ruan B., Chen J., Schroepfer G.J., Evans R.M. The orphan nuclear receptor LXR&#x003b1; is positively and negatively regulated by distinct products of mevalonatemetabolism. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>1997;<span class="ref-vol">94</span>:10588–10593.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC23411/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9380679" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=The+orphan+nuclear+receptor+LXR&#x003b1;+is+positively+and+negatively+regulated+by+distinct+products+of+mevalonatemetabolism&amp;author=B.M.+Forman&amp;author=B.+Ruan&amp;author=J.+Chen&amp;author=G.J.+Schroepfer&amp;author=R.M.+Evans&amp;volume=94&amp;publication_year=1997&amp;pages=10588-10593&amp;pmid=9380679&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib27">27. <span class="element-citation" id="sref27">Wang B., Tontonoz P. Liver X receptors in lipid signalling and membrane homeostasis. <span><span class="ref-journal">Nat. Rev. Endocrinol. </span>2018;<span class="ref-vol">14</span>:452–463.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6433546/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29904174" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Endocrinol.&amp;title=Liver+X+receptors+in+lipid+signalling+and+membrane+homeostasis&amp;author=B.+Wang&amp;author=P.+Tontonoz&amp;volume=14&amp;publication_year=2018&amp;pages=452-463&amp;pmid=29904174&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib28">28. <span class="element-citation" id="sref28">Fakheri R.J., Javitt N.B. 27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols. <span><span class="ref-journal">Steroids. </span>2012;<span class="ref-vol">77</span>:575–577.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22366074" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Steroids&amp;title=27-Hydroxycholesterol,+does+it+exist?+On+the+nomenclature+and+stereochemistry+of+26-hydroxylated+sterols&amp;author=R.J.+Fakheri&amp;author=N.B.+Javitt&amp;volume=77&amp;publication_year=2012&amp;pages=575-577&amp;pmid=22366074&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib29">29. <span class="element-citation" id="sref29">Fu X., Menke J.G., Chen Y., Zhou G., MacNaul K.L., Wright S.D., Sparrow C.P., Lund E.G. 27-Hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2001;<span class="ref-vol">276</span>:38378–38387.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11504730" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=27-Hydroxycholesterol+is+an+endogenous+ligand+for+liver+X+receptor+in+cholesterol-loaded+cells&amp;author=X.+Fu&amp;author=J.G.+Menke&amp;author=Y.+Chen&amp;author=G.+Zhou&amp;author=K.L.+MacNaul&amp;volume=276&amp;publication_year=2001&amp;pages=38378-38387&amp;pmid=11504730&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib30">30. <span class="element-citation" id="sref30">Song C., Liao S. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. <span><span class="ref-journal">Endocrinology. </span>2000;<span class="ref-vol">141</span>:4180–4184.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11089551" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Cholestenoic+acid+is+a+naturally+occurring+ligand+for+liver+X+receptor+alpha&amp;author=C.+Song&amp;author=S.+Liao&amp;volume=141&amp;publication_year=2000&amp;pages=4180-4184&amp;pmid=11089551&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib31">31. <span class="element-citation" id="sref31">Theofilopoulos S., Griffiths W.J., Crick P.J., Yang S., Meljon A., Ogundare M., Kitambi S.S., Lockhart A., Tuschl K., Clayton P.T., Morris A.A., Martinez A., Reddy M.A., Martinuzzi A., Bassi M.T., et al. Cholestenoic acids regulate motor neuron survival via liver X receptors. <span><span class="ref-journal">J.&#x000a0;Clin. Invest. </span>2014;<span class="ref-vol">124</span>:4829–4842.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4347238/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25271621" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Clin.+Invest.&amp;title=Cholestenoic+acids+regulate+motor+neuron+survival+via+liver+X+receptors&amp;author=S.+Theofilopoulos&amp;author=W.J.+Griffiths&amp;author=P.J.+Crick&amp;author=S.+Yang&amp;author=A.+Meljon&amp;volume=124&amp;publication_year=2014&amp;pages=4829-4842&amp;pmid=25271621&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib32">32. <span class="element-citation" id="sref32">Segala G., David M., de Medina P., Poirot M.C., Serhan N., Vergez F., Mougel A., Saland E., Carayon K., Leignadier J., Caron N., Voisin M., Cherier J., Ligat L., Lopez F., et al. Dendrogenin A drives LXR to trigger lethal autophagy in cancers. <span><span class="ref-journal">Nat. Commun. </span>2017;<span class="ref-vol">8</span>:1903.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5712521/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29199269" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Commun.&amp;title=Dendrogenin+A+drives+LXR+to+trigger+lethal+autophagy+in+cancers&amp;author=G.+Segala&amp;author=M.+David&amp;author=P.+de+Medina&amp;author=M.C.+Poirot&amp;author=N.+Serhan&amp;volume=8&amp;publication_year=2017&amp;pages=1903&amp;pmid=29199269&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib33">33. <span class="element-citation" id="sref33">Goldstein J.L., DeBose-Boyd R.A., Brown M.S. Protein sensors for membrane sterols. <span><span class="ref-journal">Cell. </span>2006;<span class="ref-vol">124</span>:35–46.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16413480" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Protein+sensors+for+membrane+sterols&amp;author=J.L.+Goldstein&amp;author=R.A.+DeBose-Boyd&amp;author=M.S.+Brown&amp;volume=124&amp;publication_year=2006&amp;pages=35-46&amp;pmid=16413480&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib34">34. <span class="element-citation" id="sref34">Radhakrishnan A., Ikeda Y., Kwon H.J., Brown M.S., Goldstein J.L. Sterol-regulated transport of SREBPs from endoplasmic reticulum to Golgi: oxysterols block transport by binding to Insig. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2007;<span class="ref-vol">104</span>:6511–6518.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1851665/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17428920" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Sterol-regulated+transport+of+SREBPs+from+endoplasmic+reticulum+to+Golgi:+oxysterols+block+transport+by+binding+to+Insig&amp;author=A.+Radhakrishnan&amp;author=Y.+Ikeda&amp;author=H.J.+Kwon&amp;author=M.S.+Brown&amp;author=J.L.+Goldstein&amp;volume=104&amp;publication_year=2007&amp;pages=6511-6518&amp;pmid=17428920&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib35">35. <span class="element-citation" id="sref35">Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. <span><span class="ref-journal">J.&#x000a0;Clin. Invest. </span>2002;<span class="ref-vol">109</span>:1125–1131.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC150968/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11994399" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Clin.+Invest.&amp;title=SREBPs:+activators+of+the+complete+program+of+cholesterol+and+fatty+acid+synthesis+in+the+liver&amp;author=J.D.+Horton&amp;author=J.L.+Goldstein&amp;author=M.S.+Brown&amp;volume=109&amp;publication_year=2002&amp;pages=1125-1131&amp;pmid=11994399&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib36">36. <span class="element-citation" id="sref36">Sever N., Yang T., Brown M.S., Goldstein J.L., DeBose-Boyd R.A. Accelerated degradation of HMG CoA reductase mediated by binding of insig-1 to its sterol-sensing domain. <span><span class="ref-journal">Mol. Cell. </span>2003;<span class="ref-vol">11</span>:25–33.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12535518" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell&amp;title=Accelerated+degradation+of+HMG+CoA+reductase+mediated+by+binding+of+insig-1+to+its+sterol-sensing+domain&amp;author=N.+Sever&amp;author=T.+Yang&amp;author=M.S.+Brown&amp;author=J.L.+Goldstein&amp;author=R.A.+DeBose-Boyd&amp;volume=11&amp;publication_year=2003&amp;pages=25-33&amp;pmid=12535518&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib37">37. <span class="element-citation" id="sref37">McDonald J.G., Thompson B.M., McCrum E.C., Russell D.W. Extraction and analysis of sterols in biological matrices by high performance liquid chromatography electrospray ionization mass spectrometry. <span><span class="ref-journal">Methods Enzymol. </span>2007;<span class="ref-vol">432</span>:145–170.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17954216" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Enzymol.&amp;title=Extraction+and+analysis+of+sterols+in+biological+matrices+by+high+performance+liquid+chromatography+electrospray+ionization+mass+spectrometry&amp;author=J.G.+McDonald&amp;author=B.M.+Thompson&amp;author=E.C.+McCrum&amp;author=D.W.+Russell&amp;volume=432&amp;publication_year=2007&amp;pages=145-170&amp;pmid=17954216&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib38">38. <span class="element-citation" id="sref38">Nelson J.A., Steckbeck S.R., Spencer T.A. Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1981;<span class="ref-vol">256</span>:1067–1068.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7451488" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Biosynthesis+of+24,25-epoxycholesterol+from+squalene+2,3;22,23-dioxide&amp;author=J.A.+Nelson&amp;author=S.R.+Steckbeck&amp;author=T.A.+Spencer&amp;volume=256&amp;publication_year=1981&amp;pages=1067-1068&amp;pmid=7451488&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib39">39. <span class="element-citation" id="sref39">Porstmann T., Santos C.R., Griffiths B., Cully M., Wu M., Leevers S., Griffiths J.R., Chung Y.-L., Schulze A. SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth. <span><span class="ref-journal">Cell Metab. </span>2008;<span class="ref-vol">8</span>:224–236.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2593919/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18762023" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab.&amp;title=SREBP+activity+is+regulated+by+mTORC1+and+contributes+to+Akt-dependent+cell+growth&amp;author=T.+Porstmann&amp;author=C.R.+Santos&amp;author=B.+Griffiths&amp;author=M.+Cully&amp;author=M.+Wu&amp;volume=8&amp;publication_year=2008&amp;pages=224-236&amp;pmid=18762023&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib40">40. <span class="element-citation" id="sref40">D&#x000fc;vel K., Yecies J.L., Menon S., Raman P., Lipovsky A.I., Souza A.L., Triantafellow E., Ma Q., Gorski R., Cleaver S., Vander Heiden M.G., MacKeigan J.P., Finan P.M., Clish C.B., Murphy L.O., et al. Activation of a metabolic gene regulatory network downstream of mTOR complex 1. <span><span class="ref-journal">Mol. Cell. </span>2010;<span class="ref-vol">39</span>:171–183.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2946786/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20670887" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell&amp;title=Activation+of+a+metabolic+gene+regulatory+network+downstream+of+mTOR+complex+1&amp;author=K.+D&#x000fc;vel&amp;author=J.L.+Yecies&amp;author=S.+Menon&amp;author=P.+Raman&amp;author=A.I.+Lipovsky&amp;volume=39&amp;publication_year=2010&amp;pages=171-183&amp;pmid=20670887&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib41">41. <span class="element-citation" id="sref41">Chen L., Ma M.Y., Sun M., Jiang L.Y., Zhao X.T., Fang X.X., Man Lam S., Shui G.H., Luo J., Shi X.J., Song B.L. Endogenous sterol intermediates of the mevalonate pathway regulate HMGCR degradation and SREBP-2 processing. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2019;<span class="ref-vol">60</span>:1765–1775.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6795084/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31455613" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Endogenous+sterol+intermediates+of+the+mevalonate+pathway+regulate+HMGCR+degradation+and+SREBP-2+processing&amp;author=L.+Chen&amp;author=M.Y.+Ma&amp;author=M.+Sun&amp;author=L.Y.+Jiang&amp;author=X.T.+Zhao&amp;volume=60&amp;publication_year=2019&amp;pages=1765-1775&amp;pmid=31455613&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib42">42. <span class="element-citation" id="sref42">Lund E., Bj&#x000f6;rkhem I., Furster C., Wikvall K. 24-, 25- and 27-hydroxylation of cholesterol by a purified preparation of 27-hydroxylase from pig liver. <span><span class="ref-journal">Biochim. Biophys. Acta. </span>1993;<span class="ref-vol">1166</span>:177–182.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8443234" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta&amp;title=24-,+25-+and+27-hydroxylation+of+cholesterol+by+a+purified+preparation+of+27-hydroxylase+from+pig+liver&amp;author=E.+Lund&amp;author=I.+Bj&#x000f6;rkhem&amp;author=C.+Furster&amp;author=K.+Wikvall&amp;volume=1166&amp;publication_year=1993&amp;pages=177-182&amp;pmid=8443234&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib43">43. <span class="element-citation" id="sref43">McDonald J.G., Russell D.W. Editorial: 25-hydroxycholesterol: a new life in immunology. <span><span class="ref-journal">J.&#x000a0;Leukoc. Biol. </span>2010;<span class="ref-vol">88</span>:1071–1072.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2996897/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21123296" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Leukoc.+Biol.&amp;title=Editorial:+25-hydroxycholesterol:+a+new+life+in+immunology&amp;author=J.G.+McDonald&amp;author=D.W.+Russell&amp;volume=88&amp;publication_year=2010&amp;pages=1071-1072&amp;pmid=21123296&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib44">44. <span class="element-citation" id="sref44">Zou T., Garifulin O., Berland R., Boyartchuk V.L. Listeria monocytogenes infection induces prosurvival metabolic signaling in macrophages. <span><span class="ref-journal">Infect. Immun. </span>2011;<span class="ref-vol">79</span>:1526–1535.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3067555/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21263022" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect.+Immun.&amp;title=Listeria+monocytogenes+infection+induces+prosurvival+metabolic+signaling+in+macrophages&amp;author=T.+Zou&amp;author=O.+Garifulin&amp;author=R.+Berland&amp;author=V.L.+Boyartchuk&amp;volume=79&amp;publication_year=2011&amp;pages=1526-1535&amp;pmid=21263022&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib45">45. <span class="element-citation" id="sref45">Liu S.-Y., Sanchez D.J., Aliyari R., Lu S., Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2012;<span class="ref-vol">109</span>:4239–4244.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3306696/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22371602" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Systematic+identification+of+type+I+and+type+II+interferon-induced+antiviral+factors&amp;author=S.-Y.+Liu&amp;author=D.J.+Sanchez&amp;author=R.+Aliyari&amp;author=S.+Lu&amp;author=G.+Cheng&amp;volume=109&amp;publication_year=2012&amp;pages=4239-4244&amp;pmid=22371602&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib46">46. <span class="element-citation" id="sref46">Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. <span><span class="ref-journal">Nat. Med. </span>2003;<span class="ref-vol">9</span>:213–219.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12524534" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med.&amp;title=Reciprocal+regulation+of+inflammation+and+lipid+metabolism+by+liver+X+receptors&amp;author=S.B.+Joseph&amp;author=A.+Castrillo&amp;author=B.A.+Laffitte&amp;author=D.J.+Mangelsdorf&amp;author=P.+Tontonoz&amp;volume=9&amp;publication_year=2003&amp;pages=213-219&amp;pmid=12524534&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib47">47. <span class="element-citation" id="sref47">Zelcer N., Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. <span><span class="ref-journal">J.&#x000a0;Clin. Invest. </span>2006;<span class="ref-vol">116</span>:607–614.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1386115/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16511593" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Clin.+Invest.&amp;title=Liver+X+receptors+as+integrators+of+metabolic+and+inflammatory+signaling&amp;author=N.+Zelcer&amp;author=P.+Tontonoz&amp;volume=116&amp;publication_year=2006&amp;pages=607-614&amp;pmid=16511593&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib48">48. <span class="element-citation" id="sref48">Ecker J., Liebisch G., Englmaier M., Grandl M., Robenek H., Schmitz G. Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2010;<span class="ref-vol">107</span>:7817–7822.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2867858/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20385828" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Induction+of+fatty+acid+synthesis+is+a+key+requirement+for+phagocytic+differentiation+of+human+monocytes&amp;author=J.+Ecker&amp;author=G.+Liebisch&amp;author=M.+Englmaier&amp;author=M.+Grandl&amp;author=H.+Robenek&amp;volume=107&amp;publication_year=2010&amp;pages=7817-7822&amp;pmid=20385828&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib49">49. <span class="element-citation" id="sref49">Song B.L., Javitt N.B., DeBose-Boyd R.A. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. <span><span class="ref-journal">Cell Metab. </span>2005;<span class="ref-vol">1</span>:179–189.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16054061" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab.&amp;title=Insig-mediated+degradation+of+HMG+CoA+reductase+stimulated+by+lanosterol,+an+intermediate+in+the+synthesis+of+cholesterol&amp;author=B.L.+Song&amp;author=N.B.+Javitt&amp;author=R.A.+DeBose-Boyd&amp;volume=1&amp;publication_year=2005&amp;pages=179-189&amp;pmid=16054061&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib50">50. <span class="element-citation" id="sref50">Cheng D., Chang C.C., Qu X., Chang T.Y. Activation of acyl-coenzyme A:cholesterol acyltransferase by cholesterol or by oxysterol in a cell-free system. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1995;<span class="ref-vol">270</span>:685–695.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7822296" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Activation+of+acyl-coenzyme+A:cholesterol+acyltransferase+by+cholesterol+or+by+oxysterol+in+a+cell-free+system&amp;author=D.+Cheng&amp;author=C.C.+Chang&amp;author=X.+Qu&amp;author=T.Y.+Chang&amp;volume=270&amp;publication_year=1995&amp;pages=685-695&amp;pmid=7822296&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib51">51. <span class="element-citation" id="sref51">Lange Y., Ye J., Strebel F. Movement of 25-hydroxycholesterol from the plasma membrane to the rough endoplasmic reticulum in cultured hepatoma cells. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>1995;<span class="ref-vol">36</span>:1092–1097.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7658157" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Movement+of+25-hydroxycholesterol+from+the+plasma+membrane+to+the+rough+endoplasmic+reticulum+in+cultured+hepatoma+cells&amp;author=Y.+Lange&amp;author=J.+Ye&amp;author=F.+Strebel&amp;volume=36&amp;publication_year=1995&amp;pages=1092-1097&amp;pmid=7658157&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib52">52. <span class="element-citation" id="sref52">Meaney S., Bodin K., Diczfalusy U., Bjorkhem I. On the rate of translocation in&#x000a0;vitro and kinetics in&#x000a0;vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2002;<span class="ref-vol">43</span>:2130–2135.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12454275" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=On+the+rate+of+translocation+in&#x000a0;vitro+and+kinetics+in&#x000a0;vivo+of+the+major+oxysterols+in+human+circulation:+critical+importance+of+the+position+of+the+oxygen+function&amp;author=S.+Meaney&amp;author=K.+Bodin&amp;author=U.+Diczfalusy&amp;author=I.+Bjorkhem&amp;volume=43&amp;publication_year=2002&amp;pages=2130-2135&amp;pmid=12454275&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib53">53. <span class="element-citation" id="sref53">Olkkonen V.M., Hynynen R. Interactions of oxysterols with membranes and proteins. <span><span class="ref-journal">Mol. Aspects Med. </span>2009;<span class="ref-vol">30</span>:123–133.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19248802" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Aspects+Med.&amp;title=Interactions+of+oxysterols+with+membranes+and+proteins&amp;author=V.M.+Olkkonen&amp;author=R.+Hynynen&amp;volume=30&amp;publication_year=2009&amp;pages=123-133&amp;pmid=19248802&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib54">54. <span class="element-citation" id="sref54">Lange Y., Swaisgood M.H., Ramos B.V., Steck T.L. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1989;<span class="ref-vol">264</span>:3786–3793.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/2917977" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Plasma+membranes+contain+half+the+phospholipid+and+90%+of+the+cholesterol+and+sphingomyelin+in+cultured+human+fibroblasts&amp;author=Y.+Lange&amp;author=M.H.+Swaisgood&amp;author=B.V.+Ramos&amp;author=T.L.+Steck&amp;volume=264&amp;publication_year=1989&amp;pages=3786-3793&amp;pmid=2917977&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib55">55. <span class="element-citation" id="sref55">de Duve C. Tissue fraction-past and present. <span><span class="ref-journal">J.&#x000a0;Cell Biol. </span>1971;<span class="ref-vol">50</span>:20.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2108428/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19866786" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Cell+Biol.&amp;title=Tissue+fraction-past+and+present&amp;author=C.+de+Duve&amp;volume=50&amp;publication_year=1971&amp;pages=20&amp;pmid=19866786&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib56">56. <span class="element-citation" id="sref56">van Meer G., Voelker D.R., Feigenson G.W. Membrane lipids: where they are and how they behave. <span><span class="ref-journal">Nat. Rev. Mol. Cell Biol. </span>2008;<span class="ref-vol">9</span>:112–124.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2642958/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18216768" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Mol.+Cell+Biol.&amp;title=Membrane+lipids:+where+they+are+and+how+they+behave&amp;author=G.+van+Meer&amp;author=D.R.+Voelker&amp;author=G.W.+Feigenson&amp;volume=9&amp;publication_year=2008&amp;pages=112-124&amp;pmid=18216768&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib57">57. <span class="element-citation" id="sref57">Lange Y., Steck T.L. Quantitation of the pool of cholesterol associated with acyl-CoA:cholesterol acyltransferase in human fibroblasts. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1997;<span class="ref-vol">272</span>:13103–13108.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9148923" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Quantitation+of+the+pool+of+cholesterol+associated+with+acyl-CoA:cholesterol+acyltransferase+in+human+fibroblasts&amp;author=Y.+Lange&amp;author=T.L.+Steck&amp;volume=272&amp;publication_year=1997&amp;pages=13103-13108&amp;pmid=9148923&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib58">58. <span class="element-citation" id="sref58">Radhakrishnan A., Goldstein J.L., McDonald J.G., Brown M.S. Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. <span><span class="ref-journal">Cell Metab. </span>2008;<span class="ref-vol">8</span>:512–521.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2652870/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19041766" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab.&amp;title=Switch-like+control+of+SREBP-2+transport+triggered+by+small+changes+in+ER+cholesterol:+a+delicate+balance&amp;author=A.+Radhakrishnan&amp;author=J.L.+Goldstein&amp;author=J.G.+McDonald&amp;author=M.S.+Brown&amp;volume=8&amp;publication_year=2008&amp;pages=512-521&amp;pmid=19041766&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib59">59. <span class="element-citation" id="sref59">Das A., Brown M.S., Anderson D.D., Goldstein J.L., Radhakrishnan A. Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis. <span><span class="ref-journal">Elife. </span>2014;<span class="ref-vol">3</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4086274/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24920391" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Three+pools+of+plasma+membrane+cholesterol+and+their+relation+to+cholesterol+homeostasis&amp;author=A.+Das&amp;author=M.S.+Brown&amp;author=D.D.+Anderson&amp;author=J.L.+Goldstein&amp;author=A.+Radhakrishnan&amp;volume=3&amp;publication_year=2014&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib60">60. <span class="element-citation" id="sref60">Sandhu J., Li S., Fairall L., Pfisterer S.G., Gurnett J.E., Xiao X., Weston T.A., Vashi D., Ferrari A., Orozco J.L., Hartman C.L., Strugatsky D., Lee S.D., He C., Hong C., et al. Aster proteins facilitate nonvesicular plasma membrane to ER cholesterol transport in mammalian cells. <span><span class="ref-journal">Cell. </span>2018;<span class="ref-vol">175</span>:514–529.e20.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6469685/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30220461" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Aster+proteins+facilitate+nonvesicular+plasma+membrane+to+ER+cholesterol+transport+in+mammalian+cells&amp;author=J.+Sandhu&amp;author=S.+Li&amp;author=L.+Fairall&amp;author=S.G.+Pfisterer&amp;author=J.E.+Gurnett&amp;volume=175&amp;publication_year=2018&amp;pages=514-529.e20&amp;pmid=30220461&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib61">61. <span class="element-citation" id="sref61">Naito T., Ercan B., Krshnan L., Triebl A., Koh D.H.Z., Wei F.Y., Tomizawa K., Torta F.T., Wenk M.R., Saheki Y. Movement of accessible plasma membrane cholesterol by the GRAMD1 lipid transfer protein complex. <span><span class="ref-journal">Elife. </span>2019;<span class="ref-vol">8</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6905856/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31724953" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Movement+of+accessible+plasma+membrane+cholesterol+by+the+GRAMD1+lipid+transfer+protein+complex&amp;author=T.+Naito&amp;author=B.+Ercan&amp;author=L.+Krshnan&amp;author=A.+Triebl&amp;author=D.H.Z.+Koh&amp;volume=8&amp;publication_year=2019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib62">62. <span class="element-citation" id="sref62">Ferrari A., He C., Kennelly J.P., Sandhu J., Xiao X., Chi X., Jiang H., Young S.G., Tontonoz P. Aster proteins regulate the accessible cholesterol pool in the plasma membrane. <span><span class="ref-journal">Mol. Cell. Biol. </span>2020;<span class="ref-vol">40</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7491948/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32719109" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Cell.+Biol.&amp;title=Aster+proteins+regulate+the+accessible+cholesterol+pool+in+the+plasma+membrane&amp;author=A.+Ferrari&amp;author=C.+He&amp;author=J.P.+Kennelly&amp;author=J.+Sandhu&amp;author=X.+Xiao&amp;volume=40&amp;publication_year=2020&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib63">63. <span class="element-citation" id="sref63">Trinh M.N., Brown M.S., Goldstein J.L., Han J., Vale G., McDonald J.G., Seemann J., Mendell J.T., Lu F. Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2020;<span class="ref-vol">117</span>:18521–18529.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7414171/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32690708" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Last+step+in+the+path+of+LDL+cholesterol+from+lysosome+to+plasma+membrane+to+ER+is+governed+by+phosphatidylserine&amp;author=M.N.+Trinh&amp;author=M.S.+Brown&amp;author=J.L.+Goldstein&amp;author=J.+Han&amp;author=G.+Vale&amp;volume=117&amp;publication_year=2020&amp;pages=18521-18529&amp;pmid=32690708&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib64">64. <span class="element-citation" id="sref64">Lange Y., Steck T.L. Cholesterol homeostasis and the escape tendency (activity) of plasma membrane cholesterol. <span><span class="ref-journal">Prog. Lipid Res. </span>2008;<span class="ref-vol">47</span>:319–332.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2659507/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18423408" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Prog.+Lipid+Res.&amp;title=Cholesterol+homeostasis+and+the+escape+tendency+(activity)+of+plasma+membrane+cholesterol&amp;author=Y.+Lange&amp;author=T.L.+Steck&amp;volume=47&amp;publication_year=2008&amp;pages=319-332&amp;pmid=18423408&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib65">65. <span class="element-citation" id="sref65">Lange Y., Steck T.L. Active cholesterol 20 years on. <span><span class="ref-journal">Traffic. </span>2020;<span class="ref-vol"><em>2</em>1</span>:662–674.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32930466" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Traffic&amp;title=Active+cholesterol+20+years+on&amp;author=Y.+Lange&amp;author=T.L.+Steck&amp;volume=21&amp;publication_year=2020&amp;pages=662-674&amp;pmid=32930466&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib66">66. <span class="element-citation" id="sref66">Radhakrishnan A., McConnell H.M. Chemical activity of cholesterol in membranes. <span><span class="ref-journal">Biochemistry. </span>2000;<span class="ref-vol">39</span>:8119–8124.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10889017" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Chemical+activity+of+cholesterol+in+membranes&amp;author=A.+Radhakrishnan&amp;author=H.M.+McConnell&amp;volume=39&amp;publication_year=2000&amp;pages=8119-8124&amp;pmid=10889017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib67">67. <span class="element-citation" id="sref67">McConnell H.M., Radhakrishnan A. Condensed complexes of cholesterol and phospholipids. <span><span class="ref-journal">Biochim. Biophys. Acta. </span>2003;<span class="ref-vol">1610</span>:159–173.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12648771" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta&amp;title=Condensed+complexes+of+cholesterol+and+phospholipids&amp;author=H.M.+McConnell&amp;author=A.+Radhakrishnan&amp;volume=1610&amp;publication_year=2003&amp;pages=159-173&amp;pmid=12648771&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib68">68. <span class="element-citation" id="sref68">Radhakrishnan A., Rohatgi R., Siebold C. Cholesterol access in cellular membranes controls Hedgehog signaling. <span><span class="ref-journal">Nat. Chem. Biol. </span>2020;<span class="ref-vol">16</span>:1303–1313.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7872078/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33199907" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Chem.+Biol.&amp;title=Cholesterol+access+in+cellular+membranes+controls+Hedgehog+signaling&amp;author=A.+Radhakrishnan&amp;author=R.+Rohatgi&amp;author=C.+Siebold&amp;volume=16&amp;publication_year=2020&amp;pages=1303-1313&amp;pmid=33199907&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib69">69. <span class="element-citation" id="sref69">Lange Y., Cutler H.B., Steck T.L. The effect of cholesterol and other intercalated amphipaths on the contour and stability of the isolated red cell membrane. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>1980;<span class="ref-vol">255</span>:9331–9337.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7410427" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=The+effect+of+cholesterol+and+other+intercalated+amphipaths+on+the+contour+and+stability+of+the+isolated+red+cell+membrane&amp;author=Y.+Lange&amp;author=H.B.+Cutler&amp;author=T.L.+Steck&amp;volume=255&amp;publication_year=1980&amp;pages=9331-9337&amp;pmid=7410427&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib70">70. <span class="element-citation" id="sref70">Das A., Goldstein J.L., Anderson D.D., Brown M.S., Radhakrishnan A. Use of mutant <sup>125</sup>I-Perfringolysin O to probe transport and organization of cholesterol in membranes of animal cells. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2013;<span class="ref-vol">110</span>:10580–10585.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3696761/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23754385" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Use+of+mutant+125I-Perfringolysin+O+to+probe+transport+and+organization+of+cholesterol+in+membranes+of+animal+cells&amp;author=A.+Das&amp;author=J.L.+Goldstein&amp;author=D.D.+Anderson&amp;author=M.S.+Brown&amp;author=A.+Radhakrishnan&amp;volume=110&amp;publication_year=2013&amp;pages=10580-10585&amp;pmid=23754385&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib71">71. <span class="element-citation" id="sref71">Infante R.E., Radhakrishnan A. Continuous transport of a small fraction of plasma membrane cholesterol to endoplasmic reticulum regulates total cellular cholesterol. <span><span class="ref-journal">Elife. </span>2017;<span class="ref-vol">6</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5433840/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28414269" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=Continuous+transport+of+a+small+fraction+of+plasma+membrane+cholesterol+to+endoplasmic+reticulum+regulates+total+cellular+cholesterol&amp;author=R.E.+Infante&amp;author=A.+Radhakrishnan&amp;volume=6&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib72">72. <span class="element-citation" id="sref72">Johnson K.A., Endapally S., Vazquez D.C., Infante R.E., Radhakrishnan A. Ostreolysin A and anthrolysin O use different mechanisms to control movement of cholesterol from the plasma membrane to the endoplasmic reticulum. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2019;<span class="ref-vol">294</span>:17289–17300.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6873175/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31597703" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Ostreolysin+A+and+anthrolysin+O+use+different+mechanisms+to+control+movement+of+cholesterol+from+the+plasma+membrane+to+the+endoplasmic+reticulum&amp;author=K.A.+Johnson&amp;author=S.+Endapally&amp;author=D.C.+Vazquez&amp;author=R.E.+Infante&amp;author=A.+Radhakrishnan&amp;volume=294&amp;publication_year=2019&amp;pages=17289-17300&amp;pmid=31597703&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib73">73. <span class="element-citation" id="sref73">Zhou Q.D., Chi X., Lee M.S., Hsieh W.Y., Mkrtchyan J.J., Feng A.C., He C., York A.G., Bui V.L., Kronenberger E.B., Ferrari A., Xiao X., Daly A.E., Tarling E.J., Damoiseaux R., et al. Interferon-mediated reprogramming of membrane cholesterol to evade bacterial toxins. <span><span class="ref-journal">Nat. Immunol. </span>2020;<span class="ref-vol">21</span>:746–755.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7778040/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32514064" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Immunol.&amp;title=Interferon-mediated+reprogramming+of+membrane+cholesterol+to+evade+bacterial+toxins&amp;author=Q.D.+Zhou&amp;author=X.+Chi&amp;author=M.S.+Lee&amp;author=W.Y.+Hsieh&amp;author=J.J.+Mkrtchyan&amp;volume=21&amp;publication_year=2020&amp;pages=746-755&amp;pmid=32514064&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib74">74. <span class="element-citation" id="sref74">Abrams M.E., Johnson K.A., Perelman S.S., Zhang L.S., Endapally S., Mar K.B., Thompson B.M., McDonald J.G., Schoggins J.W., Radhakrishnan A., Alto N.M. Oxysterols provide innate immunity to bacterial infection by mobilizing cell surface accessible cholesterol. <span><span class="ref-journal">Nat. Microbiol. </span>2020;<span class="ref-vol">5</span>:929–942.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7442315/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32284563" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Microbiol.&amp;title=Oxysterols+provide+innate+immunity+to+bacterial+infection+by+mobilizing+cell+surface+accessible+cholesterol&amp;author=M.E.+Abrams&amp;author=K.A.+Johnson&amp;author=S.S.+Perelman&amp;author=L.S.+Zhang&amp;author=S.+Endapally&amp;volume=5&amp;publication_year=2020&amp;pages=929-942&amp;pmid=32284563&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib75">75. <span class="element-citation" id="sref75">Dang E.V., Madhani H.D., Vance R.E. Cholesterol in quarantine. <span><span class="ref-journal">Nat. Immunol. </span>2020;<span class="ref-vol">21</span>:716–717.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32514065" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Immunol.&amp;title=Cholesterol+in+quarantine&amp;author=E.V.+Dang&amp;author=H.D.+Madhani&amp;author=R.E.+Vance&amp;volume=21&amp;publication_year=2020&amp;pages=716-717&amp;pmid=32514065&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib76">76. <span class="element-citation" id="sref76">Ormsby T.J.R., Owens S.E., Horlock A.D., Davies D., Griffiths W.J., Wang Y., Cronin J.G., Bromfield J.J., Sheldon I.M. Oxysterols protect bovine endometrial cells against pore-forming toxins from pathogenic bacteria. <span><span class="ref-journal">FASEB J. </span>2021;<span class="ref-vol">35</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC9272411/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34569656" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=FASEB+J.&amp;title=Oxysterols+protect+bovine+endometrial+cells+against+pore-forming+toxins+from+pathogenic+bacteria&amp;author=T.J.R.+Ormsby&amp;author=S.E.+Owens&amp;author=A.D.+Horlock&amp;author=D.+Davies&amp;author=W.J.+Griffiths&amp;volume=35&amp;publication_year=2021&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib77">77. <span class="element-citation" id="sref77">Larrede S., Quinn C.M., Jessup W., Frisdal E., Olivier M., Hsieh V., Kim M.-J., Eck M.V., Couvert P., Carrie A., Giral P., Chapman M.J., Guerin M., Goff W.L. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. <span><span class="ref-journal">Arterioscler. Thromb. Vasc. Biol. </span>2009;<span class="ref-vol">29</span>:1930–1936.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19729607" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arterioscler.+Thromb.+Vasc.+Biol.&amp;title=Stimulation+of+cholesterol+efflux+by+LXR+agonists+in+cholesterol-loaded+human+macrophages+is+ABCA1-dependent+but+ABCG1-independent&amp;author=S.+Larrede&amp;author=C.M.+Quinn&amp;author=W.+Jessup&amp;author=E.+Frisdal&amp;author=M.+Olivier&amp;volume=29&amp;publication_year=2009&amp;pages=1930-1936&amp;pmid=19729607&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib78">78. <span class="element-citation" id="sref78">Griffin S., Preta G., Sheldon I.M. Inhibiting mevalonate pathway enzymes increases stromal cell resilience to a cholesterol-dependent cytolysin. <span><span class="ref-journal">Sci. Rep. </span>2017;<span class="ref-vol">7</span>:17050.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5719056/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29213055" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=Inhibiting+mevalonate+pathway+enzymes+increases+stromal+cell+resilience+to+a+cholesterol-dependent+cytolysin&amp;author=S.+Griffin&amp;author=G.+Preta&amp;author=I.M.+Sheldon&amp;volume=7&amp;publication_year=2017&amp;pages=17050&amp;pmid=29213055&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib79">79. <span class="element-citation" id="sref79">Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. <span><span class="ref-journal">J.&#x000a0;Leukoc. Biol. </span>2004;<span class="ref-vol">75</span>:163–189.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14525967" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Leukoc.+Biol.&amp;title=Interferon-gamma:+an+overview+of+signals,+mechanisms+and+functions&amp;author=K.+Schroder&amp;author=P.J.+Hertzog&amp;author=T.+Ravasi&amp;author=D.A.+Hume&amp;volume=75&amp;publication_year=2004&amp;pages=163-189&amp;pmid=14525967&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib80">80. <span class="element-citation" id="sref80">Gonz&#x000e1;lez-Navajas J.M., Lee J., David M., Raz E. Immunomodulatory functions of type I interferons. <span><span class="ref-journal">Nat. Rev. Immunol. </span>2012;<span class="ref-vol">12</span>:125–135.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3727154/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22222875" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Rev.+Immunol.&amp;title=Immunomodulatory+functions+of+type+I+interferons&amp;author=J.M.+Gonz&#x000e1;lez-Navajas&amp;author=J.+Lee&amp;author=M.+David&amp;author=E.+Raz&amp;volume=12&amp;publication_year=2012&amp;pages=125-135&amp;pmid=22222875&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib81">81. <span class="element-citation" id="sref81">Inoue M., Shinohara M.L. The role of interferon-&#x003b2; in the treatment of multiple sclerosis and experimental autoimmune encephalomyelitis - in the perspective of inflammasomes. <span><span class="ref-journal">Immunology. </span>2013;<span class="ref-vol">139</span>:11–18.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3634535/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23360426" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunology&amp;title=The+role+of+interferon-&#x003b2;+in+the+treatment+of+multiple+sclerosis+and+experimental+autoimmune+encephalomyelitis+-+in+the+perspective+of+inflammasomes&amp;author=M.+Inoue&amp;author=M.L.+Shinohara&amp;volume=139&amp;publication_year=2013&amp;pages=11-18&amp;pmid=23360426&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib82">82. <span class="element-citation" id="sref82">Guarda G., Braun M., Staehli F., Tardivel A., Mattmann C., F&#x000f6;rster I., Farlik M., Decker T., Du Pasquier R.A., Romero P., Tschopp J. Type I interferon inhibits interleukin-1 production and inflammasome activation. <span><span class="ref-journal">Immunity. </span>2011;<span class="ref-vol">34</span>:213–223.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21349431" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Type+I+interferon+inhibits+interleukin-1+production+and+inflammasome+activation&amp;author=G.+Guarda&amp;author=M.+Braun&amp;author=F.+Staehli&amp;author=A.+Tardivel&amp;author=C.+Mattmann&amp;volume=34&amp;publication_year=2011&amp;pages=213-223&amp;pmid=21349431&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib83">83. <span class="element-citation" id="sref83">Dang E.V., Cyster J.G. Loss of sterol metabolic homeostasis triggers inflammasomes&#x02014;how and why. <span><span class="ref-journal">Curr. Opin. Immunol. </span>2019;<span class="ref-vol">56</span>:1–9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6395542/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30172069" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Opin.+Immunol.&amp;title=Loss+of+sterol+metabolic+homeostasis+triggers+inflammasomes&#x02014;how+and+why&amp;author=E.V.+Dang&amp;author=J.G.+Cyster&amp;volume=56&amp;publication_year=2019&amp;pages=1-9&amp;pmid=30172069&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib84">84. <span class="element-citation" id="sref84">Reboldi A., Dang E.V., McDonald J.G., Liang G., Russell D.W., Cyster J.G. Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. <span><span class="ref-journal">Science. </span>2014;<span class="ref-vol">345</span>:679–684.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4289637/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25104388" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Inflammation.+25-Hydroxycholesterol+suppresses+interleukin-1-driven+inflammation+downstream+of+type+I+interferon&amp;author=A.+Reboldi&amp;author=E.V.+Dang&amp;author=J.G.+McDonald&amp;author=G.+Liang&amp;author=D.W.+Russell&amp;volume=345&amp;publication_year=2014&amp;pages=679-684&amp;pmid=25104388&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib85">85. <span class="element-citation" id="sref85">Dang E.V., McDonald J.G., Russell D.W., Cyster J.G. Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation. <span><span class="ref-journal">Cell. </span>2017;<span class="ref-vol">171</span>:1057–1071.e11.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5693620/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29033131" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Oxysterol+restraint+of+cholesterol+synthesis+prevents+AIM2+inflammasome+activation&amp;author=E.V.+Dang&amp;author=J.G.+McDonald&amp;author=D.W.+Russell&amp;author=J.G.+Cyster&amp;volume=171&amp;publication_year=2017&amp;pages=1057-1071.e11&amp;pmid=29033131&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib86">86. <span class="element-citation" id="sref86">Zhou R., Yazdi A.S., Menu P., Tschopp J. A&#x000a0;role for mitochondria in NLRP3 inflammasome activation. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">469</span>:221–225.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21124315" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=A&#x000a0;role+for+mitochondria+in+NLRP3+inflammasome+activation&amp;author=R.+Zhou&amp;author=A.S.+Yazdi&amp;author=P.+Menu&amp;author=J.+Tschopp&amp;volume=469&amp;publication_year=2011&amp;pages=221-225&amp;pmid=21124315&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib87">87. <span class="element-citation" id="sref87">Franklin B.S., Mangan M.S., Latz E. Crystal formation in inflammation. <span><span class="ref-journal">Annu. Rev. Immunol. </span>2016;<span class="ref-vol">34</span>:173–202.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/26772211" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu.+Rev.+Immunol.&amp;title=Crystal+formation+in+inflammation&amp;author=B.S.+Franklin&amp;author=M.S.+Mangan&amp;author=E.+Latz&amp;volume=34&amp;publication_year=2016&amp;pages=173-202&amp;pmid=26772211&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib88">88. <span class="element-citation" id="sref88">Viaud M., Ivanov S., Vujic N., Duta-Mare M., Aira L.-E., Barouillet T., Garcia E., Orange F., Dugail I., Hainault I., Stehlik C., Marchetti S., Boyer L., Guinamard R., Foufelle F., et al. Lysosomal cholesterol hydrolysis couples efferocytosis to anti-inflammatory oxysterol production. <span><span class="ref-journal">Circ. Res. </span>2018;<span class="ref-vol">122</span>:1369–1384.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6034181/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29523554" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circ.+Res.&amp;title=Lysosomal+cholesterol+hydrolysis+couples+efferocytosis+to+anti-inflammatory+oxysterol+production&amp;author=M.+Viaud&amp;author=S.+Ivanov&amp;author=N.+Vujic&amp;author=M.+Duta-Mare&amp;author=L.-E.+Aira&amp;volume=122&amp;publication_year=2018&amp;pages=1369-1384&amp;pmid=29523554&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib89">89. <span class="element-citation" id="sref89">Potter J.E., Petts G., Ghosh A., White F.J., Kinsella J.L., Hughes S., Roberts J., Hodgkinson A., Brammeier K., Church H., Merrigan C., Hughes J., Evans P., Campbell H., Bonney D., et al. Enzyme replacement therapy and hematopoietic stem cell transplant: a new paradigm of treatment in Wolman disease. <span><span class="ref-journal">Orphanet J. Rare Dis. </span>2021;<span class="ref-vol">16</span>:235.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8139039/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34020687" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Orphanet+J.+Rare+Dis.&amp;title=Enzyme+replacement+therapy+and+hematopoietic+stem+cell+transplant:+a+new+paradigm+of+treatment+in+Wolman+disease&amp;author=J.E.+Potter&amp;author=G.+Petts&amp;author=A.+Ghosh&amp;author=F.J.+White&amp;author=J.L.+Kinsella&amp;volume=16&amp;publication_year=2021&amp;pages=235&amp;pmid=34020687&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib90">90. <span class="element-citation" id="sref90">Cooper J.A., Church H.J., Wu H.Y. Cholestane-3&#x003b2;, 5&#x003b1;, 6&#x003b2;-triol: further insights into the performance of this oxysterol in diagnosis of Niemann-Pick disease type C. <span><span class="ref-journal">Mol. Genet. Metab. </span>2020;<span class="ref-vol">130</span>:77–86.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32178982" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Genet.+Metab.&amp;title=Cholestane-3&#x003b2;,+5&#x003b1;,+6&#x003b2;-triol:+further+insights+into+the+performance+of+this+oxysterol+in+diagnosis+of+Niemann-Pick+disease+type+C&amp;author=J.A.+Cooper&amp;author=H.J.+Church&amp;author=H.Y.+Wu&amp;volume=130&amp;publication_year=2020&amp;pages=77-86&amp;pmid=32178982&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib91">91. <span class="element-citation" id="sref91">de Medina P., Paillasse M.R., Segala G., Poirot M., Silvente-Poirot S. Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2010;<span class="ref-vol">107</span>:13520–13525.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2922168/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20615952" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Identification+and+pharmacological+characterization+of+cholesterol-5,6-epoxide+hydrolase+as+a+target+for+tamoxifen+and+AEBS+ligands&amp;author=P.+de+Medina&amp;author=M.R.+Paillasse&amp;author=G.+Segala&amp;author=M.+Poirot&amp;author=S.+Silvente-Poirot&amp;volume=107&amp;publication_year=2010&amp;pages=13520-13525&amp;pmid=20615952&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib92">92. <span class="element-citation" id="sref92">Murphy R.C., Johnson K.M. Cholesterol, reactive oxygen species, and the formation of biologically active mediators. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2008;<span class="ref-vol">283</span>:15521–15525.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2414298/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/18285330" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Cholesterol,+reactive+oxygen+species,+and+the+formation+of+biologically+active+mediators&amp;author=R.C.+Murphy&amp;author=K.M.+Johnson&amp;volume=283&amp;publication_year=2008&amp;pages=15521-15525&amp;pmid=18285330&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib93">93. <span class="element-citation" id="sref93">Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. <span><span class="ref-journal">Chem. Phys. Lipids. </span>2011;<span class="ref-vol">164</span>:457–468.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21703250" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chem.+Phys.+Lipids&amp;title=Pathways+of+cholesterol+oxidation+via+non-enzymatic+mechanisms&amp;author=L.+Iuliano&amp;volume=164&amp;publication_year=2011&amp;pages=457-468&amp;pmid=21703250&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib94">94. <span class="element-citation" id="sref94">Taurisano R., Maiorana A., De Benedetti F., Dionisi-Vici C., Boldrini R., Deodato F. Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation. <span><span class="ref-journal">Eur. J. Pediatr. </span>2014;<span class="ref-vol">173</span>:1391–1394.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24844354" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur.+J.+Pediatr.&amp;title=Wolman+disease+associated+with+hemophagocytic+lymphohistiocytosis:+attempts+for+an+explanation&amp;author=R.+Taurisano&amp;author=A.+Maiorana&amp;author=F.+De+Benedetti&amp;author=C.+Dionisi-Vici&amp;author=R.+Boldrini&amp;volume=173&amp;publication_year=2014&amp;pages=1391-1394&amp;pmid=24844354&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib95">95. <span class="element-citation" id="sref95">Griffiths W.J., Yutuc E., Abdel-Khalik J., Crick P.J., Hearn T., Dickson A., Bigger B.W., Hoi-Yee Wu T., Goenka A., Ghosh A., Jones S.A., Covey D.F., Ory D.S., Wang Y. Metabolism of non-enzymatically derived oxysterols: clues from sterol metabolic disorders. <span><span class="ref-journal">Free Radic. Biol. Med. </span>2019;<span class="ref-vol">144</span>:124–133.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6863434/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31009661" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Free+Radic.+Biol.+Med.&amp;title=Metabolism+of+non-enzymatically+derived+oxysterols:+clues+from+sterol+metabolic+disorders&amp;author=W.J.+Griffiths&amp;author=E.+Yutuc&amp;author=J.+Abdel-Khalik&amp;author=P.J.+Crick&amp;author=T.+Hearn&amp;volume=144&amp;publication_year=2019&amp;pages=124-133&amp;pmid=31009661&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib96">96. <span class="element-citation" id="sref96">Goenka A., Ghosh A., Dixon S., Griffiths W.J., Hughes S.M., Newman W.G., Urquhart J., Wang Y., Wynn R.F., Hussell T., Jones S.A., Arkwright P.D.  <span class="ref-journal">UKPIN Conference.</span> United Kingdom Primary Immunodeficiency Network; London: 2017. Susceptibility to BCG abscess associated with deletion of two cholesterol metabolism genes: lysosomal acid lipase and cholesterol 25-hydroxylase. Brighton, UK. <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=UKPIN+Conference&amp;author=A.+Goenka&amp;author=A.+Ghosh&amp;author=S.+Dixon&amp;author=W.J.+Griffiths&amp;author=S.M.+Hughes&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib97">97. <span class="element-citation" id="sref97">Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. <span><span class="ref-journal">J.&#x000a0;Immunol. </span>1999;<span class="ref-vol">163</span>:3920–3927.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10490993" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Immunol.&amp;title=Human+toll-like+receptors+mediate+cellular+activation+by+Mycobacterium+tuberculosis&amp;author=T.K.+Means&amp;author=S.+Wang&amp;author=E.+Lien&amp;author=A.+Yoshimura&amp;author=D.T.+Golenbock&amp;volume=163&amp;publication_year=1999&amp;pages=3920-3927&amp;pmid=10490993&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib98">98. <span class="element-citation" id="sref98">Scanga C.B., Le Gros G. Development of an asthma vaccine. <span><span class="ref-journal">Drugs. </span>2000;<span class="ref-vol">59</span>:1217–1221.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10882158" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs&amp;title=Development+of+an+asthma+vaccine&amp;author=C.B.+Scanga&amp;author=G.+Le+Gros&amp;volume=59&amp;publication_year=2000&amp;pages=1217-1221&amp;pmid=10882158&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib99">99. <span class="element-citation" id="sref99">Jouanguy E., D&#x000f6;ffinger R., Dupuis S., Pallier A., Altare F., Casanova J.L. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men. <span><span class="ref-journal">Curr. Opin. Immunol. </span>1999;<span class="ref-vol">11</span>:346–351.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/10375558" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Curr.+Opin.+Immunol.&amp;title=IL-12+and+IFN-gamma+in+host+defense+against+mycobacteria+and+salmonella+in+mice+and+men&amp;author=E.+Jouanguy&amp;author=R.+D&#x000f6;ffinger&amp;author=S.+Dupuis&amp;author=A.+Pallier&amp;author=F.+Altare&amp;volume=11&amp;publication_year=1999&amp;pages=346-351&amp;pmid=10375558&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib100">100. <span class="element-citation" id="sref100">Janowski B.A., Shan B., Russell D.W. The hypocholesterolemic agent LY295427 reverses suppression of sterol regulatory element-binding protein processing mediated by oxysterols. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2001;<span class="ref-vol">276</span>:45408–45416.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11577112" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=The+hypocholesterolemic+agent+LY295427+reverses+suppression+of+sterol+regulatory+element-binding+protein+processing+mediated+by+oxysterols&amp;author=B.A.+Janowski&amp;author=B.+Shan&amp;author=D.W.+Russell&amp;volume=276&amp;publication_year=2001&amp;pages=45408-45416&amp;pmid=11577112&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib101">101. <span class="element-citation" id="sref101">Potena L., Frascaroli G., Grigioni F., Lazzarotto T., Magnani G., Tomasi L., Coccolo F., Gabrielli L., Magelli C., Landini M.P., Branzi A. Hydroxymethyl-glutaryl coenzyme A reductase inhibition limits cytomegalovirus infection in human endothelial cells. <span><span class="ref-journal">Circulation. </span>2004;<span class="ref-vol">109</span>:532–536.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14744969" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Hydroxymethyl-glutaryl+coenzyme+A+reductase+inhibition+limits+cytomegalovirus+infection+in+human+endothelial+cells&amp;author=L.+Potena&amp;author=G.+Frascaroli&amp;author=F.+Grigioni&amp;author=T.+Lazzarotto&amp;author=G.+Magnani&amp;volume=109&amp;publication_year=2004&amp;pages=532-536&amp;pmid=14744969&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib102">102. <span class="element-citation" id="sref102">Cosset F.-L., Lavillette D.  In: <span class="ref-journal">Advances in Genetics.</span> Friedmann T., Dunlap J.C., Goodwin S.F., editors. Academic Press; Amsterdam, The Netherlands: 2011. 4 - Cell entry of enveloped viruses; pp. 121–183. <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7149602/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21310296" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Advances+in+Genetics&amp;author=F.-L.+Cosset&amp;author=D.+Lavillette&amp;publication_year=2011&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib103">103. <span class="element-citation" id="sref103">Poli G., Biasi F., Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. <span><span class="ref-journal">Redox Biol. </span>2013;<span class="ref-vol">1</span>:125–130.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3757713/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24024145" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Redox+Biol.&amp;title=Oxysterols+in+the+pathogenesis+of+major+chronic+diseases&amp;author=G.+Poli&amp;author=F.+Biasi&amp;author=G.+Leonarduzzi&amp;volume=1&amp;publication_year=2013&amp;pages=125-130&amp;pmid=24024145&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib104">104. <span class="element-citation" id="sref104">Gold E.S., Diercks A.H., Podolsky I., Podyminogin R.L., Askovich P.S., Treuting P.M., Aderem A. 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2014;<span class="ref-vol">111</span>:10666–10671.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4115544/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24994901" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=25-Hydroxycholesterol+acts+as+an+amplifier+of+inflammatory+signaling&amp;author=E.S.+Gold&amp;author=A.H.+Diercks&amp;author=I.+Podolsky&amp;author=R.L.+Podyminogin&amp;author=P.S.+Askovich&amp;volume=111&amp;publication_year=2014&amp;pages=10666-10671&amp;pmid=24994901&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib105">105. <span class="element-citation" id="sref105">Cagno V., Civra A., Rossin D., Calfapietra S., Caccia C., Leoni V., Dorma N., Biasi F., Poli G., Lembo D. Inhibition of herpes simplex-1 virus replication by 25-hydroxycholesterol and 27-hydroxycholesterol. <span><span class="ref-journal">Redox Biol. </span>2017;<span class="ref-vol">12</span>:522–527.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5374874/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28359048" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Redox+Biol.&amp;title=Inhibition+of+herpes+simplex-1+virus+replication+by+25-hydroxycholesterol+and+27-hydroxycholesterol&amp;author=V.+Cagno&amp;author=A.+Civra&amp;author=D.+Rossin&amp;author=S.+Calfapietra&amp;author=C.+Caccia&amp;volume=12&amp;publication_year=2017&amp;pages=522-527&amp;pmid=28359048&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib106">106. <span class="element-citation" id="sref106">Civra A., Cagno V., Donalisio M., Biasi F., Leonarduzzi G., Poli G., Lembo D. Inhibition of pathogenic non-enveloped viruses by 25-hydroxycholesterol and 27-hydroxycholesterol. <span><span class="ref-journal">Sci. Rep. </span>2014;<span class="ref-vol">4</span>:7487.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4265783/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25501851" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Rep.&amp;title=Inhibition+of+pathogenic+non-enveloped+viruses+by+25-hydroxycholesterol+and+27-hydroxycholesterol&amp;author=A.+Civra&amp;author=V.+Cagno&amp;author=M.+Donalisio&amp;author=F.+Biasi&amp;author=G.+Leonarduzzi&amp;volume=4&amp;publication_year=2014&amp;pages=7487&amp;pmid=25501851&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib107">107. <span class="element-citation" id="sref107">Park A., Iwasaki A. Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19. <span><span class="ref-journal">Cell Host Microbe. </span>2020;<span class="ref-vol">27</span>:870–878.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7255347/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32464097" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Host+Microbe&amp;title=Type+I+and+type+III+interferons+-+induction,+signaling,+evasion,+and+application+to+combat+COVID-19&amp;author=A.+Park&amp;author=A.+Iwasaki&amp;volume=27&amp;publication_year=2020&amp;pages=870-878&amp;pmid=32464097&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib108">108. <span class="element-citation" id="sref108">Lamers M.M., Beumer J., van der Vaart J., Knoops K., Puschhof J., Breugem T.I., Ravelli R.B.G., Paul van Schayck J., Mykytyn A.Z., Duimel H.Q., van Donselaar E., Riesebosch S., Kuijpers H.J.H., Schipper D., van de Wetering W.J., et al. SARS-CoV-2 productively infects human gut enterocytes. <span><span class="ref-journal">Science. </span>2020;<span class="ref-vol">369</span>:50–54.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7199907/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32358202" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=SARS-CoV-2+productively+infects+human+gut+enterocytes&amp;author=M.M.+Lamers&amp;author=J.+Beumer&amp;author=J.+van+der+Vaart&amp;author=K.+Knoops&amp;author=J.+Puschhof&amp;volume=369&amp;publication_year=2020&amp;pages=50-54&amp;pmid=32358202&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib109">109. <span class="element-citation" id="sref109">Marcello A., Civra A., Milan Bonotto R., Nascimento Alves L., Rajasekharan S., Giacobone C., Caccia C., Cavalli R., Adami M., Brambilla P., Lembo D., Poli G., Leoni V. The cholesterol metabolite 27-hydroxycholesterol inhibits SARS-CoV-2 and is markedly decreased in COVID-19 patients. <span><span class="ref-journal">Redox Biol. </span>2020;<span class="ref-vol">36</span>:101682.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7416714/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32810737" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Redox+Biol.&amp;title=The+cholesterol+metabolite+27-hydroxycholesterol+inhibits+SARS-CoV-2+and+is+markedly+decreased+in+COVID-19+patients&amp;author=A.+Marcello&amp;author=A.+Civra&amp;author=R.+Milan+Bonotto&amp;author=L.+Nascimento+Alves&amp;author=S.+Rajasekharan&amp;volume=36&amp;publication_year=2020&amp;pages=101682&amp;pmid=32810737&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib110">110. <span class="element-citation" id="sref110">Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#x000fc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., M&#x000fc;ller M.A., Drosten C., P&#x000f6;hlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. <span><span class="ref-journal">Cell. </span>2020;<span class="ref-vol">181</span>:271–280.e8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7102627/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32142651" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=SARS-CoV-2+cell+entry+depends+on+ACE2+and+TMPRSS2+and+is+blocked+by+a+clinically+proven+protease+inhibitor&amp;author=M.+Hoffmann&amp;author=H.+Kleine-Weber&amp;author=S.+Schroeder&amp;author=N.+Kr&#x000fc;ger&amp;author=T.+Herrler&amp;volume=181&amp;publication_year=2020&amp;pages=271-280.e8&amp;pmid=32142651&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib111">111. <span class="element-citation" id="sref111">Tang T., Bidon M., Jaimes J.A., Whittaker G.R., Daniel S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. <span><span class="ref-journal">Antiviral Res. </span>2020;<span class="ref-vol">178</span>:104792.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7194977/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/32272173" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Antiviral+Res.&amp;title=Coronavirus+membrane+fusion+mechanism+offers+a+potential+target+for+antiviral+development&amp;author=T.+Tang&amp;author=M.+Bidon&amp;author=J.A.+Jaimes&amp;author=G.R.+Whittaker&amp;author=S.+Daniel&amp;volume=178&amp;publication_year=2020&amp;pages=104792&amp;pmid=32272173&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib112">112. <span class="element-citation" id="sref112">Kwon H.J., Abi-Mosleh L., Wang M.L., Deisenhofer J., Goldstein J.L., Brown M.S., Infante R.E. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. <span><span class="ref-journal">Cell. </span>2009;<span class="ref-vol">137</span>:1213–1224.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2739658/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19563754" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Structure+of+N-terminal+domain+of+NPC1+reveals+distinct+subdomains+for+binding+and+transfer+of+cholesterol&amp;author=H.J.+Kwon&amp;author=L.+Abi-Mosleh&amp;author=M.L.+Wang&amp;author=J.+Deisenhofer&amp;author=J.L.+Goldstein&amp;volume=137&amp;publication_year=2009&amp;pages=1213-1224&amp;pmid=19563754&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib113">113. <span class="element-citation" id="sref113">Yutuc E., Dickson A.L., Pacciarini M., Griffiths L., Baker P.R.S., Connell L., &#x000d6;hman A., Forsgren L., Trupp M., Vilarinho S., Khalil Y., Clayton P.T., Sari S., Dalgic B., H&#x000f6;flinger P., et al. Deep mining of oxysterols and cholestenoic acids in human plasma and cerebrospinal fluid: quantification using isotope dilution mass spectrometry. <span><span class="ref-journal">Anal. Chim. Acta. </span>2021;<span class="ref-vol">1154</span>:338259.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7988461/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33736801" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal.+Chim.+Acta&amp;title=Deep+mining+of+oxysterols+and+cholestenoic+acids+in+human+plasma+and+cerebrospinal+fluid:+quantification+using+isotope+dilution+mass+spectrometry&amp;author=E.+Yutuc&amp;author=A.L.+Dickson&amp;author=M.+Pacciarini&amp;author=L.+Griffiths&amp;author=P.R.S.+Baker&amp;volume=1154&amp;publication_year=2021&amp;pages=338259&amp;pmid=33736801&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib114">114. <span class="element-citation" id="sref114">Dzeletovic S., Breuer O., Lund E., Diczfalusy U. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. <span><span class="ref-journal">Anal. Biochem. </span>1995;<span class="ref-vol">225</span>:73–80.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/7778789" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal.+Biochem.&amp;title=Determination+of+cholesterol+oxidation+products+in+human+plasma+by+isotope+dilution-mass+spectrometry&amp;author=S.+Dzeletovic&amp;author=O.+Breuer&amp;author=E.+Lund&amp;author=U.+Diczfalusy&amp;volume=225&amp;publication_year=1995&amp;pages=73-80&amp;pmid=7778789&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib115">115. <span class="element-citation" id="sref115">Kim H., Lee H.S., Ahn J.H., Hong K.S., Jang J.G., An J., Mun Y.-H., Yoo S.-Y., Choi Y.J., Yun M.-Y., Song G.Y., Joo J., Na D.H., Kim H.N., Park H.H., et al. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm. <span><span class="ref-journal">Nano Today. </span>2021;<span class="ref-vol">38</span>:101149.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8026257/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33846686" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nano+Today&amp;title=Lung-selective+25-hydroxycholesterol+nanotherapeutics+as+a+suppressor+of+COVID-19-associated+cytokine+storm&amp;author=H.+Kim&amp;author=H.S.+Lee&amp;author=J.H.+Ahn&amp;author=K.S.+Hong&amp;author=J.G.+Jang&amp;volume=38&amp;publication_year=2021&amp;pages=101149&amp;pmid=33846686&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib116">116. <span class="element-citation" id="sref116">Ohashi H., Wang F., Stappenbeck F., Tsuchimoto K., Kobayashi C., Saso W., Kataoka M., Yamasaki M., Kuramochi K., Muramatsu M., Suzuki T., Sureau C., Takeda M., Wakita T., Parhami F., et al. Identification of anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) oxysterol derivatives in&#x000a0;vitro. <span><span class="ref-journal">Int. J. Mol. Sci. </span>2021;<span class="ref-vol">22</span>:3163.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8003796/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33808940" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int.+J.+Mol.+Sci.&amp;title=Identification+of+anti-severe+acute+respiratory+syndrome-related+coronavirus+2+(SARS-CoV-2)+oxysterol+derivatives+in&#x000a0;vitro&amp;author=H.+Ohashi&amp;author=F.+Wang&amp;author=F.+Stappenbeck&amp;author=K.+Tsuchimoto&amp;author=C.+Kobayashi&amp;volume=22&amp;publication_year=2021&amp;pages=3163&amp;pmid=33808940&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib117">117. <span class="element-citation" id="sref117">Ghzaiel I., Sassi K., Zarrouk A., Nury T., Ksila M., Leoni V., Bouhaouala-Zahar B., Hammami S., Hammami M., Mackrill J.J., Samadi M., Ghrairi T., Vejux A., Lizard G. 7-Ketocholesterol: effects on viral infections and hypothetical contribution in COVID-19. <span><span class="ref-journal">J.&#x000a0;Steroid Biochem. Mol. Biol. </span>2021;<span class="ref-vol">212</span>:105939.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8188774/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/34118414" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Steroid+Biochem.+Mol.+Biol.&amp;title=7-Ketocholesterol:+effects+on+viral+infections+and+hypothetical+contribution+in+COVID-19&amp;author=I.+Ghzaiel&amp;author=K.+Sassi&amp;author=A.+Zarrouk&amp;author=T.+Nury&amp;author=M.+Ksila&amp;volume=212&amp;publication_year=2021&amp;pages=105939&amp;pmid=34118414&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib118">118. <span class="element-citation" id="sref118">Koarai A., Yanagisawa S., Sugiura H., Ichikawa T., Kikuchi T., Furukawa K., Akamatsu K., Hirano T., Nakanishi M., Matsunaga K., Minakata Y., Ichinose M. 25-Hydroxycholesterol enhances cytokine release and toll-like receptor 3 response in airway epithelial cells. <span><span class="ref-journal">Respir. Res. </span>2012;<span class="ref-vol">13</span>:63.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3460764/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22849850" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Respir.+Res.&amp;title=25-Hydroxycholesterol+enhances+cytokine+release+and+toll-like+receptor+3+response+in+airway+epithelial+cells&amp;author=A.+Koarai&amp;author=S.+Yanagisawa&amp;author=H.+Sugiura&amp;author=T.+Ichikawa&amp;author=T.+Kikuchi&amp;volume=13&amp;publication_year=2012&amp;pages=63&amp;pmid=22849850&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib119">119. <span class="element-citation" id="sref119">Umetani M., Domoto H., Gormley A.K., Yuhanna I.S., Cummins C.L., Javitt N.B., Korach K.S., Shaul P.W., Mangelsdorf D.J. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. <span><span class="ref-journal">Nat. Med. </span>2007;<span class="ref-vol">13</span>:1185–1192.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/17873880" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Med.&amp;title=27-Hydroxycholesterol+is+an+endogenous+SERM+that+inhibits+the+cardiovascular+effects+of+estrogen&amp;author=M.+Umetani&amp;author=H.+Domoto&amp;author=A.K.+Gormley&amp;author=I.S.+Yuhanna&amp;author=C.L.+Cummins&amp;volume=13&amp;publication_year=2007&amp;pages=1185-1192&amp;pmid=17873880&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib120">120. <span class="element-citation" id="sref120">Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bess&#x000e8;de G., Corcos L., Gambert P., N&#x000e9;el D., Lizard G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. <span><span class="ref-journal">Cell Biol. Toxicol. </span>2005;<span class="ref-vol">21</span>:97–114.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/16142584" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Biol.+Toxicol.&amp;title=Comparison+of+the+cytotoxic,+pro-oxidant+and+pro-inflammatory+characteristics+of+different+oxysterols&amp;author=S.+Lemaire-Ewing&amp;author=C.+Prunet&amp;author=T.+Montange&amp;author=A.+Vejux&amp;author=A.+Berthier&amp;volume=21&amp;publication_year=2005&amp;pages=97-114&amp;pmid=16142584&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib121">121. <span class="element-citation" id="sref121">Guillemot-Legris O., Mutemberezi V., Buisseret B., Paquot A., Palmieri V., Bottemanne P., Lemaire J., Rahier J.-F., Alhouayek M., Muccioli G.G. Colitis alters oxysterol metabolism and is affected by 4&#x003b2;-hydroxycholesterol administration. <span><span class="ref-journal">J.&#x000a0;Crohns Colitis. </span>2018;<span class="ref-vol">13</span>:218–229.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30295779" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Crohns+Colitis&amp;title=Colitis+alters+oxysterol+metabolism+and+is+affected+by+4&#x003b2;-hydroxycholesterol+administration&amp;author=O.+Guillemot-Legris&amp;author=V.+Mutemberezi&amp;author=B.+Buisseret&amp;author=A.+Paquot&amp;author=V.+Palmieri&amp;volume=13&amp;publication_year=2018&amp;pages=218-229&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib122">122. <span class="element-citation" id="sref122">Barington L., Wanke F., Niss Arfelt K., Holst P.J., Kurschus F.C., Rosenkilde M.M. EBI2 in splenic and local immune responses and in autoimmunity. <span><span class="ref-journal">J.&#x000a0;Leukoc. Biol. </span>2018;<span class="ref-vol">104</span>:313–322.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29741800" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Leukoc.+Biol.&amp;title=EBI2+in+splenic+and+local+immune+responses+and+in+autoimmunity&amp;author=L.+Barington&amp;author=F.+Wanke&amp;author=K.+Niss+Arfelt&amp;author=P.J.+Holst&amp;author=F.C.+Kurschus&amp;volume=104&amp;publication_year=2018&amp;pages=313-322&amp;pmid=29741800&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib123">123. <span class="element-citation" id="sref123">Gatto D., Paus D., Basten A., Mackay C.R., Brink R. Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. <span><span class="ref-journal">Immunity. </span>2009;<span class="ref-vol">31</span>:259–269.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19615922" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Guidance+of+B+cells+by+the+orphan+G+protein-coupled+receptor+EBI2+shapes+humoral+immune+responses&amp;author=D.+Gatto&amp;author=D.+Paus&amp;author=A.+Basten&amp;author=C.R.+Mackay&amp;author=R.+Brink&amp;volume=31&amp;publication_year=2009&amp;pages=259-269&amp;pmid=19615922&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib124">124. <span class="element-citation" id="sref124">Pereira J.P., Kelly L.M., Xu Y., Cyster J.G. EBI2 mediates B cell segregation between the outer and centre follicle. <span><span class="ref-journal">Nature. </span>2009;<span class="ref-vol">460</span>:1122–1126.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2809436/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/19597478" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=EBI2+mediates+B+cell+segregation+between+the+outer+and+centre+follicle&amp;author=J.P.+Pereira&amp;author=L.M.+Kelly&amp;author=Y.+Xu&amp;author=J.G.+Cyster&amp;volume=460&amp;publication_year=2009&amp;pages=1122-1126&amp;pmid=19597478&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib125">125. <span class="element-citation" id="sref125">Gatto D., Wood K., Caminschi I., Murphy-Durland D., Schofield P., Christ D., Karupiah G., Brink R. The chemotactic receptor EBI2 regulates the homeostasis, localization and immunological function of splenic dendritic cells. <span><span class="ref-journal">Nat. Immunol. </span>2013;<span class="ref-vol">14</span>:446–453.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23502855" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Immunol.&amp;title=The+chemotactic+receptor+EBI2+regulates+the+homeostasis,+localization+and+immunological+function+of+splenic+dendritic+cells&amp;author=D.+Gatto&amp;author=K.+Wood&amp;author=I.+Caminschi&amp;author=D.+Murphy-Durland&amp;author=P.+Schofield&amp;volume=14&amp;publication_year=2013&amp;pages=446-453&amp;pmid=23502855&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib126">126. <span class="element-citation" id="sref126">Yi T., Cyster J.G. EBI2-mediated bridging channel positioning supports splenic dendritic cell homeostasis and particulate antigen capture. <span><span class="ref-journal">Elife. </span>2013;<span class="ref-vol">2</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3654440/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23682316" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Elife&amp;title=EBI2-mediated+bridging+channel+positioning+supports+splenic+dendritic+cell+homeostasis+and+particulate+antigen+capture&amp;author=T.+Yi&amp;author=J.G.+Cyster&amp;volume=2&amp;publication_year=2013&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib127">127. <span class="element-citation" id="sref127">Lu E., Dang E.V., McDonald J.G., Cyster J.G. Distinct oxysterol requirements for positioning na&#x000ef;ve and activated dendritic cells in the spleen. <span><span class="ref-journal">Sci. Immunol. </span>2017;<span class="ref-vol">2</span></span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5646419/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28738017" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Sci.+Immunol.&amp;title=Distinct+oxysterol+requirements+for+positioning+na&#x000ef;ve+and+activated+dendritic+cells+in+the+spleen&amp;author=E.+Lu&amp;author=E.V.+Dang&amp;author=J.G.+McDonald&amp;author=J.G.+Cyster&amp;volume=2&amp;publication_year=2017&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib128">128. <span class="element-citation" id="sref128">Wanke F., Moos S., Croxford A.L., Heinen A.P., Graf S., Kalt B., Tischner D., Zhang J., Christen I., Bruttger J., Yogev N., Tang Y., Zayoud M., Israel N., Karram K., et al. EBI2 is highly expressed in multiple sclerosis lesions and promotes early CNS migration of encephalitogenic CD4 T cells. <span><span class="ref-journal">Cell Rep. </span>2017;<span class="ref-vol">18</span>:1270–1284.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28147280" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep.&amp;title=EBI2+is+highly+expressed+in+multiple+sclerosis+lesions+and+promotes+early+CNS+migration+of+encephalitogenic+CD4+T+cells&amp;author=F.+Wanke&amp;author=S.+Moos&amp;author=A.L.+Croxford&amp;author=A.P.+Heinen&amp;author=S.+Graf&amp;volume=18&amp;publication_year=2017&amp;pages=1270-1284&amp;pmid=28147280&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib129">129. <span class="element-citation" id="sref129">Mutemberezi V., Buisseret B., Masquelier J., Guillemot-Legris O., Alhouayek M., Muccioli G.G. Oxysterol levels and metabolism in the course of neuroinflammation: insights from in&#x000a0;vitro and in&#x000a0;vivo models. <span><span class="ref-journal">J.&#x000a0;Neuroinflammation. </span>2018;<span class="ref-vol">15</span>:74.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5845224/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29523207" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Neuroinflammation&amp;title=Oxysterol+levels+and+metabolism+in+the+course+of+neuroinflammation:+insights+from+in&#x000a0;vitro+and+in&#x000a0;vivo+models&amp;author=V.+Mutemberezi&amp;author=B.+Buisseret&amp;author=J.+Masquelier&amp;author=O.+Guillemot-Legris&amp;author=M.+Alhouayek&amp;volume=15&amp;publication_year=2018&amp;pages=74&amp;pmid=29523207&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib130">130. <span class="element-citation" id="sref130">Wyss A., Raselli T., Perkins N., Ruiz F., Schmelczer G., Klinke G., Moncsek A., Roth R., Spalinger M.R., Hering L., Atrott K., Lang S., Frey-Wagner I., Mertens J.C., Scharl M., et al. The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis. <span><span class="ref-journal">Mucosal Immunol. </span>2019;<span class="ref-vol">12</span>:733–745.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30742043" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mucosal+Immunol.&amp;title=The+EBI2-oxysterol+axis+promotes+the+development+of+intestinal+lymphoid+structures+and+colitis&amp;author=A.+Wyss&amp;author=T.+Raselli&amp;author=N.+Perkins&amp;author=F.+Ruiz&amp;author=G.+Schmelczer&amp;volume=12&amp;publication_year=2019&amp;pages=733-745&amp;pmid=30742043&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib131">131. <span class="element-citation" id="sref131">Raselli T., Hearn T., Wyss A., Atrott K., Peter A., Frey-Wagner I., Spalinger M.R., Maggio E.M., Sailer A.W., Schmitt J., Schreiner P., Moncsek A., Mertens J., Scharl M., Griffiths W.J., et al. Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2019;<span class="ref-vol">60</span>:1270–1283.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6602130/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31113816" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Elevated+oxysterol+levels+in+human+and+mouse+livers+reflect+nonalcoholic+steatohepatitis&amp;author=T.+Raselli&amp;author=T.+Hearn&amp;author=A.+Wyss&amp;author=K.+Atrott&amp;author=A.+Peter&amp;volume=60&amp;publication_year=2019&amp;pages=1270-1283&amp;pmid=31113816&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib132">132. <span class="element-citation" id="sref132">Griffiths W.J., Crick P.J., Meljon A., Theofilopoulos S., Abdel-Khalik J., Yutuc E., Parker J.E., Kelly D.E., Kelly S.L., Arenas E., Wang Y. Additional pathways of sterol metabolism: evidence from analysis of Cyp27a1-/- mouse brain and plasma. <span><span class="ref-journal">Biochim. Biophys. Acta Mol. Cell Biol. Lipids. </span>2019;<span class="ref-vol">1864</span>:191–211.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6327153/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30471425" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta+Mol.+Cell+Biol.+Lipids&amp;title=Additional+pathways+of+sterol+metabolism:+evidence+from+analysis+of+Cyp27a1-/-+mouse+brain+and+plasma&amp;author=W.J.+Griffiths&amp;author=P.J.+Crick&amp;author=A.+Meljon&amp;author=S.+Theofilopoulos&amp;author=J.+Abdel-Khalik&amp;volume=1864&amp;publication_year=2019&amp;pages=191-211&amp;pmid=30471425&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib133">133. <span class="element-citation" id="sref133">H&#x000f6;flinger P., Hauser S., Yutuc E., Hengel H., Griffiths L., Radelfahr F., Howell O.W., Wang Y., Connor S.L., Duell P.B., DeBarber A.E., Martus P., L&#x000fc;tjohann D., Griffiths W.J., Sch&#x000f6;ls L. Metabolic profiling in serum, cerebrospinal fluid and brain of patients with cerebrotendinous xanthomatosis. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2021;<span class="ref-vol">62</span>:100078.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC8135047/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33891937" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Metabolic+profiling+in+serum,+cerebrospinal+fluid+and+brain+of+patients+with+cerebrotendinous+xanthomatosis&amp;author=P.+H&#x000f6;flinger&amp;author=S.+Hauser&amp;author=E.+Yutuc&amp;author=H.+Hengel&amp;author=L.+Griffiths&amp;volume=62&amp;publication_year=2021&amp;pages=100078&amp;pmid=33891937&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib134">134. <span class="element-citation" id="sref134">Stiles A.R., Kozlitina J., Thompson B.M., McDonald J.G., King K.S., Russell D.W. Genetic, anatomic, and clinical determinants of human serum sterol and vitamin D levels. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2014;<span class="ref-vol">111</span>:E4006–E4014.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4183318/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25201972" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Genetic,+anatomic,+and+clinical+determinants+of+human+serum+sterol+and+vitamin+D+levels&amp;author=A.R.+Stiles&amp;author=J.+Kozlitina&amp;author=B.M.+Thompson&amp;author=J.G.+McDonald&amp;author=K.S.+King&amp;volume=111&amp;publication_year=2014&amp;pages=E4006-E4014&amp;pmid=25201972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib135">135. <span class="element-citation" id="sref135">Crick P.J., Griffiths W.J., Zhang J., Beibel M., Abdel-Khalik J., Kuhle J., Sailer A.W., Wang Y. Reduced plasma levels of 25-hydroxycholesterol and increased cerebrospinal fluid levels of bile acid precursors in multiple sclerosis patients. <span><span class="ref-journal">Mol. Neurobiol. </span>2017;<span class="ref-vol">54</span>:8009–8020.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5684259/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27878760" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Neurobiol.&amp;title=Reduced+plasma+levels+of+25-hydroxycholesterol+and+increased+cerebrospinal+fluid+levels+of+bile+acid+precursors+in+multiple+sclerosis+patients&amp;author=P.J.+Crick&amp;author=W.J.+Griffiths&amp;author=J.+Zhang&amp;author=M.+Beibel&amp;author=J.+Abdel-Khalik&amp;volume=54&amp;publication_year=2017&amp;pages=8009-8020&amp;pmid=27878760&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib136">136. <span class="element-citation" id="sref136">Crick P.J., Beckers L., Baes M., Van Veldhoven P.P., Wang Y., Griffiths W.J. The oxysterol and cholestenoic acid profile of mouse cerebrospinal fluid. <span><span class="ref-journal">Steroids. </span>2015;<span class="ref-vol">99</span>:172–177.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4503871/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25759118" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Steroids&amp;title=The+oxysterol+and+cholestenoic+acid+profile+of+mouse+cerebrospinal+fluid&amp;author=P.J.+Crick&amp;author=L.+Beckers&amp;author=M.+Baes&amp;author=P.P.+Van+Veldhoven&amp;author=Y.+Wang&amp;volume=99&amp;publication_year=2015&amp;pages=172-177&amp;pmid=25759118&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib137">137. <span class="element-citation" id="sref137">Yi T., Wang X., Kelly L.M., An J., Xu Y., Sailer A.W., Gustafsson J.A., Russell D.W., Cyster J.G. Oxysterol gradient generation by lymphoid stromal cells guides activated B cell movement during humoral responses. <span><span class="ref-journal">Immunity. </span>2012;<span class="ref-vol">37</span>:535–548.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3465460/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/22999953" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Oxysterol+gradient+generation+by+lymphoid+stromal+cells+guides+activated+B+cell+movement+during+humoral+responses&amp;author=T.+Yi&amp;author=X.+Wang&amp;author=L.M.+Kelly&amp;author=J.+An&amp;author=Y.+Xu&amp;volume=37&amp;publication_year=2012&amp;pages=535-548&amp;pmid=22999953&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib138">138. <span class="element-citation" id="sref138">Clayton P.T. Disorders of bile acid synthesis. <span><span class="ref-journal">J.&#x000a0;Inherit. Metab. Dis. </span>2011;<span class="ref-vol">34</span>:593–604.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21229319" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Inherit.+Metab.+Dis.&amp;title=Disorders+of+bile+acid+synthesis&amp;author=P.T.+Clayton&amp;volume=34&amp;publication_year=2011&amp;pages=593-604&amp;pmid=21229319&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib139">139. <span class="element-citation" id="sref139">Dai D., Mills P.B., Footitt E., Gissen P., McClean P., Stahlschmidt J., Coupry I., Lavie J., Mochel F., Goizet C., Mizuochi T., Kimura A., Nittono H., Schwarz K., Crick P.J., et al. Liver disease in infancy caused by oxysterol 7 alpha-hydroxylase deficiency: successful treatment with chenodeoxycholic acid. <span><span class="ref-journal">J.&#x000a0;Inherit. Metab. Dis. </span>2014;<span class="ref-vol">37</span>:851–861.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24658845" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Inherit.+Metab.+Dis.&amp;title=Liver+disease+in+infancy+caused+by+oxysterol+7+alpha-hydroxylase+deficiency:+successful+treatment+with+chenodeoxycholic+acid&amp;author=D.+Dai&amp;author=P.B.+Mills&amp;author=E.+Footitt&amp;author=P.+Gissen&amp;author=P.+McClean&amp;volume=37&amp;publication_year=2014&amp;pages=851-861&amp;pmid=24658845&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib140">140. <span class="element-citation" id="sref140">Setchell K.D., Schwarz M., O'Connell N.C., Lund E.G., Davis D.L., Lathe R., Thompson H.R., Weslie Tyson R., Sokol R.J., Russell D.W. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. <span><span class="ref-journal">J.&#x000a0;Clin. Invest. </span>1998;<span class="ref-vol">102</span>:1690–1703.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC509117/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/9802883" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Clin.+Invest.&amp;title=Identification+of+a+new+inborn+error+in+bile+acid+synthesis:+mutation+of+the+oxysterol+7alpha-hydroxylase+gene+causes+severe+neonatal+liver+disease&amp;author=K.D.+Setchell&amp;author=M.+Schwarz&amp;author=N.C.+O'Connell&amp;author=E.G.+Lund&amp;author=D.L.+Davis&amp;volume=102&amp;publication_year=1998&amp;pages=1690-1703&amp;pmid=9802883&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib141">141. <span class="element-citation" id="sref141">Birkenbach M., Josefsen K., Yalamanchili R., Lenoir G., Kieff E. Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. <span><span class="ref-journal">J.&#x000a0;Virol. </span>1993;<span class="ref-vol">67</span>:2209–2220.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC240341/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/8383238" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Virol.&amp;title=Epstein-Barr+virus-induced+genes:+first+lymphocyte-specific+G+protein-coupled+peptide+receptors&amp;author=M.+Birkenbach&amp;author=K.+Josefsen&amp;author=R.+Yalamanchili&amp;author=G.+Lenoir&amp;author=E.+Kieff&amp;volume=67&amp;publication_year=1993&amp;pages=2209-2220&amp;pmid=8383238&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib142">142. <span class="element-citation" id="sref142">Emg&#x000e5;rd J., Kammoun H., Garc&#x000ed;a-Cassani B., Chesn&#x000e9; J., Parigi S.M., Jacob J.-M., Cheng H.-W., Evren E., Das S., Czarnewski P., Sleiers N., Melo-Gonzalez F., Kvedaraite E., Svensson M., Scandella E., et al. Oxysterol sensing through the receptor GPR183 promotes the lymphoid-tissue-inducing function of innate lymphoid cells and colonic inflammation. <span><span class="ref-journal">Immunity. </span>2018;<span class="ref-vol">48</span>:120–132.e8.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5772175/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29343433" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Oxysterol+sensing+through+the+receptor+GPR183+promotes+the+lymphoid-tissue-inducing+function+of+innate+lymphoid+cells+and+colonic+inflammation&amp;author=J.+Emg&#x000e5;rd&amp;author=H.+Kammoun&amp;author=B.+Garc&#x000ed;a-Cassani&amp;author=J.+Chesn&#x000e9;&amp;author=S.M.+Parigi&amp;volume=48&amp;publication_year=2018&amp;pages=120-132.e8&amp;pmid=29343433&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib143">143. <span class="element-citation" id="sref143">Chalmin F., Rochemont V., Lippens C., Clottu A., Sailer A.W., Merkler D., Hugues S., Pot C. Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity. <span><span class="ref-journal">J.&#x000a0;Autoimmun. </span>2015;<span class="ref-vol">56</span>:45–55.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25456971" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Autoimmun.&amp;title=Oxysterols+regulate+encephalitogenic+CD4(+)+T+cell+trafficking+during+central+nervous+system+autoimmunity&amp;author=F.+Chalmin&amp;author=V.+Rochemont&amp;author=C.+Lippens&amp;author=A.+Clottu&amp;author=A.W.+Sailer&amp;volume=56&amp;publication_year=2015&amp;pages=45-55&amp;pmid=25456971&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib144">144. <span class="element-citation" id="sref144">Clottu A.S., Mathias A., Sailer A.W., Schluep M., Seebach J.D., Du Pasquier R., Pot C. EBI2 expression and function: robust in memory lymphocytes and increased by natalizumab in multiple sclerosis. <span><span class="ref-journal">Cell Rep. </span>2017;<span class="ref-vol">18</span>:213–224.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/28052250" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Rep.&amp;title=EBI2+expression+and+function:+robust+in+memory+lymphocytes+and+increased+by+natalizumab+in+multiple+sclerosis&amp;author=A.S.+Clottu&amp;author=A.+Mathias&amp;author=A.W.+Sailer&amp;author=M.+Schluep&amp;author=J.D.+Seebach&amp;volume=18&amp;publication_year=2017&amp;pages=213-224&amp;pmid=28052250&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib145">145. <span class="element-citation" id="sref145">Rutkowska A., Preuss I., Gessier F., Sailer A.W., Dev K.K. EBI2 regulates intracellular signaling and migration in human astrocyte. <span><span class="ref-journal">Glia. </span>2015;<span class="ref-vol">63</span>:341–351.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25297897" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Glia&amp;title=EBI2+regulates+intracellular+signaling+and+migration+in+human+astrocyte&amp;author=A.+Rutkowska&amp;author=I.+Preuss&amp;author=F.+Gessier&amp;author=A.W.+Sailer&amp;author=K.K.+Dev&amp;volume=63&amp;publication_year=2015&amp;pages=341-351&amp;pmid=25297897&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib146">146. <span class="element-citation" id="sref146">Preuss I., Ludwig M.G., Baumgarten B., Bassilana F., Gessier F., Seuwen K., Sailer A.W. Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages. <span><span class="ref-journal">Biochem. Biophys. Res. Commun. </span>2014;<span class="ref-vol">446</span>:663–668.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24480442" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Biophys.+Res.+Commun.&amp;title=Transcriptional+regulation+and+functional+characterization+of+the+oxysterol/EBI2+system+in+primary+human+macrophages&amp;author=I.+Preuss&amp;author=M.G.+Ludwig&amp;author=B.+Baumgarten&amp;author=F.+Bassilana&amp;author=F.+Gessier&amp;volume=446&amp;publication_year=2014&amp;pages=663-668&amp;pmid=24480442&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib147">147. <span class="element-citation" id="sref147">Serafini B., Rosicarelli B., Veroni C., Zhou L., Reali C., Aloisi F. RORgammat expression and lymphoid neogenesis in the brain of patients with secondary progressive multiple sclerosis. <span><span class="ref-journal">J.&#x000a0;Neuropathol. Exp. Neurol. </span>2016;<span class="ref-vol">75</span>:877–888.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/27413074" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Neuropathol.+Exp.+Neurol.&amp;title=RORgammat+expression+and+lymphoid+neogenesis+in+the+brain+of+patients+with+secondary+progressive+multiple+sclerosis&amp;author=B.+Serafini&amp;author=B.+Rosicarelli&amp;author=C.+Veroni&amp;author=L.+Zhou&amp;author=C.+Reali&amp;volume=75&amp;publication_year=2016&amp;pages=877-888&amp;pmid=27413074&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib148">148. <span class="element-citation" id="sref148">Wang Y., Kumar N., Crumbley C., Griffin P.R., Burris T.P. A&#x000a0;second class of nuclear receptors for oxysterols: regulation of RORalpha and RORgamma activity by 24S-hydroxycholesterol (cerebrosterol) <span><span class="ref-journal">Biochim. Biophys. Acta. </span>2010;<span class="ref-vol">1801</span>:917–923.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2886165/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20211758" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochim.+Biophys.+Acta&amp;title=A&#x000a0;second+class+of+nuclear+receptors+for+oxysterols:+regulation+of+RORalpha+and+RORgamma+activity+by+24S-hydroxycholesterol+(cerebrosterol)&amp;author=Y.+Wang&amp;author=N.+Kumar&amp;author=C.+Crumbley&amp;author=P.R.+Griffin&amp;author=T.P.+Burris&amp;volume=1801&amp;publication_year=2010&amp;pages=917-923&amp;pmid=20211758&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib149">149. <span class="element-citation" id="sref149">Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. <span><span class="ref-journal">Annu. Rev. Biochem. </span>2003;<span class="ref-vol">72</span>:137–174.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/12543708" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu.+Rev.+Biochem.&amp;title=The+enzymes,+regulation,+and+genetics+of+bile+acid+synthesis&amp;author=D.W.+Russell&amp;volume=72&amp;publication_year=2003&amp;pages=137-174&amp;pmid=12543708&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib150">150. <span class="element-citation" id="sref150">Bjorkhem I., Diczfalusy U., Lovgren-Sandblom A., Starck L., Jonsson M., Tallman K., Schirmer H., Ousager L.B., Crick P.J., Wang Y., Griffiths W.J., Guengerich F.P. On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2014;<span class="ref-vol">55</span>:1165–1172.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4031947/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24771866" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=On+the+formation+of+7-ketocholesterol+from+7-dehydrocholesterol+in+patients+with+CTX+and+SLO&amp;author=I.+Bjorkhem&amp;author=U.+Diczfalusy&amp;author=A.+Lovgren-Sandblom&amp;author=L.+Starck&amp;author=M.+Jonsson&amp;volume=55&amp;publication_year=2014&amp;pages=1165-1172&amp;pmid=24771866&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib151">151. <span class="element-citation" id="sref151">Shinkyo R., Xu L., Tallman K.A., Cheng Q., Porter N.A., Guengerich F.P. Conversion of 7-dehydrocholesterol to 7-ketocholesterol is catalyzed by human cytochrome P450 7A1 and occurs by direct oxidation without an epoxide intermediate. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2011;<span class="ref-vol">286</span>:33021–33028.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3190903/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/21813643" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Conversion+of+7-dehydrocholesterol+to+7-ketocholesterol+is+catalyzed+by+human+cytochrome+P450+7A1+and+occurs+by+direct+oxidation+without+an+epoxide+intermediate&amp;author=R.+Shinkyo&amp;author=L.+Xu&amp;author=K.A.+Tallman&amp;author=Q.+Cheng&amp;author=N.A.+Porter&amp;volume=286&amp;publication_year=2011&amp;pages=33021-33028&amp;pmid=21813643&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib152">152. <span class="element-citation" id="sref152">Schweizer R.A., Zurcher M., Balazs Z., Dick B., Odermatt A. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. <span><span class="ref-journal">J.&#x000a0;Biol. Chem. </span>2004;<span class="ref-vol">279</span>:18415–18424.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/14973125" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Biol.+Chem.&amp;title=Rapid+hepatic+metabolism+of+7-ketocholesterol+by+11beta-hydroxysteroid+dehydrogenase+type+1:+species-specific+differences+between+the+rat,+human,+and+hamster+enzyme&amp;author=R.A.+Schweizer&amp;author=M.+Zurcher&amp;author=Z.+Balazs&amp;author=B.+Dick&amp;author=A.+Odermatt&amp;volume=279&amp;publication_year=2004&amp;pages=18415-18424&amp;pmid=14973125&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib153">153. <span class="element-citation" id="sref153">Hult M., Elleby B., Shafqat N., Svensson S., Rane A., Jornvall H., Abrahmsen L., Oppermann U. Human and rodent type 1 11beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. <span><span class="ref-journal">Cell. Mol. Life Sci. </span>2004;<span class="ref-vol">61</span>:992–999.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/15095019" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell.+Mol.+Life+Sci.&amp;title=Human+and+rodent+type+1+11beta-hydroxysteroid+dehydrogenases+are+7beta-hydroxycholesterol+dehydrogenases+involved+in+oxysterol+metabolism&amp;author=M.+Hult&amp;author=B.+Elleby&amp;author=N.+Shafqat&amp;author=S.+Svensson&amp;author=A.+Rane&amp;volume=61&amp;publication_year=2004&amp;pages=992-999&amp;pmid=15095019&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib154">154. <span class="element-citation" id="sref154">Mitic T., Shave S., Semjonous N., McNae I., Cobice D.F., Lavery G.G., Webster S.P., Hadoke P.W., Walker B.R., Andrew R. 11beta-Hydroxysteroid dehydrogenase type 1 contributes to the balance between 7-keto- and 7-hydroxy-oxysterols in&#x000a0;vivo. <span><span class="ref-journal">Biochem. Pharmacol. </span>2013;<span class="ref-vol">86</span>:146–153.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3694296/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/23415904" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem.+Pharmacol.&amp;title=11beta-Hydroxysteroid+dehydrogenase+type+1+contributes+to+the+balance+between+7-keto-+and+7-hydroxy-oxysterols+in&#x000a0;vivo&amp;author=T.+Mitic&amp;author=S.+Shave&amp;author=N.+Semjonous&amp;author=I.+McNae&amp;author=D.F.+Cobice&amp;volume=86&amp;publication_year=2013&amp;pages=146-153&amp;pmid=23415904&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib155">155. <span class="element-citation" id="sref155">Abdel-Khalik J., Hearn T., Dickson A.L., Crick P.J., Yutuc E., Austin-Muttitt K., Bigger B.W., Morris A.A., Shackleton C.H., Clayton P.T., Iida T., Sircar R., Rohatgi R., Marschall H.U., Sjovall J., et al. Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: potential importance of pathway intermediates. <span><span class="ref-journal">J.&#x000a0;Steroid Biochem. Mol. Biol. </span>2020;<span class="ref-vol">206</span>:105794.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7816163/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/33246156" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Steroid+Biochem.+Mol.+Biol.&amp;title=Bile+acid+biosynthesis+in+Smith-Lemli-Opitz+syndrome+bypassing+cholesterol:+potential+importance+of+pathway+intermediates&amp;author=J.+Abdel-Khalik&amp;author=T.+Hearn&amp;author=A.L.+Dickson&amp;author=P.J.+Crick&amp;author=E.+Yutuc&amp;volume=206&amp;publication_year=2020&amp;pages=105794&amp;pmid=33246156&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib156">156. <span class="element-citation" id="sref156">Jin L., Martynowski D., Zheng S., Wada T., Xie W., Li Y. Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor RORgamma. <span><span class="ref-journal">Mol. Endocrinol. </span>2010;<span class="ref-vol">24</span>:923–929.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2870936/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/20203100" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol.+Endocrinol.&amp;title=Structural+basis+for+hydroxycholesterols+as+natural+ligands+of+orphan+nuclear+receptor+RORgamma&amp;author=L.+Jin&amp;author=D.+Martynowski&amp;author=S.+Zheng&amp;author=T.+Wada&amp;author=W.+Xie&amp;volume=24&amp;publication_year=2010&amp;pages=923-929&amp;pmid=20203100&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib157">157. <span class="element-citation" id="sref157">Soroosh P., Wu J., Xue X., Song J., Sutton S.W., Sablad M., Yu J., Nelen M.I., Liu X., Castro G., Luna R., Crawford S., Banie H., Dandridge R.A., Deng X., et al. Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation. <span><span class="ref-journal">Proc. Natl. Acad. Sci. U. S. A. </span>2014;<span class="ref-vol">111</span>:12163–12168.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4143045/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25092323" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc.+Natl.+Acad.+Sci.+U.+S.+A.&amp;title=Oxysterols+are+agonist+ligands+of+RORgammat+and+drive+Th17+cell+differentiation&amp;author=P.+Soroosh&amp;author=J.+Wu&amp;author=X.+Xue&amp;author=J.+Song&amp;author=S.W.+Sutton&amp;volume=111&amp;publication_year=2014&amp;pages=12163-12168&amp;pmid=25092323&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib158">158. <span class="element-citation" id="sref158">Griffiths W.J., Gilmore I., Yutuc E., Abdel-Khalik J., Crick P.J., Hearn T., Dickson A., Bigger B.W., Wu T.H., Goenka A., Ghosh A., Jones S.A., Wang Y. Identification of unusual oxysterols and bile acids with 7-oxo or 3beta,5alpha,6beta-trihydroxy functions in human plasma by charge-tagging mass spectrometry with multistage fragmentation. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2018;<span class="ref-vol">59</span>:1058–1070.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC5983402/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/29626102" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=Identification+of+unusual+oxysterols+and+bile+acids+with+7-oxo+or+3beta,5alpha,6beta-trihydroxy+functions+in+human+plasma+by+charge-tagging+mass+spectrometry+with+multistage+fragmentation&amp;author=W.J.+Griffiths&amp;author=I.+Gilmore&amp;author=E.+Yutuc&amp;author=J.+Abdel-Khalik&amp;author=P.J.+Crick&amp;volume=59&amp;publication_year=2018&amp;pages=1058-1070&amp;pmid=29626102&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib159">159. <span class="element-citation" id="sref159">Beck K.R., Inderbinen S.G., Kanagaratnam S., Kratschmar D.V., Jetten A.M., Yamaguchi H., Odermatt A. 11beta-Hydroxysteroid dehydrogenases control access of 7beta,27-dihydroxycholesterol to retinoid-related orphan receptor gamma. <span><span class="ref-journal">J.&#x000a0;Lipid Res. </span>2019;<span class="ref-vol">60</span>:1535–1546.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6718442/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31273032" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Lipid+Res.&amp;title=11beta-Hydroxysteroid+dehydrogenases+control+access+of+7beta,27-dihydroxycholesterol+to+retinoid-related+orphan+receptor+gamma&amp;author=K.R.+Beck&amp;author=S.G.+Inderbinen&amp;author=S.+Kanagaratnam&amp;author=D.V.+Kratschmar&amp;author=A.M.+Jetten&amp;volume=60&amp;publication_year=2019&amp;pages=1535-1546&amp;pmid=31273032&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib160">160. <span class="element-citation" id="sref160">Lyons M.A., Brown A.J. Metabolism of an oxysterol, 7-ketocholesterol, by sterol 27-hydroxylase in HepG2 cells. <span><span class="ref-journal">Lipids. </span>2001;<span class="ref-vol">36</span>:701–711.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/11521968" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lipids&amp;title=Metabolism+of+an+oxysterol,+7-ketocholesterol,+by+sterol+27-hydroxylase+in+HepG2+cells&amp;author=M.A.+Lyons&amp;author=A.J.+Brown&amp;volume=36&amp;publication_year=2001&amp;pages=701-711&amp;pmid=11521968&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib161">161. <span class="element-citation" id="sref161">Beck K.R., Kanagaratnam S., Kratschmar D.V., Birk J., Yamaguchi H., Sailer A.W., Seuwen K., Odermatt A. Enzymatic interconversion of the oxysterols 7beta,25-dihydroxycholesterol and 7-keto,25-hydroxycholesterol by 11beta-hydroxysteroid dehydrogenase type 1 and 2. <span><span class="ref-journal">J.&#x000a0;Steroid Biochem. Mol. Biol. </span>2019;<span class="ref-vol">190</span>:19–28.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/30902677" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J.&#x000a0;Steroid+Biochem.+Mol.+Biol.&amp;title=Enzymatic+interconversion+of+the+oxysterols+7beta,25-dihydroxycholesterol+and+7-keto,25-hydroxycholesterol+by+11beta-hydroxysteroid+dehydrogenase+type+1+and+2&amp;author=K.R.+Beck&amp;author=S.+Kanagaratnam&amp;author=D.V.+Kratschmar&amp;author=J.+Birk&amp;author=H.+Yamaguchi&amp;volume=190&amp;publication_year=2019&amp;pages=19-28&amp;pmid=30902677&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib162">162. <span class="element-citation" id="sref162">Hu X., Wang Y., Hao L.Y., Liu X., Lesch C.A., Sanchez B.M., Wendling J.M., Morgan R.W., Aicher T.D., Carter L.L., Toogood P.L., Glick G.D. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORgamma agonists. <span><span class="ref-journal">Nat. Chem. Biol. </span>2015;<span class="ref-vol">11</span>:141–147.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25558972" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat.+Chem.+Biol.&amp;title=Sterol+metabolism+controls+T(H)17+differentiation+by+generating+endogenous+RORgamma+agonists&amp;author=X.+Hu&amp;author=Y.+Wang&amp;author=L.Y.+Hao&amp;author=X.+Liu&amp;author=C.A.+Lesch&amp;volume=11&amp;publication_year=2015&amp;pages=141-147&amp;pmid=25558972&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib163">163. <span class="element-citation" id="sref163">Santori F.R., Huang P., van de Pavert S.A., Douglass E.F., Jr., Leaver D.J., Haubrich B.A., Keber R., Lorbek G., Konijn T., Rosales B.N., Rozman D., Horvat S., Rahier A., Mebius R.E., Rastinejad F., et al. Identification of natural RORgamma ligands that regulate the development of lymphoid cells. <span><span class="ref-journal">Cell Metab. </span>2015;<span class="ref-vol">21</span>:286–297.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4317570/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25651181" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Metab.&amp;title=Identification+of+natural+RORgamma+ligands+that+regulate+the+development+of+lymphoid+cells&amp;author=F.R.+Santori&amp;author=P.+Huang&amp;author=S.A.+van+de+Pavert&amp;author=E.F.+Douglass&amp;author=D.J.+Leaver&amp;volume=21&amp;publication_year=2015&amp;pages=286-297&amp;pmid=25651181&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib164">164. <span class="element-citation" id="sref164">Koscielny G., Yaikhom G., Iyer V., Meehan T.F., Morgan H., Atienza-Herrero J., Blake A., Chen C.-K., Easty R., Di Fenza A., Fiegel T., Grifiths M., Horne A., Karp N.A., Kurbatova N., et al. The International Mouse Phenotyping Consortium Web Portal, a unified point of access for knockout mice and related phenotyping data. <span><span class="ref-journal">Nucleic Acids Res. </span>2013;<span class="ref-vol">42</span>:D802–D809.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC3964955/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/24194600" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic+Acids+Res.&amp;title=The+International+Mouse+Phenotyping+Consortium+Web+Portal,+a+unified+point+of+access+for+knockout+mice+and+related+phenotyping+data&amp;author=G.+Koscielny&amp;author=G.+Yaikhom&amp;author=V.+Iyer&amp;author=T.F.+Meehan&amp;author=H.+Morgan&amp;volume=42&amp;publication_year=2013&amp;pages=D802-D809&amp;pmid=24194600&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib165">165. <span class="element-citation" id="sref165">Uhlen M., Fagerberg L., Hallstrom B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson A., Kampf C., Sjostedt E., Asplund A., Olsson I., Edlund K., Lundberg E., Navani S., Szigyarto C.A., et al. Proteomics. Tissue-based map of the human proteome. <span><span class="ref-journal">Science. </span>2015;<span class="ref-vol">347</span>:1260419.</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/25613900" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Proteomics.+Tissue-based+map+of+the+human+proteome&amp;author=M.+Uhlen&amp;author=L.+Fagerberg&amp;author=B.M.+Hallstrom&amp;author=C.+Lindskog&amp;author=P.+Oksvold&amp;volume=347&amp;publication_year=2015&amp;pages=1260419&amp;pmid=25613900&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="bib166">166. <span class="element-citation" id="sref166">Meljon A., Crick P.J., Yutuc E., Yau J.L., Seckl J.R., Theofilopoulos S., Arenas E., Wang Y., Griffiths W.J. Mining for oxysterols in Cyp7b1(-/-) mouse brain and plasma: relevance to spastic paraplegia type 5. <span><span class="ref-journal">Biomolecules. </span>2019;<span class="ref-vol">9</span>:149.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC6523844/">PMC free article</a>]</span> [<a href="https://pubmed.ncbi.nlm.nih.gov/31013940" ref="reftype=pubmed&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biomolecules&amp;title=Mining+for+oxysterols+in+Cyp7b1(-/-)+mouse+brain+and+plasma:+relevance+to+spastic+paraplegia+type+5&amp;author=A.+Meljon&amp;author=P.J.+Crick&amp;author=E.+Yutuc&amp;author=J.L.+Yau&amp;author=J.R.+Seckl&amp;volume=9&amp;publication_year=2019&amp;pages=149&amp;" target="_blank" rel="noopener noreferrer" ref="reftype=other&amp;article-id=8953665&amp;issue-id=403962&amp;journal-id=568&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr /><div class="half_rhythm">Articles from <span class="acknowledgment-journal-title">Journal of Lipid Research</span> are provided here courtesy of <strong>American Society for Biochemistry and Molecular Biology</strong></div><hr /></div><div id="body-link-poppers"><span></span></div></div>
            
        </section>
    </article>
    <aside class="usa-width-one-fourth usa-layout-docs-sidenav pmc-sidebar">
         
  

<div class="scroller">

    
        <section>
                <h6>Other Formats</h6>
                <ul class="pmc-sidebar__formats">
                  <li class="pdf-link other_item"><a href="/pmc/articles/PMC8953665/pdf/main.pdf" class="int-view">PDF (1.9M)</a></li>
                </ul>
        </section>
    
    <section>
        <h6>Actions</h6>
        <ul class="pmc-sidebar__actions">
            <li>
                <button role="button" class="citation-button citation-dialog-trigger ctxp"
                        aria-label="Open dialog with citation text in different styles" data-ga-category="save_share" data-ga-action="cite" data-ga-label="open"
                        data-all-citations-url="/pmc/resources/citations/8953665/"
                        data-citation-style="nlm"
                        data-download-format-link="/pmc/resources/citations/8953665/export/"
                >
                    <span class="button-label">Cite</span>
                </button>
            </li>
            <li>
                
                    

<link type="text/css" href="ncbi-overlay-block/src/overlay-block.css">
<div class="collections-button-container" data-article-id="8953665" data-article-db="pmc">
  <button class="collections-button collections-dialog-trigger"
          aria-label="Save article in MyNCBI collections."
          data-ga-category="collections_button"
          data-ga-action="click"
          data-ga-label="collections_button"
          data-collections-open-dialog-enabled="false"
          data-collections-open-dialog-url="https://www.ncbi.nlm.nih.gov/account?back_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8953665%2F%23open-collections-dialog"
          data-in-collections="false">
      <span class="button-label">Collections</span>
  </button>
  <div class="overlay" role="dialog">
  <div id="collections-action-dialog"
       class="dialog collections-dialog"
       aria-hidden="true">
    <div class="title">Add to Collections</div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/pmc/list-existing-collections/"
      data-add-to-existing-collection-url="/pmc/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/pmc/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

  <input type="hidden" name="csrfmiddlewaretoken" value="DF653QqqEB4boJpTnkCaqE0Jowe5i0cF5qhVp28FBS5iiBfistRfoTENoaF7Y5cg">

  

  <div class="choice-group" role="radiogroup">
    <ul class="radio-group-items">
      <li>
        <input type="radio"
               id="collections-action-dialog-new-aside "
               class="collections-new"
               name="collections"
               value="new"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_new">
        <label for="collections-action-dialog-new-aside ">Create a new collection</label>
      </li>
      <li>
        <input type="radio"
               id="collections-action-dialog-existing-aside "
               class="collections-existing"
               name="collections"
               value="existing"
               checked="true"
               data-ga-category="collections_button"
               data-ga-action="click"
               data-ga-label="collections_radio_existing">
        <label for="collections-action-dialog-existing-aside ">Add to an existing collection</label>
      </li>
    </ul>
  </div>

  <div class="controls-wrapper">
    <div class="action-panel-control-wrap new-collections-controls">
      <label for="collections-action-dialog-add-to-new" class="action-panel-label required-field-asterisk">
        Name your collection:
      </label>
      <input
        type="text"
        name="add-to-new-collection"
        id="collections-action-dialog-add-to-new"
        class="collections-action-add-to-new"
        pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
        maxlength=""
        data-ga-category="collections_button"
        data-ga-action="create_collection"
        data-ga-label="non_favorties_collection">
      <div class="collections-new-name-too-long usa-input-error-message selection-validation-message">
        Name must be less than  characters
      </div>
    </div>
    <div class="action-panel-control-wrap existing-collections-controls">
      <label for="collections-action-dialog-add-to-existing" class="action-panel-label">
        Choose a collection:
      </label>
      <select id="collections-action-dialog-add-to-existing"
              class="action-panel-selector collections-action-add-to-existing"
              data-ga-category="collections_button"
              data-ga-action="select_collection"
              data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
      </select>
      <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
        Unable to load your collection due to an error<br>
        <a href="#">Please try again</a>
      </div>
    </div>
  </div>

  <div class="action-panel-actions">
    <button class="action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
      Add
    </button>
    <button class="action-panel-cancel"
            aria-label="Close 'Add to Collections' panel"
            ref="linksrc=close_collections_panel"
            aria-controls="collections-action-panel"
            aria-expanded="false"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="cancel">
      Cancel
    </button>
  </div>
</form>
    </div>
  </div>
</div>
</div>
                
            </li>

        </ul>
    </section>
    
        <section class="social-sharing">
            <h6>Share</h6>
            <ul class="pmc-sidebar__share">
                <li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8953665%2F&amp;text=Cholesterol%20metabolism%3A%20from%20lipidomics%20to%20immunology" alt="Share on Twitter"><i class="fa fa-twitter fa-stack-1x">&#160;</i></a></li> 
<li><a class="fa-stack fa-lg" target="_blank" rel="noopener noreferrer" role="button" href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8953665%2F" alt="Share on Facebook"><i class="fa fa-facebook fa-stack-1x">&#160;</i></a></li>
                <li>
                    <div class="share-permalink">
                        <button class="trigger"  alt="Show article permalink" aria-expanded="false" aria-haspopup="true">
                            <i class="fa-stack fa-lg" >
                                <i class="fa fa-link fa-stack-1x">&nbsp;</i>
                            </i>
                        </button>
                        <div class="dropdown dropdown-container" hidden>
                              <div class="title">
                                Permalink
                              </div>
                              <div class="content">
                                  <input type="text" class="permalink-text" value="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953665/" aria-label="Article permalink"><button class="permalink-copy-button usa-button-primary" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                                      <span class="button-title">Copy</span>
                                  </button>
                              </div>
                        </div>
                    </div>
                </li>
            </ul>
        </section>
    
    <section>
        <h6>RESOURCES</h6>
        <ul class="pmc-sidebar__resources">
        
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_similar_articles"
                            data-ga-label="/pmc/articles/PMC8953665/"
                            class="usa-accordion-button"
                            aria-controls="similar-articles-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_similar_articles"
                            data-action-close="close_similar_articles"
                    >
                        Similar articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/similar-article-links/34953867/"
                            

                         class="usa-accordion-content pmc-sidebar__resources--citations" id="similar-articles-accordion-aside" aria-hidden="true">
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_cited_by"
                            data-ga-label="/pmc/articles/PMC8953665/"
                            class="usa-accordion-button"
                            aria-controls="cited-by-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_cited_by"
                            data-action-close="close_cited_by"
                    >
                        Cited by other articles
                    </button>
                    <div
                            
                                data-source-url="/pmc/resources/cited-by-links/34953867/"
                            
                            class="usa-accordion-content pmc-sidebar__resources--citations"
                            id="cited-by-accordion-aside"
                            aria-hidden="true"
                    >
                        
                    </div>
                </div>
            </li>
            <li>
                <div class="usa-accordion">
                    <button
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/pmc/articles/PMC8953665/"
                            class="usa-accordion-button"
                            aria-controls="links-accordion-aside"
                            aria-expanded="false"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                    >
                        Links to NCBI Databases
                    </button>
                    <div data-source-url="/pmc/resources/db-links/8953665/" class="usa-accordion-content" id="links-accordion-aside" aria-hidden="true"></div>
                </div>
            </li>

            
        
        </ul>
    </section>

 </div>

    </aside>
</main>

    <div class="overlay" role="dialog" aria-label="Citation Dialog">
  <div class="dialog citation-dialog">
    <button class="close-overlay" tabindex="1">[x]</button>
    <div class="title">Cite</div>
    <div class="citation-text-block">
  <div class="citation-text"></div>
  <div class="citation-actions">
    <button
      class="copy-button dialog-focus"
      data-ga-category="save_share"
      data-ga-action="cite"
      data-ga-label="copy"
      tabindex="2">
      Copy
    </button>

      <a href="#"
              class="export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
          <span class="title">Download .nbib</span>
          <span class="title-mobile">.nbib</span>
      </a>


    

<div class="citation-style-selector-wrapper">
  <label class="selector-label">Format:</label>
  <select aria-label="Format" class="citation-style-selector" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
  </div>
</div>
  </div>
</div>

     <!-- ========== BEGIN FOOTER ========== -->
 <footer>
      <section class="icon-section">
        <div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
        <div class="grid-container container">
          <div class="icon-section_container">
            <a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11 {
                      fill: #737373;
                    }
                  </style>
                </defs>
                <title>Twitter</title>
                <path class="cls-11"
                  d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>Facebook</title>
                <path class="cls-11"
                  d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_linkedin"
              href="https://www.linkedin.com/company/ncbinlm"
              aria-label="LinkedIn"><svg data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <title>LinkedIn</title>
                <path class="cls-11"
                  d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
                </path>
              </svg></a>
            <a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg
                data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 300 300">
                <defs>
                  <style>
                    .cls-11,
                    .cls-12 {
                      fill: #737373;
                    }

                    .cls-11 {
                      fill-rule: evenodd;
                    }
                  </style>
                </defs>
                <title>GitHub</title>
                <path class="cls-11"
                  d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
                </path>
                <path class="cls-12"
                  d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
                </path>
                <path class="cls-12"
                  d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
                </path>
                <path class="cls-12"
                  d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
                <path class="cls-12"
                  d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
                </path>
                <path class="cls-12"
                  d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
                </path>
                <path class="cls-12"
                  d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
                </path>
                <path class="cls-12"
                  d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
              </svg></a>
            <a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
              <svg id="Layer_1" data-name="Layer 1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 40"><defs><style>.cls-1{fill:#737373;}</style></defs><path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"/></svg>
            </a>
          </div>
        </div>
      </section>

      <section class="container-fluid bg-primary">
        <div class="container pt-5">
          <div class="row mt-3">
            <div class="col-lg-3 col-12">
              <p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
              <ul class="list-inline social_media">
                <li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st20 {
                          fill: #FFFFFF;
                        }

                        .st30 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Twitter</title>
                      <g>
                        <g>
                          <g>
                            <path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7
                                                c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116
                                                c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3
                                                c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6
                                                C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
                          </g>
                        </g>
                        <circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
                      </g>
                    </svg></a></li>
                <li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine"
                    aria-label="Facebook" rel="noopener noreferrer" target="_blank">
                    <svg version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px"
                      y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <style type="text/css">
                        .st10 {
                          fill: #FFFFFF;
                        }

                        .st110 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }
                      </style>
                      <title>SM-Facebook</title>
                      <g>
                        <g>
                          <path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9
                                                      v67.5H135v-67.5h21.7L159,99.1z"></path>
                        </g>
                      </g>
                      <circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
                    </svg>
                  </a></li>
                <li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube"
                    target="_blank" rel="noopener noreferrer"><svg version="1.1" xmlns="http://www.w3.org/2000/svg"
                      xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 0 249 249"
                      style="enable-background:new 0 0 249 249;" xml:space="preserve">
                      <title>SM-Youtube</title>
                      <style type="text/css">
                        .st4 {
                          fill: none;
                          stroke: #FFFFFF;
                          stroke-width: 8;
                          stroke-miterlimit: 10;
                        }

                        .st5 {
                          fill: #FFFFFF;
                        }
                      </style>
                      <circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
                      <g transform="translate(0,-952.36218)">
                        <path class="st5"
                          d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7
                                            v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
                      </g>
                    </svg></a></li>
              </ul>
            </div>
            <div class="col-lg-3 col-12">
              <p class="address_footer text-white">National Library of Medicine<br>
                <a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323"
                  class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br>
                  Bethesda, MD 20894</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br>
                <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office"
                  class="text-white">FOIA</a><br>
                <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
            </div>
            <div class="col-lg-3 col-12 centered-lg">
              <p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br>
                <a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br>
                <a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
            </div>
          </div>
          <div class="row">
            <div class="col-lg-12 centered-lg">
              <nav class="bottom-links">
                <ul class="mt-3">
                  <li>
                    <a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
                  </li>
                  <li>
                    <a class="text-white"
                  href="https://www.nih.gov/">NIH</a>
                  </li>
                  <li>
                    <a class="text-white" href="https://www.hhs.gov/">HHS</a>
                  </li>
                  <li>
                    <a
                  class="text-white" href="https://www.usa.gov/">USA.gov</a>
                  </li>
                </ul>
              </nav>
            </div>
          </div>
        </div>
      </section>
    </footer>
 <!-- ========== END FOOTER ========== -->
  <!-- javascript to inject NWDS meta tags. Note: value of nwds_version is updated by "npm version" command -->
 
  <script type="text/javascript">
    var nwds_version = "1.1.9-2";

    var meta_nwds_ver = document.createElement('meta');
    meta_nwds_ver.name = 'ncbi_nwds_ver';
    meta_nwds_ver.content = nwds_version;
    document.getElementsByTagName('head')[0].appendChild(meta_nwds_ver);

    var meta_nwds = document.createElement('meta');
    meta_nwds.name = 'ncbi_nwds';
    meta_nwds.content = 'yes';
    document.getElementsByTagName('head')[0].appendChild(meta_nwds);

	var alertsUrl = "/core/alerts/alerts.js";
	if (typeof ncbiBaseUrl !== 'undefined') {
		alertsUrl = ncbiBaseUrl + alertsUrl;
	}
  </script>



  
    <!-- JavaScript -->
    <script src="/pmc/static/CACHE/js/output.0f72d6a64937.js"></script>
  
  
    <script src="https://code.jquery.com/jquery-3.5.0.min.js"
          integrity="sha256-xNzN2a4ltkB44Mc/Jz3pT4iU1cmeR0FkXs4pru/JxaQ="
          crossorigin="anonymous">
    </script>
    <script>
        var fallbackJquery = "/pmc/static/base/js/jquery-3.5.0.min.js";
        window.jQuery || document.write("<script src=" + fallbackJquery + ">\x3C/script>")
    </script>
  

  <script src="/pmc/static/CACHE/js/output.a212a9fcf845.js"></script>
<script src="/pmc/static/CACHE/js/output.7999321d1aac.js"></script>
<script src="/pmc/static/CACHE/js/output.7ca436b2ea51.js"></script>
<script src="/pmc/static/CACHE/js/output.f8422046fbe0.js"></script>
<script src="/pmc/static/CACHE/js/output.ff40c7d85ff8.js"></script>
<script src="/pmc/static/CACHE/js/output.a6a84a0ad361.js"></script>

<script type="text/javascript" src="/pmc/static/bundles/base/base.038d36e4e31104b40a19.js" ></script>

    <script type="text/javascript">
        if(typeof jQuery !=='undefined') {
            jQuery.migrateMute = true;
        }
    </script>
    <script type="text/javascript" src="https://code.jquery.com/jquery-migrate-1.4.1.js"></script>
    <script type="text/javascript" src="/core/jig/1.15.2/js/jig.nojquery.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/crb.min.js?_=3.18">//</script><script type="text/javascript" src="/corehtml/pmc/js/jactions.min.js?_=3.18">//</script><script type="text/javascript">window.name="mainwindow";</script>

    <script type="text/javascript">var exports = {};</script>
    <script src="/pmc/static/CACHE/js/output.340a3b9cce7f.js"></script>
<script src="/pmc/static/CACHE/js/output.228f96f3298e.js"></script>
    <script type="text/javascript" src="/pmc/static/bundles/article/article.b7dd20e527283dd68f45.js" ></script>
    <script type="text/javascript">
        window.ncbi.pmc.articlePage.init({ pageURL: '/pmc/articles/PMC8953665/', citeCookieName: 'pmc-cf'});
    </script>


  
  
  <script  type="text/javascript" src="https://www.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


  
      
  

</body>
</html>
